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CHAPTER 1 
GENERAL INTRODUCTION 
6 Chapter 1 
In this thesis we present several epidemiological, methodological and clinical studies 
on vasospastic syndromes. The studies were performed in healthy volunteers, in 
patients with Raynaud's phenomenon (RP) and in patients with migraine. 
Vasospastic syndromes 
The precise pathophysiology of the mechanism which causes the characteristic attacks 
of white, blue and red discolorations of the fingers or toes in RP is still unknown. 
In primary RP arterial vasospasm, provoked by cold or emotions, is responsible for 
the discolorations.1 In migraine vasospasm is also an important component of an 
attack. It is still a matter of debate whether this vasospasm is primarily due to 
vascular alterations2 or is secondary to neural disturbances.3 Vasospasm is also known 
to occur in coronary/ pulmonary3 and many other arteries.6 7 ' Moreover, the 
simultaneous presence of migraine or variant angina in patients with primary or 
secondary RP'10 " 12 13 " as well as disturbances in vascular reactivity not restricted 
to a specific vascular bed13 " 17 all suggest that a common systemic factor causing 
vasospasm might be responsible. 
Epidemiology 
The diagnosis RP is only rarely recorded in general practice or in population 
morbidity surveys, indicating that its symptoms are either not often presented to or 
largely underestimated by general practitioners. However, in epidemiological studies 
the prevalence of RP varies from 5% up to 20% in otherwise healthy females." " 
Reported prevalence figures of RP vary largely, depending on the different criteria 
used for the diagnosis, on the local climate and on the composition (for instance with 
regard to age and sex) of the sample group studied. Although apparently the 
complaints of 'dead fingers' are often not serious or alarming enough to seek medical 
attention, the disorder can cause great discomfort in daily life or at work, especially 
in the cold and wet climate of Western Europe. 
Reported prevalence figures of migraine vary from 2 to 25 %."21 n As in RP these 
differences are due to the sex and age composition of the study group, as well as to 
the diagnostic criteria used. Furthermore it is difficult to distinguish migraine from 
other types of headaches. Migraine seems to be part of a heterogeneous spectrum of 
disorders which forms a continuum ranging from tension headache via migraine 
without aura to migraine with aura.23 Although migraine quantitatively comprises a 
minority of these types of headaches, its incapacitating character makes it an 
important disorder. 
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Influence of sex hormones 
In primary RP the female to male ratio ranges between 2:1 and 9:1.24 M In studies on 
peripheral skin blood flow healthy women in the fertile phase of their lives show a 
50% lower skin blood flow when compared with men, whereas no sex difference is 
observed before the menarche and after the menopause.™ " The severity and 
frequency of cold-induced vasospastic attacks* as well as the skin blood flow 
measured29 x vary within the menstrual cycle, although no unequivocal cyclical 
patterns were found. During pregnancy the frequency and the severity of the attacks 
were observed to diminish in some patients.25 Moreover, anecdotal reports suggest 
that oral contraceptives worsen the complaints," n although paradoxically the finger 
blood flow has actually been observed to increase.33 
Migraine is far more common in females than in males, particularly from the onset 
of puberty. A relationship between the complaints of migraine and the menstrual 
cycle, oral contraceptives, pregnancy and menopause has been described.54 35 
All these findings suggest that sex hormones may influence vascular reactivity. 
Unfortunately, there are no studies showing a relation between physiological levels 
of sex hormones and the finger blood flow or the incidence or severity of migraine 
attacks. Moreover, the absence of unequivocal results in the above-mentioned studies 
makes it impossible to identify which of the sex hormones influences vasospasm and 
to what degree. Therefore, controversies still exist about the precise influence of sex 
hormones on the microcirculation and the mechanisms involved. In animal studies an 
influence has been found of both natural and synthetic estrogens, progestagens and 
androgens on the vascular reactivity of different vascular beds.36 
The cutaneous blood flow of the fingers and the response to cold challenge is 
regulated by the sympathetic nervous system, which releases catecholamines that may 
stimulate vasoconstrictive α-adrenoceptors and vasodilating ßj-adrenoceptors. A minor 
disturbance anywhere within the balance between vasoconstriction and vasodilation 
may result in the excessive vasospasm, as already supposed by Maurice Raynaud in 
1862. There are studies that indicate an influence of estrogens on the sympathetic 
nervous system, inducing an up-regulation of (vasoconstrictive) a2-adrenoceptors.37 38 ^ 
A similar influence of the female sex hormones on vascular reactivity by modulation 
of the sympathetic nervous system has been claimed in patients with migraine.40 4142 43 
In conclusion, there are a number of arguments supporting the hypothesis that sex 
hormones exhibit their vasoactive effects by influencing the sympathetic nervous 
system. 
Measurement techniques and provocation tests 
To objectify vasospasm the finger skin blood flow of healthy subjects and of Raynaud 
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patients should be measured. Quantification of peripheral skin blood flow is 
complicated. Under physiological conditions the skin blood flow varies extremely, 
even within very short periods of time. This is probably due to the pronounced 
sensitivity of skin blood vessels to endogenous and exogenous stimuli. Many different 
cold provocation tests are used to investigate vasospasm. Some apply local cold to the 
finger or hand, while others use contralateral or whole body cooling. Also a wide 
variety of measurement techniques is used, like for example the measurement of 
finger skin temperature,44 laser Doppler fluxmetry,45 finger plethysmography46 and 
nailfold dynamic capillary microscopy.47 There is little uniformity both in provocation 
tests and in measurement techniques. Most of the tests are not carefully standardized 
and their reproducibility and diagnostic values have not been stated. 
In brief, in this thesis we try to find answers to the following questions: 
1. What is the prevalence in males and females of both migraine and Raynaud's 
phenomenon? Do these disorders often occur simultaneously? 
2. Do female sex hormones affect these vasospastic complaints? Do sex hormones 
influence the regulation of peripheral blood flow? And if so, which of the sex 
hormones could be responsible? 
OUTLINE OF THE THESIS 
The first part of this thesis evaluates epidemiological aspects of RP and migraine. To 
assess the influence of sex and of the female sex hormonal status on vasospastic 
complaints, we investigated the prevalence in males and females, and the influence 
of respectively menarche, menopause, pregnancy, the use of oral contraceptives and 
the menstrual cycle phase. 
In Chapter 2 we describe the prevalence of migraine in general practice, as 
registered in the Continuous Morbidity Registration (CMR) project of Nijmegen48 in 
accordance with the criteria of the International Classification of Health Problems in 
Primary Care. The combined presence of migraine and RP and the influence of the 
sex hormonal status on symptoms in women were investigated. A group of subjects 
with (non-vasospastic) tension headaches were selected from the same CMR 
population and were compared with the migraine group. 
Chapter 3 describes the prevalence of RP in males and females, using several 
different criteria for its diagnosis. Furthermore, the combined presence of RP and 
migraine was assessed again. Since RP is not registered as a diagnosis in the CMR, 
a large group of patients visiting their general practitioners were investigated. The 
influence of their sex hormonal status on the subjective complaints of RP in patients 
attending the out-patient clinic are evaluated in Chapter 4. 
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The second part of this thesis compnses studies on the finger skin blood flow. We 
used a standardized finger cooling test (with local cooling in a 16 aC water bath for 
S min and a recovery period of 20 min afterwards) to assess peripheral skin 
circulation by measurement of the finger skin temperature and the laser Doppler flux. 
This test has been performed in large groups of healthy subjects and in patients with 
RP. 
First, in Chapter 5 the relation between the test results and the subjective severity 
of the Raynaud attacks is investigated. The reproducibility of this finger cooling test 
is described in Chapter 6. Its diagnostic value is evaluated and differences between 
males and females in test results are analyzed in Chapter 7. To assess the influence 
of cyclical changes and of sex hormone levels, we studied the finger skin circulation 
of healthy female volunteers in different phases of their menstrual cycles (Chapter 8). 
To improve the standardization of our provocation test (by adding a 30" С water bath 
before provocation to standardize baseline finger skin temperature) and to introduce 
a heat challenge (45<'C water bath for 10 min), a combined finger heating and cooling 
test was used. Differences in finger skin blood flow between healthy subjects with 
different hormonal status were studied in four groups: males, premenopausal women, 
postmenopausal women and women using oral contraceptives (Chapter 9). Finally, in 
Chapter 10 a placebo controlled double blind study is described, in which the effect 
of the naturally occurring female sex hormones ITß-estradiol and progesterone on 
finger skin circulation was investigated. 
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ABSTRACT 
The objective of this study was to determine the prevalence of migrane headache in 
a family practice patient population. In addition, this study evaluated the simultaneous 
presence of Raynaud's phenomenon and migraine, and examined the influence of sex 
hormonal status on migraine symptoms. Data from the Continuous Morbidity 
Registration (CMR) project of Nijmegen, the Netherlands, were used to identify all 
patients in the registration who had migraine headache, and to identify a comparison 
group of patients with поп-vasospastic tension headache. Questionnaires were used 
to verify the diagnosis and to determine signs and symptoms of both headaches. There 
was an average annual prevalence of migraine headache of 4 per 1000 men and 16 
per 1000 women. Eightyfive percent of patients diagnosed by family physicians as 
having migraine were found to fulfill the International Classification of Health 
Problems in Primary Care (ICHPPC) criteria for migraine headache. Migraine 
differed from tension headache with regard to the duration of the attacks, concomitant 
photo- and phonophobia, provoking factors, and the need to use analgesic 
medications. Raynaud's phenomenon was present in 15% of the migraine group and 
in 16% of the tension headache group, and occurred almost exclusively in women. 
The headaches were worse during and before menstruation in both groups. They were 
improved during pregnancy and menopause in the migraine group to greater extent 
than in the tension headache group. The use of the ICHPPC-criteria for migraine 
headache is reliable in morbidity surveys in family practice. Although there was an 
overlap, migraine differed in various aspects from tension headache. Digital 
vasospasm and an influence of female hormonal changes were present in both 
headache groups. 
INTRODUCTION 
Headache is one of the most frequently-reported health complaints.' Various types of 
headache can be discerned. Although migraine headache quantitatively comprises a 
minority of headaches, its incapacitating character makes it an important disorder.2 3 
Reported prevalence of migraine varies from 2 to 25 % .2 ' 4 ' * These differences 
are due to various factors. First, as only 25 to 50% of all migraine patients seek 
professional medical care,1 4 practice-based surveys and population surveys report 
different figures. Second, demographic characteristics of the population under study 
are important; migraine is more common in women and less-frequent at older ages. ' 
2
 Third, no standardized and universely accepted diagnostic criteria are used for the 
definition of migraine.'23 7 * The definition formulated by the Ad Hoc Committee on 
the Classification of Headache was used as a standard for many years,' but many 
attempts have been made to create more specific criteria. Recently new definitions 
Migraine in Family Practice 15 
have been formulated, including those of the International Headache Society,10 and the 
criteria of the International Classification of Health Problems in Primary Care 
(ICHPPC)." Finally, migraine, with or without aura, and tension headache can be 
present in one patient on different occasions.12 " Migraine headache sometimes 
changes into tension headache with advancing age. It is hypothesized that migraine 
comprises a heterogenic spectrum of disorders, forming a continuum ranging from 
tension headache via migraine without aura to migraine with aura.12 I4 
The pathophysiology of migraine is controversial. Whether primary vascular 
alterations," primary neural disturbances with secondary vascular changes,16 
dysbalance of the autonomic nervous system,17 platelets," or numerous vasoactive 
substances are responsible, vasospasm is an important component in the complex of 
a migraine attack. In fact, several studies point to a simultaneous prevalence of 
migraine and other vasospastic disorders, such as Raynaud's phenomenon (RP) and 
variant angina,19 x 21 ^ " suggesting a common systemic vascular disturbance. 
Interestingly, migraine and RP are far more common in females, particularly from the 
onset of puberty. In addition, a relationship, though inconclusive, between migraine 
and the menstrual cycle,24 и and an influence of oral contraceptives,2* pregnancy27 and 
menopause, has been described. Therefore, it has been hypothesized that both 
migraine and RP may be influenced by female sex hormones. 
The aim of the present study was to assess the prevalence of migraine headache 
in family practice according to the ICHPPC-criteria and the clinical characteristics of 
the patients involved. Furthermore, the combined presence of migraine and RP, and 
the influence of sex hormonal status on symptoms in women were investigated. A 
group with non-vasospastic tension headache was selected from the same population 
and compared with the migraine group. 
METHODS 
To investigate the prevalence of migraine, we used data from the Continuous 
Morbidity Registration project (CMR) of the Department of Family Medicine at the 
University of Nijmegen in the Netherlands.2* The essential features of this registration 
project have recently been described.2' It involves 12,000 persons, the practice 
population of the four participating practices. The registration project started in 1967, 
and since 1971, all four practices have participated. The number of patients has 
remained stable since 1971. Socio-demographic information about all patients in these 
practices are kept up to date. Every episode of illness seen by the family physicians 
or reported to them by specialists is registered and the diagnosis is classified as soon 
as established. 
All patients of the current practice population classified as having migraine, were 
selected for this study. Of all patients classified, the diagnosis migraine was confirmed 
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with a short self-administered questionnaire, using the ICHPPC-criteria." This 
questionnaire contained questions (Table 2.1) related to the ICHPPC-criteria for 
diagnosis of migraine headache. The questionnaire also included items concerning 
frequency and character of the headache. Inclusion in the study required either 
recurrent episodes of unilateral headache with at least one of the following 
characteristics: a) nausea or vomiting; b) aura; c) neurological disturbance, including 
visual; d) family history of migraine, or recurrent bilateral headaches with three or 
more of the above characteristics. 
A group of patients with tension headache was selected from the same CMR-
population. Tension headache is not a separate diagnosis in the CMR, but is classified 
under 'nervous disorders'. These include complaints for which no evidence of organic 
pathology can be found after investigation and for which a psychological explanation 
seems to be likely. To obtain a group not significantly different from the migraine 
group, two subjects were selected from this category who matched each migraine 
patient in sex, age, social class, and medical practice from which they received care. 
These patients completed the same questionnaire. Tension headache was considered 
present if headache occurred more than once every two months, and migraine 
characteristics were absent. 
After this selection process was completed, a more extensive questionnaire was 
mailed to both the patients with migraine and the patients with tension headache. This 
questionnaire consisted of both preceded answers and open questions, asking about 
duration and perceived seriousness of the headaches, provoking factors, accompanying 
signs and symptoms, (self)medication, the use of professional medical services and, 
for women, the influence of the menstrual cycle, pregnancy, the use of oral 
contraceptives, and menopause. These questionnaires were personally collected at 
patients' home by the author (MLB), who checked for and clarified incomplete 
responses. Female respondents with regular menstrual cycles were asked to keep a 
diary during four consecutive months, recording the occurrence of headache attacks 
and menstrual cycles. 
RP was diagnosed if the patient gave a positive answer on the following 
questionnaire items: complaints of cold fingers, the occurrence of a white, blue and/or 
red discoloration of the fingers of both hands in response to cold or emotion, and 
sensory disturbances during the attack and tingling afterwards.30 
Statistical comparison of patients with migraine and patients with tension headache 
was performed by means of a chi-square test. Ρ values of less than 0.0S (two-sided) 
were considered significant. 
RESULTS 
The prevalence of migraine headache among patients in the four practices was 4 per 
Migraine in Family Practice 17 
1000 men, 16 per 1000 women, and 10 per 1000 subjects overall. During the period 
1982-1987, migraine had been diagnosed in 176 patients, but 26 of these patients had 
left the practice by the time of the study. Thus, the questionnaire was mailed to ISO 
patients. There was a return response rate of 140 (93%). Frequencies of positive 
answers of these 140 subjects are shown in Table 2.1. 
Table 2.1. Percentages of positive answers in the migraine group (n=140) on the questions 
in the first questionnaire, ihe letters a,b,c and d refer to the criteria as mentioned in the text. 
Do you feel the headache at one side of the head? 88.8 
Are you sick when having headache? (a) 83.7 
Do you have to vomit when having headache? (a) 61.5 
Do you see flashes, black spots or experience other 
visual disturbances preceding the headache? (b) 62.4 
Do you have sensations of numbness or 
tickling in the face preceding the headache? (c) 34.6 
Or in any other part of the body? (c) 20.2 
Do you experience a weakness in a part of the 
body when having headache? (c) 23.8 
Does anyone in your family (mother, father, sister, brother 
or daughter) experience the same headache? (d) 61.5 
Using the ICHPPC-criteria, the prior diagnosis of migraine headache proved to be 
correct in 119 of the 140 patients (85%). Thirty-two patients fulfilled all four criteria 
for migraine, 38 fulfilled three, 35 two, and 14 one. Associated nausea or vomiting 
was present in all but 10 patients. There were 21 of the 140 patients who could not 
be classified as having migraine headache for the following reasons. In 6, the inquiry 
about laterality remained unanswered; in 11 the bilateral headaches did not fulfill the 
migraine criteria (only 4 of the 15 bilateral headaches did); and 4 patients with 
unilateral headache did not have another positive criterion. Age and sex characteristics 
of the resultant migraine group (n=119) are depicted in Figure 2.1. There was a 
female to male ratio of 5:1. 
The questionnaire was also sent to 197 patients with nervous disorders, of whom 
162 responded (82%). Fifty-nine patients had no headache at all, or had headaches 
less than once every two months; these 59 patients were therefore excluded. To 
ensure that the remaining comparison group (n=103) consisted of patients with true 
tension headache, subjects who might be classified as migraine based on their 
questionnaire responses were excluded. Thirty such subjects were excluded; 11 
patients because of a family history of headache and 19 patients mostly because of 
headaches accompanied by nausea. After excluding these subjects tension headache 
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was considered to be present in 73 patients (see Figure 2.1). This group did not differ 
significantly from the migraine group considering practice, sex, age and social class. 
The diagnosis tension headache was verified by clinical interview when investigators 
visited subjects at home. 
number of patients 
10-14 15-24 25-34 35-44 45-54 55-64 65-74 
age 
I I migraine malos (m) К Д І migraine lemalos (f) 
^ Н tension headache (m) ШШ tension headache (f) 
Figure 2.1. Age and sex characteristics of the respondents to the first questionnaire in the 
migraine group (n = 119) and in the tension headache group (n = 73). 
The second questionnaire (see Table 2.2) was sent to all the patients with migraine 
according to the ICHPPC-criteria (n=119) and was completed by 102 of them (86%): 
86 women and 16 men. Of the patients with tension headache, 56 responded (77% of 
73): 49 women and 7 men. The remaining subjects could not be reached or refused 
to have the questionnaire collected by the investigator. 
Photophobia and phonophobia were far more common in patients with migraine. 
Nearly half of the migraine group stayed at home during an attack, compared to less 
than 10% in the tension headache group. Frequency of the headache and character of 
the pain were not significantly different, but duration of the headache attack was 
longer in the patients with migraine. Patients with migraine used more doses of 
analgesic medications than did patients with tension headache. Patients with migraine 
also visited specialists more often, but no difference was found in frequency of visits 
to family physicians. An open question considering provoking factors revealed that 
stress and menstruation were spontaneously mentioned in both groups, whereas only 
patients with migraine mentioned dietary ingredients, such as coffee or alcohol. 
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A cyclical pattern of headache was present in 49 (57%) of the women with migraine, 
with headaches being more common just before or during menstruation. This cyclical 
occurrence of migraine was significantly more frequent (p=0.01) in those 
premenopausal women (n=58) who experienced premenstrual symptoms such as 
tenderness of breasts, weight gain, or irritability. 
Table 2.2. Clinical characteristics of the patients with migraine (n=102) and the patients with 
tension headache (n=56). The results are given in percentages. Significant differences (chi-
square test) between the groups are represented by *. 
Frequency 
once to several times a week 
once to several times a month 
less 
Duration 
up to hours 
up to one day 
more then one day 
Character 
throbbing pain (yes) 
tight feeling (yes) 
Smoking (yes) 
Staying at home (yes-always, -often) 
Photophobia (yes-always, -often) 
Phonophobia (yes-always, -often) 
Use of medications (yes) 
analgesics 
ergotamin 
ami-nauseants 
Specialist consultation for the headache 
Family physician consultation 
once a year 
two to five times a year 
more than five times a year 
Provoking factor 
diet 
menstruation (% women) 
stress 
Migraine 
29.7 
46.6 
23.7 
23.5 
23.5 
53.0 
84.9 
53.1 
38.2 
51.0 
90.2 
89.2 
88.2 
60.8 
37.3 
9.8 
19.6 
35.3 
57.8 
6.9 
31.4 
33.7 
67.6 
* 
* 
* 
* 
* 
* 
* 
* 
Tension headache 
26.8 
40.8 
32.4 
44.6 
39.3 
16.1 
76.1 
56.4 
25.0 
9.0 
51.8 
64.3 
69.6 
70.4 
0.0 
0.0 
7.3 
25.5 
70.9 
3.6 
0.0 
22.4 
78.6 
(p=0.02) 
(p<0.0001) 
(p<0.0001) 
(p<0.0001) 
(p< 0.004) 
(p<0.04) 
Among the women with tension headache, 23 (47%) reported a cyclic influence, again 
with an increase in frequency and seriousness of the attacks in the premenstrual 
period. There were no significant differences regarding this influence of the menstrual 
cycle between the migraine and the tension headache groups. 
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To investigate more thoroughly the influence of the menstrual cycle in women with 
migraine headache, 23 women completed prospective headache diaries. Of the total 
of 360 headache attacks registered in the diaries, nearly half (179) occurred in the 
period of 5 days before the onset of menstruation until the end of menstruation. 
Questionnaire responses to the perceived effects of pregnancy, menopause, and the 
use of oral contraceptives are shown in Table 2.3. The influence of pregnancy on the 
headaches was significantly different (p=0.01) between patients with migraine and 
tension headache: the majority reported that their migraine improved and in 8 (16%) 
patients, headaches completely disappeared during pregnancy. Menopausal women (8 
with migraine and 5 with tension headache) and postmenopausal women (28 with 
migraine and 22 with tension headache) were analyzed together because of small 
numbers and comparable results. The influence of menopause was significantly 
different between the both headache groups (p=0.003). No differences, however, 
were found in the effects of oral contraceptives. Subjects in both groups reported 
worsening of the headache, but some subjects also reported improvement and many 
women reported no difference in headache frequency when using oral contraceptives. 
Table 2.3. Effects of pregnancy, menopause and the use of oral contraceptives on the 
headache in the women with migraine and with tension headache (controls). Results are given 
in absolute numbers (percentages). Significant differences between the groups (chi-square test, 
all ρ< 0.01) are represented by *. 
Pregnancy 
Migraine 
Controls 
Menopause 
Migraine 
Controls 
Oral contraceptives 
Migraine 
Controls 
Improvement 
32(64) 
6(22) 
21 (58) 
5(19) 
9(14) 
1 (3) 
No difference 
6(12) 
6(22) 
8(22) 
6(22) 
24 (38) 
15 (48) 
Deterioration 
7(14) 
0 
5(14) 
12 (44) 
19 (30) 
5(16) 
Do not know 
5(10) 
15 (56) 
2 (6) 
4(15) 
12 (18) 
10 (33) 
Total 
50 * 
27 
36 * 
27 
64 
31 
In the group of women with migraine 8 (9%) reported the onset of the migraine 
headaches before the age of ten, 32 (37%) reported headache onset between the age 
of ten and twenty years, and 46 (54%) women had the onset of headache between 
twenty and fifty years of age. In only one woman, migraine started after menopause. 
In the group of women with tension headache, these numbers were, respectively, 4 
(8%), 20 (41%), 18 (37%) and in 7 (14%) after fifty years of age. These figures 
differed significantly between both groups (p=0.006), in contrast to the figures for 
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males (data not shown). RP occurred in 15 (17%) of the female migraine group and 
in7(14%)ofthe female tension headache group (no significant difference). Two men 
were affected with RP, both in the tension headache group. For males and females 
together, the prevalence was 15% and 16%, respectively. Attacks of discoloration of 
the digits never occurred simultaneously with a headache. In patients who had both 
migraine and RP, 7 used ergotamin-containing medications during an attack and one 
used a β-adrenoceptor blocking drug daily. The use of these medications did not differ 
significantly when compared to the total migraine group. Only one woman in the 
migraine group and one woman in the control group had consulted a physician for 
RP. 
DISCUSSION 
The annual prevalence of migraine headache in our population was 4 per 1000 men 
and 16 per 1000 women. These figures include both patients already known with 
migraine plus newly diagnosed cases. It is likely that in the total population, the 
prevalence of migraine is higher, as not all patients with migraine headache will seek 
medical advice.14 
Of 140 respondents, diagnosed with migraine by their family physician, 85% 
fulfilled the ICHPPC-criteria. A question remains as to whether patients who did not 
fulfill these criteria had migraine or not. Use of a retrospective questionnaire to 
diagnose migraine headache might be inaccurate. In addition, the criteria used to 
define migraine place emphasis upon the unilaterality of the headache. In some new 
classifications,10 unilaterality is not considered an obligatory feature of migraine. 
Among our patients who carried a diagnosis tension headache, some fulfilled criteria 
for migraine (unilaterality and nausea). Similarly, pulsating quality of the headache 
was not specific for migraine, but also occurred in patients with tension headache. 
These findings support the hypothesis that migraine and tension headache might form 
a continuum. The problems of different, sometimes non-specific, diagnostic criteria 
and the apparent overlap in symptoms should be kept in mind when interpreting 
survey data and evaluating patients. 
Furthermore, this study shows that migraine, more than non-vasospastic tension 
headache, is influenced by female hormonal changes. The withdrawal of estrogens (as 
is the case premenstrually) may play a role.31 и In pregnancy and after the 
menopause, when cyclical changes in estrogen levels are absent, the migraine attacks 
were less frequent. But how vascular reactivity is influenced is still a matter of 
debate.33 M Some authors claim a major role for the sympathetic nervous system in 
migraine.3* Estrogens have been shown to be able to increase aI-adrenergic receptors, 
which have a vasoconstrictive effect after sympathetic stimulation.31 As RP has also 
been associated with sympathetic nervous system imbalance,34 the combined presence 
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of migraine and RP could point to a systemic sympathetic disturbance. The prevalence 
of RP in the population is not clearly documented and varies from 2 to 20%, 
according to the criteria used and the subjects studied.37 ^ " Prevalence estimations 
of RP in our population range about 3% (unpublished observations). We found no 
higher prevalence of RP in the migraine group compared to the tension headache 
group. It is possible that patients with tension headache are also more liable to 
develop digital vasospasm in response to stress than a non-headache control group. 
Further studies are needed to establish whether estrogens are responsible for the 
influence of sex hormonal status on migraine symptoms and to establish whether 
sympathetic nervous system disturbances play a role. 
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ABSTRACT 
Studies that present prevalence rates for Raynaud's phenomenon show great variation. 
Figures range from a few to more than 20%. In this study, 508 patients who attended 
their general practitioner filled in a questionnaire dealing with symptoms of Raynaud's 
phenomenon. When strict criteria (cold digits, numbness and at least a biphasic 
discoloration) were applied, prevalence was 0.5% in males and 2.9% infernales. 
When a monophasic white discoloration was included, prevalence figures increased 
by 5.4% in males and by 7.5% infernales. The respective percentages became 10.4% 
and 21.2% when subjects with cold digits and at least a monophasic white or blue 
discoloration were included. Complairas of cold digits were present in 22.7% of the 
males and in 35% of the females. We conclude that a great deal of the variation in 
prevalence of Raynaud's phenomenon can be explained by differences in its definition. 
INTRODUCTION 
Raynaud's phenomenon (RP) is only rarely mentioned in general practice or in 
population morbidity surveys. This may indicate that a physician is not often 
confronted by a patient with these symptoms. In contrast, studies dealing with the 
prevalence of RP give figures ranging from a few to more than 20%.' 2 3 4 3 " 
Considering these high figures, complaints of RP are either largely underestimated 
or not serious enough to seek medical attention. Indeed, only a minority of Raynaud 
patients consult a general practitioner and even fewer visit an out-patient clinic.45 
On the other hand, RP could be an early sign of a more serious disease. Referred 
patients often represent the more serious cases of RP and nearly half of them can be 
classified as secondary RP.7 Reliable prevalence figures of RP could provide 
information about the nature of this disorder: whether it is harmless and quite 
common in the population, or whether it indeed represents a serious warning. 
Climatological differences could account for the different prevalence rates in 
various parts of the world. Besides geographical differences and selection of the 
population samples studied, differences in criteria defining RP may largely be 
responsible for the variation in prevalence figures. Complaints of cold fingers and feet 
which are associated with either mono-, bi- or triphasic discoloration and either with 
or without numbness are all considered by investigators to represent RP. 
In the present study we assessed the prevalence of RP in a Dutch population and 
used several different criteria for its diagnosis. 
METHODS 
In three group practices, patients waiting to consult their general practitioner for any 
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reason, were asked at random to fill in a short questionnaire. Children under 10 yr 
of age and those who could not read Dutch were excluded. The questionnaire had 
previously been validated in a group of 44 patients with either primary or secondary 
RP visiting the out-patient clinic of internal medicine. Also, a group of 48 subjects 
known not to have complaints of RP took part in this pilot study. Sensitivity of the 
questionnaire was 86% and specificity 96%. The questionnaire consisted of the 
following yes/no items. 
1. Do you regularly experience cold fingers or toes? (yes/no) 
2. Do your fingers or toes regularly feel numb, so-called 'dead' fingers or toes? 
(yes/no) 
3. Have you ever noticed your fingers or toes changing colour when they are cold? 
(yes/no) 
White? (yes/no) Blue? (yes/no) Red? (yes/no) 
4. Have you ever consulted your general practitioner (yes/no) or a specialist (yes/no) 
with regard to these symptoms? 
Sex and age were also filled in. The investigation took place during the period of one 
week in each practice in the winter. We decided that the presence of bi- or triphasic 
discolorations alone was not enough to diagnose RP reliably with the questionnaire. 
Therefore, RP was assumed if cold digits, numbness and a bi- or triphasic 
discoloration were present. 
RESULTS 
The questionnaire was completed by 508 subjects: 202 men and 306 women. The total 
group was divided into four age classes (10-24 yr: 29 males (6%) and 44 females 
(9%), 25-39 yr: 67 males (13%) and 138 females (27%), 40-54 yr: 52 males (10%) 
and 75 females (15%), ^55 yr: 54 males (11%) and 49 females (10%)). Only a few 
patients refused to cooperate. The responses and combinations of responses to the 
different items are shown in Table 3.1. 
Many subjects had cold digits (46 males (22.7%) and 107 females (35%)). A 
monophasic white (34 males (16.8%) and 54 females (17.7%)) or blue discoloration 
(16 males (7.9%) and 25 females (8.2%)) was also frequently present. In this study, 
RP was assumed if cold digits, numbness and a bi- or triphasic discoloration were 
present. According to these criteria, the prevalence of RP was 0.5% (1/202) in men 
and 2.9% (9/306) in women. This difference between men and women was significant 
(chi-square test, ρ<0.05). No age-related significant difference in prevalence of RP 
was found. Four female patients visited a general practitioner because of their 
Raynaud symptoms, and one of them also consulted a specialist. 
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Table 3.1. Absolute and percentual (in parentheses) frequencies of the positive answers to the 
first three items of the questionnaire. 
Cold fingers, numbness and 
bi/trifasic discolorations 
Cold fingers, no numbness and 
bi/trifasic discolorations 
Cold fingers and 
bi/trifasic discolorations 
Cold fingers, numbness and mono-
fasic white discolorations 
Cold fingers, no numbness and mono-
phasic white discolorations 
Cold fingers and monofasic 
white discolorations 
Cold fingers, numbness and mono-
phasic white or monophasic blue 
discolorations 
Cold fingers, no numbness and mono-
phasic white or monophasic blue 
discolorations 
Cold fingers and monophasic white 
or monophasic blue discolorations 
Cold fingers 
Numbness 
Monophasic white discolorations 
Monophasic blue discolorations 
Bi/triphasic discolorations 
Males (n=202) 
1 
0 
1 
11 
5 
16 
13 
7 
20 
(0.5) 
(0.5) 
(5.4) 
(2.5) 
(7.9) 
(6.4) 
(3.5) 
(9.9) 
46 (22.7) 
50 (24.8) 
34 (16.8) 
16 
10 
(7.9) 
(5.0) 
Females (n=306) 
9 (2.9) 
6 (2.0) 
15 (4.9) 
23 (7.5) 
12 (3.9) 
35 (11.4) 
27 (8.8) 
23 (7.5) 
50 (16.3) 
107(35.0) 
72 (23.5) 
54 (17.7) 
25 (8.2) 
23 (7.5) 
If in addition to cold digits, numbness and a bi- or triphasic discoloration, a 
monophasic white discoloration was also included in the definition of RP, the 
prevalence became 5.9% in men and 10.4% in women. If a monophasic blue 
discoloration was included as well, the figures again increased: 6.9% (men) and 
11.7% (women). When symptoms of cold digits were considered together with at least 
monophasic white or blue discoloration, the prevalence figures reached 10.4% (men) 
and 21.2% (women). Bi- or triphasic discolorations (with or without cold fingers or 
numbness) were present in 5.0% (men) and 7.5% (women). 
DISCUSSION 
Symptoms of cold extremities or a monophasic discoloration turned out to be quite 
common in the population. When strict criteria are applied, the prevalence of RP is 
much lower. Furthermore, it is shown that with less strict definitions the prevalence 
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figures of RP increase. Therefore, it is likely that subjects with a monophasic 
discoloration compose the middle of a continuum, ranging from no symptoms at one 
extreme and triphasic RP at the other. 
In concordance with most reports,1*547 in our sample more women were affected than 
men. Part of the sex difference may be a reflection of the female predominance in the 
study group. The sex difference in prevalence is, however, too convincing to attribute 
it completely to the distribution of males and females. 
The 40- to 55-yr age group was larger than the other age categories. However, no 
influence of age on the questionnaire answers was found. Moreover, an influence of 
age in the group of RP could not be detected, although this might be due to the small 
numbers. It would, therefore, appear that the unequal distribution over age categories 
has no important effect on the results. 
In the diagnosis of RP, the patient's history is the most important source of 
information. A questionnaire can, therefore, be used. Colour charts are also used by 
some investigators who try to objectify the discolorations of the digits.6 Besides a 
questionnaire, a cold provocation test is used by some investigators to confirm the 
diagnosis of RP.2 These tests often do not provide more diagnostic information 
because of the wide overlap in results between normals and patients. 
In the present study we did not try to differentiate between primary and secondary 
RP. A questionnaire can be used to detect RP, but clinical and laboratory tests are 
required for further differentiation.7 
Geographical differences can account for some of the variation in prevalence 
figures. Figures from warm South Carolina" could therefore be lower than those 
from Denmark,2 Sweden' or Great Britain.14 As shown by our results, differences in 
prevalence figures of RP can also be ascribed to differences in definitions. Until there 
is consensus on definitions, prevalence figures for RP are not reliable and cannot be 
compared. 
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ABSTRACT 
Recent studies with standardized laboratory measurements of skin blood flow suggest 
an influence of female sex hormones on vasospasm. Therefore we evaluated the 
influence of the sex hormonal status on the subjective complaints of Raynaud's 
phenomenon and furthermore the combined presence of Raynaud's phenomenon with 
migraine. A detailed questionnaire was filled in by 130 primary Raynaud patients 
(31 males, 99 females), while 27females, with regular menstrual cycles without the 
use of oral contraceptives, kept a diary with daily registration (during three months) 
of frequency, severity, and duration of the vasospastic attacks. Complaints improved 
during pregnancy in 6 out of 23 females. No influence of the menopause or the use 
of oral contraceptives was found. An exacerbation in some phases of the menstrual 
cycle was present in 15 out of 80 females. The diaries, however, did not show such 
influence of menstrual cycle phase. Migraine was present in 21% of the Raynaud 
patients. In contrast to most reports in the literature and contrary to the results of 
laboratory research, this study shows that most females do not experience an 
important subjective influence of sex hormonal status on vasospastic attacks. 
INTRODUCTION 
Raynaud's phenomenon (RP) is defined by attacks of an at least biphasic discoloration 
(white, blue or red) of fingers or toes, provoked by cold or emotional stress. 
Although the precise pathophysiology is unknown as yet, primary RP (PRP) is 
assumed to be caused by excessive arterial vasospasm.1 Vasospasm is also known to 
occur in coronary,2 pulmonary,3 cerebral/ esophageal,5 ocular6 and penile7 arteries. 
Moreover, the simultaneous presence of RP and migraine or variant angina in 
primary' ' 10 " as well as in secondary RP12 " suggests that this vasospasm is not 
restricted to the digital arteries, but that it represents a more generalized phenomenon. 
RP is more common in females than in males, particularly from the onset of 
puberty.' After menopause the complaints often disappear.' The aggravation of RP 
during the use of oral contraceptives, although described in only a few patients, has 
led to the discussion whether RP should be regarded as a contra-indication.14 13 16 
During pregnancy symptoms were observed to improve in some patients.17 All these 
findings suggest an influence of female sex hormones on the occurrence of vasospasm. 
Recently the diagnostic value of the different signs and symptoms in a large group 
of Raynaud patients was described.18 The present study investigates more thoroughly 
the influence of sex hormonal status on the complaints in women with PRP and the 
combined presence of PRP and migraine. 
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SUBJECTS AND METHODS 
PRP was diagnosed in 160 subjects who visited the out-patient clinic because of 
complaints of digital discolorations. They all fullfilled the criteria of Allen and 
Brown,19 supplemented by negative clinical signs" and immunological findings30 of an 
underlying disease. All these 160 PRP patients (36 males and 124 females) were sent 
a postal questionnaire, which comprised questions with preceded answers. The 
questions concerned the characteristics of the Raynaud attacks, the possible co-
existence of migraine and, in females, the influences of respectively menarche, the 
menstrual cycle, pregnancy, the use of oral contraceptives, and the menopause on 
the complaints. After the questionnaire had been returned, a telephone interview 
followed to check whether the questions were understood and the responses were 
filled in correctly. Hundred-thirty subjects could be contacted by telephone. Thirty 
subjects, of which only 11 returned the questionnaire, could not be reached, mostly 
because their present phonenumbers could not be traced. The remaining 130 
questionnaires were analyzed. 
Migraine patients were selected by means of criteria of the International 
Classification of Health Problems in Primary Care21 for migraine headache. Inclusion 
requires either recurrent episodes of unilateral headache with at least one of the 
following: a) nausea or vomiting; b) aura; c) neurological disturbance, including 
visual; d) family history of migraine, or recurrent bilateral headaches with three or 
more of the above. 
Physical responses to stress were investigated by the use of a standardized, 
validated, list with 21 yes/no questions concerning the presence of common 
complaints related to stress (such as palpitations, tiredness, low back pain, abdominal 
complaints).22 The results of this stress list are presented as the average of the number 
of positive answers. 
To detect a possible influence of hormonal factors, we asked for the relation 
between the Raynaud attacks and the phase of the menstrual cycle. It was asked 
whether complaints especially occurred two weeks preceding, just before, during or 
just after menstruation. Combinations of answers were possible. To investigate the 
influence of pregnancy, the use of oral contraceptives and the menopause, two 
questions concerning both quality and frequency of the attacks were used. A 
deterioration of PRP was assumed when the attacks became more severe or were 
more often present and improvement was assumed when the attacks became less 
severe or were less often present. Females were considered postmenopausal when 
their menstruation had been absent for more than half a year and were considered 
menopausal when menstruations recently became irregular with an absence of 
menstruation for less than half a year. 
To determine the influence of the menstrual cycle on the complaints more reliably, 
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female Raynaud patients who had a regular menstrual cycle (between 26 and 32 days) 
without oral contraceptives were asked to keep a diary (n=33). This diary had been 
used previously to measure the subjective improvement during therapeutic studies.23 
During 3 winter months (January to March) the number of attacks, their mean 
severity (on a 10 point scale) and their mean duration (in min) were daily annotated. 
Medications were kept constant during the whole period and menstruation was 
registered. Afterwards, the maximum temperature of each day according to the 
National Weather Service and the number of the day of the menstrual cycle were 
added. Day -14 represented the assumed day of ovulation, while day 1 was the first 
day of menstruation. If a menstrual cycle did not completely fit in this 3 months 
period, the incomplete cycles were given cycle day numbers based upon the mean 
cycle length. In the analysis four cycle periods were defined: cycle day -2 to 0 
(premenstrual), cycle day 1 to 3 (menstrual), cycle day -8 to -5 (mid-luteal) and the 
remaining cycle days (rest). Means of severity, frequency and duration and the 
product of all three were calculated over the four periods. 
Table 4.1. Characteristics of the patients with PRP (n = 130). Absolute numbers and 
percentages (%). 
Sex 
male 31 (23.8) 
female 99 (76.2) 
Age (yr) 
male 42.7 ± 12.7° (range 15-72) 
female 39.8 ± 11.7° (range 14-69) 
Smoking 
yes 50 (38.5) 
no 80 (62.5) 
Medications in general 
yes 59 (45.5), 14 males, 45 females 
no 71 (54.6), 17 males, 54 females 
Medication for RP 
yes 66 (50.8), 17 males, 49 females 
no 64 (49.2), 14 males, 50 females 
mean ± SD 
RESULTS 
Subjects (Table 4.1) 
Questionnaires of 31 male and 99 female PRP patients were analyzed. The age of 
these subjects ranged between 14 and 72 yr (mean ± SD; females, 39.8 ± 11.7 and 
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males, 42.7 ± 12.7). About half of them used medication for RP and 38.5% were 
smokers. 
Characteristics of the Raynaud attacks (Table 4.2) 
Ninety-four percent of the patients had bilateral attacks. The frequency of the attacks 
differed between winter and summer. More than 40% of the patients experienced 
attacks only several times a month or not at all during the summer. In the winter the 
majority experienced attacks one or more times daily (69.8%). 
Cold was mentioned by almost every subject as provoking factor, while emotions 
and smoking were also mentioned. Cold as the only provoking factor was present in 
58.1%, cold combined with emotions in 21.7%. Emotions and smoking were never 
mentioned as single provoking factor. Smoking was mentioned by two subjects only. 
As other factors tight pressure and damp weather were mentioned. 
Table 4.2. Characteristics of the attacks in patients with PRP. Absolute numbers and 
percentages (%). 
Bilateral 
yes 
no 
missing 
Frequency in: 
>5/day 
1-5/day 
several/week 
several/month 
never 
missing 
Provoking factors 
cold 
cold + smoking 
cold + emotions 
cold + smoking + emotions 
cold + other 
cold + emotions + other 
do not know 
missing 
Family history 
yes 
no 
do not know 
118 (93.7) 
8 (6.3) 
4 
Winter 
32 (24.8) 
58 (45.0) 
30 (23.3) 
9 (7.0) 
0 
1 
75 (58.1) 
2 (1.6) 
28 (21.7) 
2 (1.6) 
14 (10.9 ) 
5 (3.9) 
2 (1.6) 
2 
32e(24.6) 
71 (54.6) 
27 (20.8) 
Summer 
8 (6.3) 
28(21.9) 
36(28.1) 
32 (25.0) 
24 (18.8) 
2 
"6 males and 26 females 
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About a quarter of the patients (24.6%, n=32), of whom 26 were females, knew of 
a family member with the same complaints (mother in 8, father in 8, sister in 11, 
brother in S and son and daughter in 2 cases). 
Influence of sex hormonal status (Table 4.3) 
Menarche 
The age at which the complaints presented itself at first was not significantly different 
between males and females (chi-square test). However, in females the onset of 
complaints seems to be more common under 40 yr of age. 
Pregnancy 
Of the 64 women who had been pregnant, 32 women had complaints of RP before 
their pregnancy. An improvement of RP in pregnancy was stated by 6 of those 32 
females (19%). 
Menopause 
Thirty-seven women were menopausal (n=6) or postmenopausal (n=31) at the time 
of the study of whom 24 experienced RP before menopause. In 13 females the onset 
of complaints was during or after the menopause. Only 4 women experienced some 
kind of difference (3 an improvement, 1 a deterioration) as compared with their 
complaints before the menopause. Most menopausal and postmenopausal women did 
not experience an important difference in complaints (16 experienced no difference, 
4 did not know). 
Oral contraceptives 
Fifty-seven women used oral contraceptives. Forty females had a history of RP before 
they started to use the pill. Half of the women did not know whether the oral 
contraceptives changed their complaints, the other half had not observed any 
difference. Only one women experienced an exacerbation of complaints during the use 
of oral contraceptives. 
Menstrual cycle 
Eighty of the 99 females experienced complaints of RP while in their fertile period 
of life. In 13 females complaints started after menopause and 6 females started to use 
oral contraceptives soon after menarche. An influence of the menstrual cycle was only 
mentioned by IS of those 80 females (19%). In this group the attacks most often 
occurred premenstrually. 
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Table 4.3. Hormonal influences on PRP. Absolute numbers and percentages (%) 
Age of onset of complaints 
Yr of age 
<9 
10-14 
15-19 
20-29 
30-39 
4049 
>50 
Influence on complaints of: 
worse or more often 
less worse or less often 
no difference 
do not know 
Influence of Menstrual Cycle 
premenstrual 
premenstrual and during 
All 
7 ( 5.4) 
31 (23.8) 
11(8.5) 
30(23.1) 
27 (20.8) 
15(11.5) 
9 ( 6.9) 
Pregnancy 
(ii=32) 
1 
6 
10 
15 
Males 
1 
4 
1 
7 
8 
7 
3 
Menopause 
(ii=24) 
1 
3 
16 
4 
: (n=80); exacerbation of RP: 
menstruation 
during menstruation, premenstrual and 
premenstrual and at midcycle 
do not know 
at midcycle 
Females 
6 
27 
10 
23 
19 
8 
6 
Oral 
(n= 
0 
1 
20 
19 
6 
6 
2 
1 
65 
1 contraceptives 
40) 
(19.0) 
(81.0) 
Diaries (Table 4.4) 
Twenty-seven of the initiate 33 women filled in the diary completely during these 3 
months. Six diaries were filled in incompletely (because of e.g. illness) or were left 
out because there had been a change in medication. One diary was left out of the 
analysis because the product of frequency and duration regularly surmounted the 24 
hr a day. First we determined the mean duration, frequency, severity of the attacks 
and its products in each cycle period. The mean duration of an attack was highest in 
the menstrual period, followed by the premenstrual period (ANOVA, ρ < 0.001). 
Mean frequency and severity did not differ between the four cycle periods. However, 
some females had annotated a very long duration of their attacks and this mainly 
during the menstrual period. Therefore, we repeated the analysis after constructing 
categories for mean duration (0, 1-5, 6-15, 16-30, 31-60 min), mean severity (0, 1-
4, 5-7, 8-10) and number of attacks (0, 1, 2, 3-5, > 5 times daily). There were no 
significant differences between the cycle periods anymore. 
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Table 4.4. Diary results. Means ± SD of daily duration (in min), number and severity (on 
a 10-point scale) of the attacks and the ambient daily temperature in "C (A). Frequency, 
severity and duration during the whole period in percentages (B). 
A 
duration 
number 
severity 
temperature 
27.6 ± 
3.1 ± 
4.3 ± 
10.3 ± 
12.4 
0.4 
0.6 
3.9 
В 
Frequency of the attacks (%) 
0 
1 
2 
3-5 
>5 
Severity on 
0 
M 
5-7 
8-10 
23.1 
15.5 
15.7 
28.4 
17.3 
lO-point scale (%) 
23.7 
25.3 
30.0 
20.9 
Duration in minutes (%) 
0 
1-5 
6-15 
16-30 
31-60 
>60 
23.2 
17.8 
23.1 
16.2 
12.6 
7.0 
The outside temperature (mean, 10.3 ± 3.90C; range, 1.2 to 21.40C) was not 
significantly different in the four cycle periods. The outside temperature significantly 
influenced the number, the severity as well as the duration of the attacks (analysis of 
co-variance, ρ < 0.001). 
In conclusion, with these diaries we could not find a clear influence of menstrual 
cycle phase on number, duration or severity of Raynaud attacks. 
Migraine and stress 
Headache was present in 93 patients (71.5%), whereas 37 (28.5%) patients never 
experienced any headache. Migraine was present in 5 males and 22 females, 21 % of 
the PRP patients. The average number of confirmative answers on the stress list was 
9.3 (out of 22). 
DISCUSSION 
Although RP is more often present in females, this study shows that most females do 
not experience an important influence of hormonal status on their complaints of RP. 
Migraine is frequently present, especially in the female PRP patients. 
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Some limitations are applicable to this study. Most patients with RP do not consult 
a general practitioner.24 Even less patients are therefore seen in hospital. 
Consequently, this out-patient study group may not be completely representative for 
the Raynaud population in general. Besides, patients with RP in the out-patient 
department comprise a large proportion of RP secondary to an underlying disease. 
Although reliable screening for connective tissue disease has been carried out in our 
study group, it is not excluded that a number of them will eventually develop a 
connective tissue disease as RP can be a symptom preceding other symptoms for 
many years.25 * 
Further, in contrast to a standardized measurement in the laboratory, a 
questionnaire deals with subjective complaints and is therefore largely depending on 
the attitude and recall of the subjects. No standardization of other factors, influencing 
the complaints of RP, is possible. It was clearly shown by the question on provoking 
factors and in the diaries, that cold is the most important subjective factor provoking 
Raynaud attacks. 
General characteristics 
Out of the PRP patients 38.5% were smokers. In a previous study smoking was not 
different between RP cases and controls.27 
Females clearly predominate in this group of PRP patients: there were three times 
as much females as males. This might be a consequence of the fact that females more 
often consult a physician. However, a recent prevalence study carried out in the open 
population confirms the higher prevalence of RP in females compared with males.27 
Hormonal influences 
Under standardized laboratory conditions, modulation of finger skin blood flow 
reactivity by female sex hormones has been demonstrated. Studies determining finger 
skin blood flow confirm a lower baseline blood flow and a more pronounced 
vasoconstriction during cold challenge with a slower recovery afterwards in females.2* 
An influence of menstrual cycle phase was demonstrated in both healthy subjects and 
in patients with RP.29 x 3' Oral contraceptives possibly also influence skin blood 
flow.32 Finger skin blood flow increases during pregnancy33 as well as in 
postmenopausal women when compared to premenopausal women.34 Estrogens can 
modulate vasoconstriction in different vessels, both in vitro and in vivo (mostly shown 
in animals).35 The influence of this female sex hormone has been suggested to take 
place through the upregulation of vasoconstrictive a-adrenoceptors.36 No definite prove 
that this hypothesis plays a role in human RP has been given yet. Moreover, although 
many standardized laboratory studies suggest an important influence of hormonal 
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factors, we were unable to detect such a clear relationship on the subjective 
complaints in this group of PRP patients. 
However, many articles reviewing RP suggest an important influence of female 
sex hormones as well.1 Most studies report that symptoms in females start in their 
fertile phase of life.17 " " " Other studies investigating the influence of pregnancy, the 
use of oral contraceptives, the menopause and the menstrual cycle, find an association 
with the complaints of RP.1137 However, in the first study" no questionnaire was used 
and in the second37 it is unclear of which questions the used questionnaire consisted. 
Maurice Raynaud already described a female patient who noticed the complete 
disappearance of her attacks as the first index of a commencing pregnancy. Other 
studies report an improvement in 45% out of 138 patients'7 and 70% out of 40 
patients.18 As pregnancy increases cardiac output and circulating blood volume, the 
observed increase in skin blood flow33 may reflect these changes. The altered level of 
sex hormones may play an additive role. A positive influence of pregnancy is only 
observed in 6 of our 32 patients (19%). 
The assumed negative influence of oral contraceptives14 " " was not confirmed by 
this or other studies. " Therefore there seems to be no reason to discourage the use 
of oral contraceptives to patients with PRP. 
An influence of menopause, with either improvement117 or deterioration of the 
complaints,37 as reported previously, was not present in our study, but this was 
possibly due to the small number or the short follow up. 
Nineteen percent (of 32 subjects) experienced an exacerbation of symptoms during 
a phase of the menstrual cycle, mostly premenstrual or menstrual. This is in line with 
the figure of 15% out of 200 females in another study.37 A diary study to measure the 
influence of the menstrual cycle has never been performed before. In this study, 
however, no clear influence of the cycle phase could be detected. Other factors such 
as outside temperature and stress may have had a stronger influence. However, only 
5 of the 15 females who perceived an influence of the menstrual cycle were included 
in the diary group. The analysis of these 5 diaries indeed confirmed that in the 
mentioned phase of the cycle they experienced a deterioration of their complaints. In 
a way this supports the accuracy of the diaries. Perhaps a subgroup of female PRP 
patients experiences an influence of the menstrual cycle on their vasospasm. 
Migraine 
Our study confirms other studies with regard to the simultaneous presence of migraine 
and RP.171837U The vasospasm that accompanies migraine may be generalized and 
could be a result of an imbalance of the sympathetic nervous system, as was suggested 
previously.39 Also in migraine it was suggested that estrogens may play a role in this 
sympathetic imbalance.'10 Therefore it could be possible that the pathophysioloy of 
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migraine and RP is closely related. However, ал overlap in symptoms of tension 
headache via migraine without aura to migraine with aura exists, causing difficulties 
to distinguish between the various types of headache. No control group was used for 
this part of the questionnaire. Yet it was shown to be accurate in 85 % of migraine 
patients in a previous study. 
Stress 
In almost 30% of the Raynaud patients emotional stress provoked the vasospasm, 
possibly by stimulating the sympathetic nervous system. To study whether Raynaud 
patients are more sensitive to stress, other physical complaints that might be 
considered as a reaction to stress were measured as well. The average sumscore on 
the stress list was 9.3 (of 21). In a previous study we used this stress list in a group 
of patients with migraine and with tension headache. The score was 6.1 for the 
tension headache group, a significant difference when compared to the score of 4.8 
for the migraine group. The influence of stress reflects a more systemic cause, as 
does the combined occurrence of vasospasm elsewhere. 
Conclusion 
Although in many review articles on RP female sex hormones are claimed to play an 
important role and many standardized laboratory studies also suggest a role for sex 
hormones, this study shows that most females do not experience an important 
influence of hormonal status on their complaints. In concordance with others we found 
migraine to be frequently present in patients with PRP. 
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ABSTRACT 
The results of objective circulatory tests inpatients with Raynaud's phenomenon have 
only rarely been related to subjective complaints. Therefore we investigated the 
correlation between daily self-recorded frequency, duration, and severity of 
vasospastic attacks and the measurement of finger skin blood flow during local cooling 
in 55 Raynaud patients. No significant correlations were found between complaints 
as registered in the diaries and, respectively, finger skin temperature and laser 
Doppler flux before, during, and after standardized cooling. In conclusion, finger skin 
blood flow measurements do not necessarily reflect digital vasospasm in daily life. 
Besides studies to evaluate the diagnostic value and the reproducibility of skin blood 
flow measurements in Raynaud's phenomenon, the relationship of test results with 
subjective complaints should be established. 
INTRODUCTION 
The diagnosis of Raynaud's phenomenon (RP) can often be made on the patient's 
history alone: attacks of (at least biphasic) digital discolorations, provoked by cold, 
or, sometimes, emotional stress. Additional cold provocation tests, with measurement 
of finger blood flow, are used to objectify RP and to evaluate therapy. Such tests are 
performed using different measurement techniques, either during local, or during 
whole body cooling.12 ' *5 In our clinic, a Raynaud attack is imitated by measurement 
of finger skin temperature (FST) and laser Doppler flux (LDF) during a standardized 
local cooling procedure.16 Though inter- and intraindividual variation in finger skin 
blood flow during cold provocation is considerable, groups can reliably be compared 
in pathophysiological and therapeutic studies. '7 
The subjective severity of RP can be assessed by means of a diary in which 
patients daily keep record of the frequency, the duration and the severity of their 
attacks.' During therapeutic studies, a decrease in subjective complaints of patients 
with RP has been shown by means of this diary.17 
Since other studies failed to present such a relationship, we assessed the 
correlation between the patient's complaints and the results of an objective finger 
cooling test. For this purpose, 55 Raynaud patients recorded their daily attacks in a 
standardized diary during 2 weeks. A finger cooling test was performed at the end of 
this period. Subsequently, we looked for correlations between the results of the diaries 
and the cooling tests. 
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METHODS 
Subjects 
We selected 55 Raynaud patients (mean age, 41.4 ± 14.1 yr); 33 patients (22 
females, 11 males) with primary RP (PRP) and 22 patients (16 females, 6 males) with 
secondary RP (SRP). The patients with PRP fulfilled the criteria of Allen and Brown,' 
supplemented by negative clinical* and immunological10 signs of an underlying disease. 
All SRP-patients had a connective tissue disease, fulfilling the criteria of the American 
Rheumatism Association (ARA)," or other appropriate criteria for, respectively, 
progressive systemic sclerosis (n=10), systemic lupus erythematosus (n=2), the 
CREST-syndrome (calcinosis, RP, esophageal motility disturbances, sclerodactyly, 
teleangiectasia; n=3), mixed connective tissue disease (n=3), rheumatoid arthritis 
(n=l) . Three subjects had signs of a connective tissue disease but could not be 
classified yet according to ARA-criteria (undifferentiated connective tissue disease). 
All patients had to be older than 18 years of age and should be without 
cardiovascular disease. They were not allowed to use vasoactive medication (if 
patients did use medications, these were stopped at least four weeks preceding the 
diary period). They experienced at least one Raynaud attack daily. All patients were 
normotensive (blood pressure < 160/90 mmHg). 
Methods 
All patients kept a diary in which they daily noted the frequency, the mean duration 
(in min) and the mean severity (on a 10-point scale) of the Raynaud attacks during a 
period of 14 days in the months of January and February. Average ambient 
temperature (in "C) at 4 pm, as recorded by the National Weather Service, was noted. 
Daily frequency, mean daily duration, mean daily severity, and its product were used 
in the analysis. 
The day the diary period ended, a finger cooling test was performed. All tests 
were performed in the morning, in a quiet climatized room (ambient temperature, 
24.4 + 0.6oC; humidity, 56.9 ± 4.0%). All subjects were asked to abstain from 
smoking for 24 hr, from caffeine- and alcohol-containing beverages for 12 hr and to 
fast for at least 2 hr preceding the test. 
The subjects acclimatized for at least 20 min in a comfortable supine position with 
their arms supported at heart level. Subsequently, the following measurements were 
performed. FST was measured on the second volar fingertip of the right hand (in eC; 
Thermocouple, Ellab Instruments, Copenhagen, Denmark). LDF was measured by an 
unhealed probe fixed on the third volar fingertip of the right hand (in arbitrary units 
(AU); Periflux Pf-ld, Perimed, Stockholm, Sweden). The gain was adjusted to 3, the 
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cutoff frequency to 12 kHz and the time constant to 3 sec. The LDF signal was 
continuously written on a chart recorder. Zero calibration was performed by 
readjusting the pen to zero, when the probe was fixed to a white, nonmoving surface. 
The values were averaged during a 1-min period. The average of three pretest values 
obtained within five minutes were used as baseline. Subsequently, the gloved right 
hand was immersed to just beyond the metacarpophalangeal joints into a 160C water 
bath for 5 min. Every minute momentary FST was registered. Measurement of LDF 
during cooling was not possible. During the recovery period of 20 min FST and LDF 
were obtained every 2 min. 
Data Analysis 
Results are given as means ± SD, unless stated otherwise. In the analysis for both 
FST and LDF the following parameters were used: the baseline value, the value at 
the end of the cooling period and the values after 12 and after 20 min of recovery/ 
Furthermore, we calculated the mean level during recovery and the mean level during 
the whole test by determining the area under the curve, divided by the duration of that 
period.' 
Differences between patients with PRP and SRP were calculated with the Wilcoxon 
two sample test. As there were no significant differences between primary and 
secondary Raynaud patients, both in skin blood flow and in the diaries (except for the 
mean duration of attacks), the results of the total group of patients were used in the 
analysis. 
Correlations between diary characteristics and the finger cooling test values were 
tested by the Spearman rank correlation test. A ρ value of less than 0.05 (two-sided) 
was considered to be significant. 
RESULTS 
Baseline FST was 29.1 ± 4.30C. FST dropped to 18.6 ± 1.6eC after cooling and 
recovered up to 25.6 ± 5.0oC. The mean level during recovery was 23.4 ± 4.0oC. 
The mean level during the whole test was 24.3 ± 3.50C. 
Baseline LDF was 21.3 ± 17.1 AU, with a drop to 6.0 ± 6.8 AU after cooling 
and an increase up to 12.8 ± 15.3 AU after recovery. The mean level of LDF during 
recovery was 10.0 ± 11.3 AU. The daily frequency of Raynaud attacks was 4.6 ± 
3.3. The mean duration of attacks was 24.2 ± 18.6 min. The mean duration in 
primary Raynaud patients was significantly lower than in secondary Raynaud patients 
(17.4 ± 1 1 . 1 versus 34.3 ± 22.9 min, ρ<0.001). Mean severity of attacks was 4.8 
± 1.8. The product of mean daily frequency, duration, and severity was 29.8 ± 
39.2. The mean daily ambient temperature during the diary period was 3.0 ± 2.3°C 
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(minimum, -3.5 "С and maximum, 6.7eC). 
None of the diary characteristics showed a significant correlation with any of the 
finger cooling test parameters. A representive example of this poor correlation is 
shown in Figure S.l for the mean FST during the test and the product of frequency, 
duration, and severity of attacks. The only significant, although only weak, 
correlations were found between the daily ambient temperature and both FST and 
LDF at the end of cooling (both r=0.3, ρ<0.05). 
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Figure 5.1. The subjective severity (expressed as the produa of frequency, duration, and 
severity) of Raynaud attacks and the mean level of finger skin temperature (FST, in "Q during 
the cooling test in 55 Raynaud patients. 
DISCUSSION 
In this study, we found no correlation between the subjective complaints of patients 
with RP registered in diaries and the objective measurements of finger skin blood flow 
during cold challenge. 
This lack of correlation can partly be explained by the fact that a cold challenge 
test poorly reflects the normal daily life provocation of RP, as no actual discoloration 
was observed in any patient. Other investigators also fail to induce the phenomenon 
in laboratory conditions. Failure to provoke an attack occurs with local as well as 
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with total body cooling, with short term as well as with long term cold exposure, and 
with mild as well as with extreme cold provocations.2 3 4 ' '2 " The acclimatization 
period of 20 min is used to enable the subjects to relax and to exclude the influence 
of outside weather conditions. However, this period may be too long, or the ambient 
room temperature of 24.4 ± 0.6oC may be too high, preventing the development of 
a Raynaud attack. As stated before, total body cooling is not always a sufficient 
stimulus either, but we might have found a better correlation between test results and 
subjective complaints if local finger cooling and body cooling would have been 
combined. A more pronounced cold provocation might give a better correlation, but 
many patients experience pain and cannot sustain such low temperatures. Therefore 
a mild cold stimulus of a 160C water bath was chosen. 
Another factor that may contribute to the lack of correlation in this study, is the 
fact that the registration of subjective complaints and their severity in a diary may 
very well not be adequate or sufficiently standardized. This method is largely 
dependent on the recall and compliance of the individual patients. Other factors, 
besides cold, that influence the complaints, such as number of provocative moments, 
emotional stress, mood, and day of the menstrual cycle have not been recorded. For 
example, Freedman et al found that about one third of Raynaud attacks were 
precipitated by emotional stress, with or without accompanying cold exposure.14 
Psychological and emotional factors in daily life may play a greater role than is 
generally acknowledged. 
In therapeutic studies we have found both subjective and objective improvement 
in Raynaud patients.17 Tooke et al, however, noticed a considerable disparity between 
the results of the objective and subjective evaluation of the efficacy of ketanserin in 
the treatment of RP." Surprisingly, we found no other studies in which the 
relationship between subjective complaints and objective measurements in RP is 
investigated. Moreover, nearly all vascular laboratories use their own exclusive 
cooling tests, with different measurement techniques, provocation tests, and ambient 
room temperatures. Also, insufficient data are available to describe the diagnostic 
sensitivity, specificity, or reproducibility of these tests. In conclusion, standardized 
laboratory measurements of finger skin blood flow appear not to reflect the 
multifactorial influences on Raynaud attacks in daily life. It seems mandatory that 
authors who publish skin blood flow data in RP present the relationship between the 
test results and subjective complaints, besides showing the diagnostic value and the 
reproducibility of their test. As long as these data are not available, current tests to 
evaluate RP cannot be compared nor be improved. 
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ABSTRACT 
A finger cooling test is used to objectify Raynaud's phenomenon and to assess its 
severity. For this purpose, finger skin temperature (FST) and laser Doppler flux (LDF) 
are measured on the fingertips before and during cooling of the hand (160C water 
bath for 5 min) and a subsequent recovery period (20 min). To study reproducibility, 
this test was performed twice within 3 months in 34 healthy subjects and in 56 
Raynaud patients. Three test parameters were used in the analysis: the baseline value, 
the value after 12 min of recovery, and the mean level during recovery. We 
determined the limits of agreement (mean differences between the first and the second 
test ± 2SD) and the coefficients of variation. No systematic differences between the 
first and second test were found. Outside temperature did not influence FST or LDF. 
FST was shown to have a better reproducibility than LDF. For the baseline value in 
the total group the coefficient of variation was 3.3% for FST and, rather high, 21.6% 
for LDF. The limits of agreement for the baseline value in the total group were -4.8 
to 4.2"Сfor FST and -25.2 to 22.2 arbitrary units for LDF. The applied cooling test 
has limited value in individual cases, but can be useful when comparing large groups 
in pathophysiologic or therapeutic studies. 
INTRODUCTION 
Standardized measurements of finger blood flow during cold provocation are in 
clinical use to objectify digital vasospasm and to differentiate healthy subjects from 
patients with Raynaud's phenomenon (RP). 
Many different cold provocation tests are used. Some apply local cold to the finger 
or hand, while others use contralateral or whole body cooling. Also, a wide variety 
of measurement techniques is used, such as the measurement of finger skin 
temperature (FST),1 laser Doppler fluxmetry (LDF),2 finger plethysmography,3 and 
nailfold dynamic capillary microscopy.4 Because skin blood flow varies enormously 
under normal physiological conditions, it is important to know the reproducibility of 
the circulatory responses to cooling tests. Yet the response of skin blood vessels to 
a cold challenge during repeated application has not been studied systematically. 
For years we used a standardized provocative finger cooling test with 
measurements of FST.1 Later the measurement of finger skin blood flow by LDF was 
added.2 In this study we report on the reproducibility of the finger cooling test by 
performing this test twice in a group of 34 healthy subjects and in a group of 56 
Raynaud patients. 
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SUBJECTS AND METHODS 
Subjects 
We selected 34 outside controls (32 females and 2 males) and 56 Raynaud patients (40 
females and 16 males). Thirty patients fulfilled the criteria of Allen and Brown,3 and 
were classified as primary RP. Twenty-six patients had secondary RP due to an 
underlying disease. Of the secondary Raynaud patients, 8 suffered of vascular 
occlusive disease, revealed by angiography of the digital arteries. The remaining 18 
patients had a connective tissue disease, fulfilling criteria of the American 
Rheumatism Association or other appropriate criteria6: progressive systemic sclerosis 
(n=8), the CREST-syndrome (calcinosis, RP, esophageal motility disturbances, 
sclerodactyly, teleangiectasia; η=4), Polyarteriitis nodosa (n=l), systemic lupus 
erythematosus (n=2), rheumatoid arthritis (n = l), Sjogren's syndrome (n = l) and 
mixed connective tissue disease (n=l). Two had clinical signs of a connective tissue 
disease that could not be classified yet. Of the healthy subjects, none had any signs 
or symptoms of a vascular disease, none had hypertension (blood pressure > 160/90 
mmHg) and none used any vasoactive drug. If patients with RP used drugs for their 
complaints, these were stopped at least two weeks preceding a test. 
Methods 
In all 90 subjects two finger cooling tests were performed within a period of 3 months 
(mean ± SD, 21.3 ± 20.8; range, 3 to 89 days). All tests were performed in the 
morning, in a quiet climatized room (ambient temperature (mean + SD), 24.5 ± 
1.0oC; humidity, 59 ± 0.9%), with the subjects in a comfortable supine position with 
their hands supported at heart level. Outside temperature was registered as well. All 
subjects were asked to abstain from smoking for 24 hr and from caffeine- and alcohol-
containing beverages for 12 hr and to fast for at least 2 hr preceding the test. After 
an acclimatization period of at least 20 min the following measurements were 
performed. 
Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured 
at the left upper arm by an Arteriosonde (in mmHg; Roche Medical Electronics, Inc., 
Oranjeburg, NJ, USA).7 Heart rate (in beats per minute) was calculated from 10 RR-
intervals of an electrocardiogram strip. Forearm blood flow (FBF) was measured at 
the left forearm by strain gauge venous occlusion plethysmography (in ml/100 
ml/min; Loosco BVP 96, Hoekloos, Amsterdam, The Netherlands). A wrist cuff was 
inflated up to 40-50 mmHg to exclude the venous return from the hand. FST was 
measured on the second volar fingertip of the right hand (in "С; Thermocouple, Ellab 
Instruments, Copenhagen, Denmark). LDF was measured by an unheated 90° probe 
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fixed on the third volar fingertip of the right hand (in arbitrary units (AU); Periflux 
Pf-ld, Perimed, Stockholm, Sweden). The gain was adjusted to 3, the cutoff 
frequency to 12 kHz and the time constant to 3 sec. The LDF signal was continuously 
monitored on a chart recorder. Zero calibration was performed by readjusting the 
pen to zero when the probe was fixed to a white, nonmoving surface. LDF values 
were averaged afterward on the recording as the mean during a 1-min period. 
For all measurements, the average of three pretest values obtained within an 
interval of 10 min was used as the baseline value. Subsequently, the right hand was 
covered with a well-fitting plastic glove and was immersed into a water bath of 16°C 
for 5 min. Every minute momentary FST and mean LDF were registered. During the 
recovery period of 20 min FST and LDF were obtained every 2 min. 
Data analysis 
All calculations were performed for the whole group as well as for the subgroups of 
healthy subjects and Raynaud patients. Because there were no significant differences 
in the differences in test results between the patients with primary and secondary RP, 
both groups of patients with RP were joined. Results are given as means ± SD, 
unless stated otherwise. A ρ less than 0.05 (two-sided) was considered to be 
significant. 
Baseline FBF, heart rate, SBP, and DBP were used in the analysis. The mean 
arterial blood pressure (MAP; in mmHg) was calculated from the formula 
MAP=(SBP+2DBP)/3. Differences between the healthy subjects and the Raynaud 
patients in these parameters were analyzed with the Student t test. 
FST and LDF during the test were expressed as three separate values: the mean 
of three pretest values (baseline), the value after 12 min of recovery,1 and the mean 
level during recovery, by determining the area under the curve during recovery 
divided by the duration of the recovery period.2 The differences between the first and 
the second test were used to assess the reproducibility of FST and LDF. 
Preliminary tests were performed to investigate the presence of possible systematic 
differences between the first and the second test (Wilcoxon's signed rank test). 
We determined limits of agreement (the mean differences between the first and the 
second test ± 2SD).' In order to evaluate the variation of the parameters between the 
two tests in relation to the level of response, the coefficient of variation (in %) was 
also calculated for each individual subject. The average was presented as a measure 
of the reproducibility. 
By calculating Pearson correlation coefficients, the influence of factors such as 
age, outside temperature, FBF, heart rate, and MAP on the differences between the 
test parameters was investigated as well. The influence of factors such as sex and 
diagnosis was considered by means of analysis of variance. 
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RESULTS 
Some baseline characteristics of the healthy subjects and the patients are given in 
Table 6.1. In the group of healthy subjects females predominate. The healthy control 
subjects were significantly younger than the Raynaud patients (p< 0.001). Besides 
age, baseline SBP, DBP, heart rate, and FBF were all significantly higher in the 
patients (all ρ < 0.01). 
Table 6.1. Charaaeristics of the total group (All), the healthy subjects, and the group of 
patients with Raynaud's phenomenon. Values are given as means ± SD, as measured in the 
first test. 
Number 
Sex (male/female) 
Age (yr) 
Blood pressure (mmHg) 
Systolic 
Diastolic 
Heart rate 
(beats/min) 
Forearm blood flow 
(ml/100ml/min) 
All 
90 
18/72 
34.5 
117.3 
74.1 
69.0 
3.7 
± 
± 
± 
± 
± 
13. 
16. 
9. 
B. 
1. 
.2 
.β 
.8 
.8 
.4 
Healthy 
Subjects 
34 
2/32 
25.4 
104.7 
70.0 
63.4 
3.0 
± 
± 
± 
± 
± 
4. 
7, 
7. 
9. 
1. 
.2 
,7 
.4 
.1 
.6 
Raynaud 
Patients 
56 
16/40 
40.0 ± 13.7 
124.7 ± 16.3 
76.5 ± 10.3 
72.5 ± 6.7 
4.1 ± 1.0 
In Figure 6.1 FST and LDF during the first and the second finger cooling tests are 
shown for the healthy subjects and the Raynaud patients. Results of FST for the total 
group as well as for the healthy subjects and the Raynaud patients are shown in Table 
6.2 and the corresponding values of LDF are shown in Table 6.3. 
Baseline values of FST and LDF in the first and second finger cooling tests 
showed no significantly different results, which indicates that there were no systematic 
differences between the first and the second test. 
Coefficients of variation for FST were lower in comparison with LDF. For all 
shown test parameters the limits of agreement were smaller in the Raynaud patients 
than in the healthy subjects. Also, the coefficient of variation was lower in the 
patients than in the healthy subjects. Figure 6.2 depicts the mean level during 
recovery of the two tests (for both FST and LDF and for both healthy subjects and 
Raynaud patients) in relation to the differences of these parameters between the two 
tests. The inter- as well as the intraindividual variability is large. The coefficient of 
variation, giving a relative value, best represents the increasing variability when 
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values of both FST and LDF are higher. 
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Figure 6.1. Finger skin temperature (top) and laser Doppler flux ftn arbitrary units, AU, 
bottom) during the first and the second finger cooling tests for the healthy subjects (left) and 
the patients with Raynaud's phenomenon (right). Finger skin temperature and laser Doppler 
flux are shown before cooling (-5 to 0 min), during cooling (0 to 5 min), and during the 
subsequent recovery period (5 to 25 min). 
There was no correlation between the mean baseline FBF of both tests (being higher 
in patients) and the differences of FST or LDF. Differences in baseline FBF between 
both tests were significantly related with differences of FST and LDF (mean level 
during recovery of FST, r=0.54, ρ< 0.001; and the corresponding value of LDF, 
r=0.3, p<0.05). 
There was no significant correlation between age, MAP, or heart rate and the 
differences of FST or LDF. Also, outside temperature (ranging from -4 to +32 0C) 
did not influence reproducibility. Moreover, the difference between both finger 
cooling tests in MAP, heart rate, or outside temperature did not correlate with the 
differences in FST and LDF in the first and second tests. 
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Table 6.2. Reproducibility of the finger skin temperature for the total group (All, n=90),for 
the healthy subjects (HS, n=34), and for the patients with Raynaud's phenomenon (RP, 
n=56). The mean values ± SD of both tests, the limits of agreement and the coefficients of 
variation (CV in %) are shown. 
Finger вкіп temp fC) 
Parameter Group lat test 2nd teat Limita of CV (%) 
agreement 
Baseline 
After 12 
min 
recovery 
Mean level 
during 
recovery 
All 
HS 
RP 
All 
HS 
RP 
All 
HS 
RP 
29.8 
33.1 
27.6 
25.1 
28.2 
23.2 
24.2 
27.4 
22.4 
± 
± 
± 
± 
± 
± 
± 
± 
± 
4.3 
2.8 
3.9 
5.0 
5.3 
3.7 
4.6 
4.9 
3.2 
30.2 
33.9 
27.9 
25.1 
28.8 
22.8 
24.3 
27.5 
22.3 
± 
± 
± 
± 
± 
± 
± 
± 
± 
4.5 
2.3 
3.9 
4.8 
5.0 
2.9 
4.3 
4.7 
2.6 
-4.8 
-6.7 
-3.3 
-6.3 
-9.4 
-3.5 
-5.9 
-8.8 
-3.4 
to 
to 
to 
to 
to 
to 
to 
to 
to 
4.2 
5.1 
3.3 
6.3 
8.2 
4.2 
5.9 
8.4 
3.6 
3.3 
4.0 
2.9 
5.2 
8.0 
3.5 
4.8 
7.9 
2.9 
Table 6.3. Reproducibility of the laser Doppler flux (in arbitrary units, AU) for the total group 
(All, n=90), for the healthy subjects (HS, n=34), and for the patients with Raynaud's 
phenomenon (RP, n=56). The mean values ± SD of both tests, the limits of agreement and 
the coefficients of variation (CV in %) are shown. 
Laaer Doppler flux (AU) 
Parameter Group let teat 2nd teat Limita of CV (%) 
agreement 
Baseline 
After 12 
min 
recovery 
Mean level 
during 
recovery 
All 
HS 
RP 
All 
HS 
RP 
All 
HS 
RP 
25.4 
38.4 
17.6 
14.3 
25.1 
7.8 
14.5 
24.0 
7.3 
18.3 
17.4 
14.0 
16.6 
20.1 
9.5 
16.0 
18.7 
8.5 
26.7 
40.3 
18.7 
14.6 
25.7 
8.0 
14.4 
24.0 
7.9 
± 
± 
± 
± 
± 
± 
± 
± 
± 
18.2 
13.9 
15.5 
15.2 
16.4 
9.6 
14.8 
16.0 
9.6 
-25.2 
-36.4 
-16.2 
-23.8 
-35.0 
-14.0 
-22.8 
-32.1 
-10.9 
to 
to 
to 
to 
to 
to 
to 
to 
to 
22.2 
32.2 
14.0 
23.2 
34.4 
13.4 
21.2 
31.5 
7.5 
21.6 
26.7 
18.6 
31.9 
35.4 
29.9 
30.2 
34.0 
27.3 
DISCUSSION 
This study shows that the reproducibility of the finger cooling test is better for FST 
than for LDF, for all of the shown parameters. 
There were no systematic differences between both tests. This implies that no 
adaptation to the finger cooling test was observed. Adaptation was shown before by 
others using finger systolic pressure.' 
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Figure 6.2. The mean level during recovery of the »wo tests depicted against the differences 
between both tests, for finger skin temperature (FST) and laser Doppler flux (LDF, in 
arbitrary units, AU) in the healthy subjects (left) and the patients with Raynaud's phenomenon 
(right). Limits of agreement are shown as well. 
The large standard deviation indicates a wide interindividual variability. As can be 
seen by the limits of agreement and the coefficient of variation, the intraindividual 
variability is large as well. A great deal of this variation can be explained by 
biological variability. Under physiological conditions, skin blood flow varies 
extremely, with enormous changes within a short period. The pronounced sensitivity 
of skin blood vessels to endogenous and exogenous stimuli is probably responsible. 
To minimize these stimuli we carefully tried to standardize several influencing 
factors.1 The room temperature was constant and auditory and visual disturbances 
were kept to a minimum. The subjects abstained from smoking, caffeine- and alcohol-
containing beverages, and food before the test. The site (always in the center of the 
pulp lines of the volar fingertip) and the fixation of the LDF probe (double-sided tape) 
were standardized. An acclimatization period of at least 20 min minimized the 
influence of outside temperature. 
Some limitations in standardization could to some extent account for the moderate 
reproducibility of the test. First, individual factors such as stress are more difficult 
to control in a laboratory setting. Smoking habits outside the period of 24 hr could 
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still be of influence. 
Second, in premenopausal women not using oral contraceptives the phase of the 
menstrual cycle is of influence10 and tests ideally should have been performed on 
comparable days of the menstrual cycle. 
Third, when we started to perform the LDF measurements the 25% calibration 
solution was not available yet. Apparatus drift might have influenced our 
reproducibility results slightly, although recent calibration results showed a maximal 
drift of 8% (mean 5%) in 3 months. 
Fourth, we did not subtract the biological zero. As we found before," this value 
is of little importance in healthy subjects, but may be important in patients with a low 
baseline flow. However, as it is supposed to be rather constant in one person, it is not 
likely to have influenced reproducibility in a major way. 
Finally, biological and hemodynamic factors could influence the test results. 
However, as body mass index, amount of subcutaneous fat, and hand volume remain 
rather constant over time, reproducibility is not likely to be influenced. Blood pressure 
and FBF can change more substantially over time. Both could influence skin blood 
flow: the blood pressure by determining skin perfusion pressure and the forearm blood 
flow (composed mostly of muscle blood flow) possibly by a competitive mechanism 
with skin blood flow. The latter, however, is not substantiated by our results. As 
blood pressure or FBF were not significantly different between the two tests for each 
group, they are likely not to have influenced our results. 
The better reproducibility of FST compared to LDF can partly be explained by the 
fact that FST is the resultant of total blood flow in the finger with adelay in reaction 
time. In contrast, LDF measures the blood flow instantaneously in a small volume of 
approximately 1 cm3 that includes nutritional capillaries and part of the arteriovenous 
anastomoses.12 LDF measurement is liable to be far more influenced by momentary 
changes, resulting in large temporal variation.1314 A slightly different site of the LDF 
probe in duplicate tests may influence the results as inhomogenities of the 
microvascular architecture in the small measuring volumes may account for the great 
spatial variations.15 
The finger cooling test in healthy subjects has a worse reproducibility than in 
patients with RP. Some factors have to be considered. 
First, Raynaud patients have a lower baseline finger skin blood flow and could 
therefore be less responsive to vasoconstrictive factors. Previously we have shown that 
vasoconstrictive reactivity is lower in the case of a low baseline skin blood flow.16 
Furthermore, there were differences in sex between both groups. As stated before, 
the variable hormone levels during the female menstrual cycle could influence the 
peripheral circulation.10 Although the mean age was higher in the patient group, only 
seven females were more than 50 years of age. The remaining females are most likely 
to be premenopausal and also under the influence of fluctuating hormone levels. In 
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the healthy subjects it was not possible to compare the reproducibility of males with 
females because of the relative lack of men. In the patient group no correlation was 
found between sex and the differences between the first and the second test. Therefore 
it can be assumed that sex differences between the groups do not influence 
reproducibility. 
Finally, FBF differed significantly between the groups. To our surprise it was 
higher in the Raynaud patients. There was no correlation of the mean FBF and the 
differences in FST and LDF between both finger cooling tests, but the difference in 
FBF between the first and the second test (also higher in patients; data not shown) 
was significantly related with the differences of FST and LDF. This could indicate 
that the regulation of skin and muscle blood flow is somehow related. 
Previously, a good reproducibility of FST in this finger cooling test was found in 
a small group.1 The reproducibility of LDF is mentioned in only a few other studies 
and includes small subgroups only. In studies on finger skin circulation an adequate 
reproducibility is seldom obtained." 13 " " " Because of the different setups of all 
cold provocation tests, results are difficult to compare. However, it is clear that all 
measurements of peripheral skin circulation are seriously hampered by the great 
biological variability. 
It is important to know, besides reproducibility, if a test discriminates between 
patients and healthy subjects. We have already shown that FST discriminates well 
between groups of patients and healthy volunteers.1 The finger cooling test has also 
been successfully used to monitor a patients' progress in several placebo-controlled 
therapeutic studies.2 30 
In conclusion, the measurement of finger skin blood flow by the use of FST and 
LDF before, during, and after cold challenge has limited value in individual cases 
because of its moderate reproducibility. However, these types of tests could be useful 
when comparing large groups or when performing repeated measurements. 
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ABSTRACT 
In the diagnosis of Raynaud's phenomenon, the patient's history is not always 
sufficient. Supplementary we use a standardized finger cooling test, of which the 
diagnostic value was investigated in the present study. In 99 patients with primary 
Raynaud's phenomenon, in 97patients with secondary Raynaud's phenomenon and 
in 101 healthy subjects, finger skin temperature and laser Doppler flux were measured 
before, during and after immersion of the hand in a 160C water bath. We determined 
respectively the baseline value, the values at the end of the cooling period and after 
12 and 20 min of recovery, the percentual decrease during cooling and the mean 
levels during cooling, during recovery and during the whole test. Most of the finger 
skin temperature and laser Doppler flux parameters were significantly lower infernales 
than in males in all three groups. There were no significant differences between 
patients with either primary or secondary Raynaud's phenomenon. In both sexes all 
test parameters (with exception of the percentual decrease during cooling) were 
significantly lower in the Raynaud patients when compared with the healthy subjects. 
With a diagnostic specificity of 70%, the sensitivity varied between 55% and 81% for 
the different test parameters. In conclusion, although in both sexes finger skin 
temperature and laser Doppler flux values before, during and after cooling were 
significantly lower in Raynaud patients compared to healthy subjects, the considerable 
overlap between both groups limits the diagnostic value in individual cases. 
INTRODUCTION 
To establish the diagnosis of Raynaud's phenomenon (RP), the patient's history is 
essential. RP is assumed by a history of attacks of an at least biphasic discoloration 
(white, blue or red) of fingers or toes, provoked by cold or emotional stress. In case 
the patient's history is not conclusive, an appropriate diagnostic test is needed. Such 
a test should also provide information regarding the seventy or the prognosis of RP. 
Finally such a test can be used to evaluate therapy and to perform pathophysiological 
studies. 
Clinically it is often difficult to differentiate between primary RP (PRP) and 
secondary RP (SRP). The latter is usually part of the clinical spectrum of a connective 
tissue disease. RP may precede other clinical manifestations of connective tissue 
diseases for many years.1 2 Besides the patient's history and a physical examination 
revealing signs or symptoms of a connective tissue disease, capillary nailfold 
microscopy and laboratory tests for specific auto-antibodies are used to demonstrate 
the type of underlying connective tissue disease.3 4 
Measurements of finger blood flow during cold provocation are widely used to 
differentiate healthy subjects from patients with RP and within the latter group 
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between the primary and the secondary subtype. Local direct and indirect cooling 
procedures as well as whole body cooling are used to provoke digital vasospasm. A 
great variety of measurement techniques is used to quantify the circulatory response.5 б 
7
 ' * No uniform, reliable and standardized test is available at present. 
A finger cooling test is used in our clinic to mimic a Raynaud's attack and to 
assess the finger skin blood flow as measured by fìnger skin temperature (FST) and 
laser Doppler flux (LDF) before, during and after a standardized cooling procedure. 
Previously we have demonstrated that FST recovery after cooling has an acceptable 
reproducibility if room temperature and smoking are controlled.10 Recovery was 
significantly slower in Raynaud patients than in healthy subjects and test results were 
shown to improve with successful therapeutic treatment." n " However, since this 
diagnostic study was only performed in a small number of patients, larger groups of 
both healthy subjects and patients with either PRP or SRP were included in the 
present study. Test results were compared between the healthy subjects and the 
Raynaud patients and between the patients with PRP and with SRP. 
As RP is more common in females than in males and sex differences in skin 
perfusion have been described in healthy subjects,14 test results between males and 
females were compared within and between the different groups. 
SUBJECTS AND METHODS 
Subjects 
We selected 99 consecutive patients with PRP (78 females, 21 males), 97 consecutive 
patients with SRP (66 females, 31 males) and 101 healthy subjects (66 females, 35 
males). The patients with PRP fulfilled the criteria of Allen and Brown15, 
supplemented with negative clinical" and immunological3 signs of an underlying 
disease. In the group of patients with SRP 24 patients suffered from vascular 
occlusive disease, revealed by angiography of the digital arteries. The remaining 73 
patients had a connective tissue disease, fulfilling the criteria of the American 
Rheumatism Association (ARA) or other appropriate criteria for respectively: 
progressive systemic sclerosis (n=22), systemic lupus erythematosus (n=9), the 
CREST-syndrome (calcinosis, RP, esophageal motility disturbances, sclerodactyly, 
teleangiectasia; n=6), Polyarteriitis nodosa (n=2), rheumatoid arthritis (n=6), 
Sjogren's syndrome (n=4), mixed connective tissue disease (n=3) and 
dermatomyositis (n=l). Twenty subjects had signs of a connective tissue disease but 
could not be classified yet according to ARA criteria (undifferentiated connective 
tissue disease). None of the healthy subjects had any sign or symptom of a vascular 
disease, nor used any vasoactive drug. All were normotensive (blood pressure 
< 160/90 mmHg). If patients with RP used drugs for their complaints, these were 
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stopped at least two weeks preceding the test. 
Methods 
All tests were performed in the morning, in a quiet climatized room (ambient 
temperature (mean ± SD), 24.4 ± 0.6oC·, humidity, 56.9 ± 4.0%). All subjects 
were asked to abstain from smoking for 24 hr, from caffeine- and alcohol-containing 
beverages for 12 hr and to fast for at least 2 hr preceding the test. 
The amount of subcutaneous fat (% of total body mass) was determined by 
measuring skinfold thickness at four standardized sites of the body (in mm), after 
which the corresponding percentage of subcutaneous fat according to age and sex was 
read from a table.17 The hand volume (in ml) was determined by the increase in 
volume after immersion of the hand up to the wrist in a defined amount of water. 
Length (in m) and weight (in kg) were determined to calculate the body mass index. 
The subjects acclimatized for at least 20 min in a comfortable supine position with 
their arms supported at heart level. Subsequently the following measurements were 
performed. 
Systolic (SBP) and diastolic blood pressure (DBP) were measured at the left upper 
arm by an Arteriosonde (in mmHg; Roche Medical Electronics Inc., Oranjeburg, NJ, 
USA)." Heart rate (in beats per minute) was calculated from 10 RR intervals of an 
electrocardiogramstrip. 
Forearm muscle blood flow (FBF) was measured at the left forearm by strain 
gauge venous occlusion plethysmography (in ml/100 ml/min; Loosco BVP 96, 
Hoekloos, Amsterdam, The Netherlands). A wrist cuff was inflated up to 40 mmHg 
to exclude the venous return from the hand. 
FST was measured on the second volar fingertip of the right hand (in "C; 
Thermocouple, Ellab Instruments, Copenhagen, Denmark). 
LDF was measured by an unhealed 90° probe fixed on the third volar fingertip of 
the right hand (in arbitrary units (AU); Periflux Pf-ld, Perimed, Stockholm, Sweden). 
The gain was adjusted to 3, the cutoff frequency to 12 kHz and the time constant to 
3 sec. The LDF signal was continuously written on a chart recorder. Zero calibration 
was performed by readjusting the pen to zero, when the probe was fixed to a white, 
nonmoving surface. LDF values were calculated afterwards as the mean during a 1-
min period. 
Transcutaneous oxygen tension (TcP02) was measured on the fourth volar 
fingertip of the right hand (in mmHg; Tacomette, Novametrix Medical Systems Inc., 
Connecticut, USA) with the probe heated to 45 eC. 
In all previously mentioned measurements the average of three pretest values 
obtained within 10 min were used as baseline value. Subsequently, the cooling 
procedure followed. The right hand, with a fitting plastic glove, was immersed to 
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just beyond the metacarpophalangeal joints into a water bath of 16°C for S min. 
Every minute the momentary FST was registered and the mean LDF was averaged 
during that minute. During the recovery period of 20 min FST and LDF were 
obtained every 2 min. FBF, heart rate, SBP, and DBF were measured every 10 min. 
Data analysis 
Results are given as means ± SD, unless stated otherwise. A ρ value of less than 
0.05 (two-tailed) was considered to be significant. While the study evolved some 
measurement techniques were added or changed and some results are consequently not 
available for the whole group. 
As FBF, heart rate, SBP, or DBP did not change during the test, the baseline 
value was used in the analysis. The mean arterial blood pressure (MAP; in mmHg) 
was calculated from the formula MAP=(SBP+2DBP)/3. The body mass index was 
calculated by dividing weight by height2 and expressed in kg/m\ 
In the analysis for both FST and LDF the following parameters were used: the 
mean of three pretest values (baseline), the value at the end of the cooling period, the 
percentual decrease during cooling and the value after 12 and 20 min of recovery. 
Furthermore, we calculated the mean level during cooling, the mean level during 
recovery and the mean level during the whole test by determining the area under the 
curve divided by the duration of that test period." 
Differences between groups were calculated with the Wilcoxon two sample test. 
Multiple (stepwise) regression was used to detect factors possibly influencing the skin 
circulation parameters such as blood pressure, heart rate, FBF, age, body mass index, 
hand volume, and amount of subcutaneous fat. 
Sensitivity (i.e. the proportion of true Raynaud patients recognized) and specificity 
(i.e. the proportion of true negative subjects) were determined for all FST and LDF 
parameters during the finger cooling test, separately for males and females. We also 
calculated the likelihood ratio of a positive test result (sensitivity/1-specificity) and the 
positive predictive value (prevalence/{prevalence + (l-prevalence)/likelihood ratio}." 
RESULTS 
General characteristics 
The general characteristics of the healthy subjects and the patients with RP are shown 
in Table 7.1. Both groups are subdivided according to sex. 
In both groups, i.e. the healthy subjects and the Raynaud patients, males were 
older (p<0.05), had a greater hand volume (p< 0.001) and had a smaller amount of 
subcutaneous fat (respectively ρ < 0.05 and ρ < 0.001) compared with females. 
Table 7.1. General characteristics of the healthy subjects and the patients with Raynaud's phenomenon (means ± SD). Both groups are divided 
according to sex. 
Number 
Age 
(yr) 
Range 
Body mass index 
(kg/m2) 
Hand volume 
(ml) 
Amount of subcutaneous 
(*) 
fat 
Healthy Subjects 
Males 
35 
39.5 ± 13.4 θ * 
21-67 
23.7 ± 2.7 (28) 
485.4 ± 36.1 (12)* 
25.6 ± 6.1 (13)* 
Females 
66 
34.8 ± 13.9 θ 
17-63 
22.9 ± 3.4 (54) 
334.1 ± 64.7 (53) 
30.9 ± 8.0 (53) 
Raynaud's Phenomenon 
Males 
52 
45.7 ± 12.6 * 
14-70 
23.2 ± 3.3 (19) 
488.2 ± 66.8 (17)· 
22.1 ± 5.θ (19)* 
Females 
144 
41.2 ± 15.6 
12-79 
22.6 t 4.6 (59) 
326.0 ± 54.1 (56) 
31.5 ± 6.0 (55) 
The numbers between parentheses refer to the number of subjects, when different from the whole group. * refers to a significant difference (p<0.05) 
between males and females in each group. @ refers to a significant difference (p<0.05) between the healthy subjects and the Raynaud patients in 
males and females, respectively. 
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Both male and female patients were significantly older (p<0.01) than the male and 
female healthy subjects. Body mass index, the amount of subcutaneous fat and the 
hand volume were not significantly different between the patients and the healthy 
subjects. 
Hemodynamic parameters 
Hemodynamic parameters of the healthy subjects and of the patients with RP are 
shown in Table 7.2. In the healthy subjects SBP, DBF and MAP were significantly 
higher (all ρ < 0.05) in males. In the Raynaud patients only SBP was higher in males 
(p<0.05). 
In the Raynaud patients (both in the females and in the males) heart rate, SBP, 
DBP and MAP were significantly higher than in the healthy subjects (all ρ < 0.05). 
Peripheral circulation 
Values of FBF and TcP02 are shown in Table 7.2. FBF was higher in the healthy 
males (5.4 ± 1.4 ml/100ml/min) than in the healthy females (3.9 ± 1.6 
ml/100ml/min, ρ < 0.05). In the Raynaud patients there was no sex difference in FBF. 
FBF in the male healthy subjects (5.4 ± 1.4 ml/100ml/min) was significantly higher 
than in the male Raynaud patients (3.9 ± 1.2 ml/100ml/min, p<0.01). In females 
there was no difference between the Raynaud patients and healthy controls. Between 
the PRP and SRP patients FBF was not significantly different (data not shown). 
TcP02 did not differ between the sexes, neither in the healthy subjects nor in the 
Raynaud patients. TcP02 was significantly higher in the group of healthy subjects 
compared with the group of patients (30.0 ± 17.4 and 22.9 ± 13.5 mmHg, 
ρ < 0.001). In the SRP patients TcP02 was lower when compared with the PRP 
patients (respectively 18.7 ± 14.5 and 27.0 ± 1 1 . 1 mmHg, ρ < 0.001). When the 
SRP patients with scleroderma and CREST (n=28) were compared with the remaining 
patients with SRP, TcP02 was significantly lower in the patients with scleroderma 
and CREST (10.3 ± 10.0 versus 22.7 ± 14.3 mmHg, ρ<0.001). 
Finger cooling test 
Finger skin temperature 
All FST parameters were significantly higher in the control subjects than in the 
Raynaud patients (all ρ<0.001). Between the PRP and SRP patients no significant 
differences in FST parameters were found. When both groups of healthy subjects and 
Raynaud patients were divided according to sex (see Figure 7.1 (upper panel) and 
Table 7.3 (upper panel)), the following differences were observed. Healthy females, 
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when compared with healthy males, recovered more slowly after cooling: the mean 
level during recovery for females was 27.4 ± 4.80C and for males 30.7 + 3.90C, 
ρ < 0.01. Female Raynaud patients, when compared with male patients, had a lower 
baseline FST (females, 28.6 ± 4.10C; males, 31.3 ± 3.80C, p<0.001) and they also 
recovered more slowly after cooling (mean level during recovery in females, 23.1 ± 
3.80C; males, 26.6 ± 4.8'>C, p<0.001). 
15 20 25 30 
5 10 15 20 25 30 
time (minutes) 
F HS F RP M HS M FIP 
Figure 7.1. Finger skin temperature (upper panel) and laser Doppler flux, in arbitrary units 
(AU, lower panel), means ± SEM before and during cooling in a 16°С water bath and 
during 20 min of recovery afterwards in the female healthy subjects (F HS), the male healthy 
subjects (M HS), the female patients with Raynaud's phenomenon (F RP) and the male 
patients with Raynaud's phenomenon (M RP). 
When comparing the male healthy subjects with the male patients, all FST parameters 
except for the percentual decrease during cooling were significantly higher in the male 
healthy subjects (all ρ < 0.001). In the females all FST parameters were significantly 
higher in the healthy subjects than in the Raynaud patients (all ρ <0.001). 
Table 7.2. Hemodynamic baseline parameters in the healthy subjects and the patients with Raynaud's phenomenon (means ± SD). Both groups are 
divided according to sex. 
Healthy Subjects Raynaud's Phenomenon 
Males Females Males Females 
Number 35 66 52 144 
Blood pressure (nrniHg) 
Systolic 114.0 ± 10.2 θ * 107.1 ± 9.6 @ 125.7 ± 16.3 * 119.5 ± 19.0 
Diastolic 73.2 ± 6.7 @ * 70.2 ± 6.1 θ 78.3 ± 10.1 76.4 ± 10.0 
Mean 86.8 ± 6.8 θ * 82.5 ± 6.3 θ 94.1 ± 11.3 90.8 ± 11.9 
Heart rate 
(beatβ/min) 66.4 1 9.2 β 66.3 ± 9.7 θ 71.6 ± 9.7 72.3 ± 9.4 
Forearm blood flow 
(ml/100ml/min) 5.4 ± 1.4 θ (9) * 3.9 ± 1.6 (43) 3.9 ± 1.2 (43) 3.6 ± 1.6 (130) 
Transcutaneous oxygen pressure 
(mmHg) 40.0 ± 15.2 θ (25) 37.3 ± 11.3 θ (47) 24.6 ± 14.6 22.8 ± 12.8 
The numbers between parentheses refer to the number of subjects, when different from the whole group. * refers to a significant difference φ < 0.05) 
between males and females in each group. @ refers to a significant difference (p<0.05) between the healthy subjects and the Raynaud patients in 
males and females, respectively. 
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In Table 7.4 (upper panel) the FST data between the PRP patients and the SRP 
patients are compared, again divided according to sex. In the PRP patients all 
parameters were significantly lower in females compared with males (all ρ<0.001). 
Also in the SRP patients these differences were present (all ρ < 0.05), except for 
respectively the baseline value, the percentual decrease during cooling and the mean 
level during cooling. 
When comparing either the male PRP patients with the male SRP patients or the 
female PRP patients with the female SRP patients, no significant differences were 
observed. 
Laser Doppler flux 
AU LDF parameters, with the exception of the percentual decrease during cooling, 
were significantly higher in the healthy subjects (all p<0.001). Between the PRP and 
SRP patients no significant differences in the LDF parameters were seen. 
In Figure 7.1 (lower panel) and Table 7.3 (lower panel) the LDF values during 
the finger cooling test are shown separately for the males and for the females in the 
healthy subjects as well as in the Raynaud patients. 
In accordance with FST, LDF was significantly different between males and 
females in both groups. When compared with healthy males, healthy females 
recovered more slowly after cooling: the mean level during recovery for females was 
23.4 ± 17.4 AU and for males 32.5 ± 16.3 AU, ρ < 0.01. In the patients with RP, 
women had a lower baseline value (females, 16.6 ± 13.4 AU; males, 25.7 ± 15.5 
AU, ρ < 0.001) and they also recovered more slowly after cooling than males (mean 
level during recovery in females, 8.2 ± 9.0 AU; males, 17.5 ± 15.4 AU, p<0.001). 
In Table 7.4 (lower panel) all LDF parameters of the PRP patients and the SRP 
patients are compared for both males and females. In the PRP patients all parameters 
were significantly lower in females compared with males (all ρ < 0.001). In the SRP 
patients these significant differences were also present (all ρ < 0.05), except for the 
baseline value, the percentual decrease during cooling and the mean level during 
cooling. 
When comparing either the male PRP patients with the male SRP patients or the 
female PRP patients with the female SRP patients no significant differences in LDF 
parameters were observed. Finally, the patients with scleroderma or CREST, when 
compared with the remaining SRP patients, showed a significantly lower baseline 
LDF, LDF after cooling, and after 12 and 20 min of recovery, and mean LDF during 
recovery (all p<0.05, data not shown). 
Table 7.3. Means ± SD of finger skin temperature parameters (FST, upper panel) and laser Doppler flux parameters (LDF, in arbitrary units (AU), 
lower panel) before, during and after cooling in the healthy subjects and in the patients with Raynaud's phenomenon. Both groups are divided 
according to sex (M=males and F=females). The numbers between parentheses refer to the number of subjects, when different from the whole group. 
Healthy Subjects Raynaud's Phenomenon) 
M (n=35) F (n=66) M (n=52) F (n=144) 
FST (eC) 
Baseline 
End of cooling 
Decrease (%) 
Mean level during cooling 
After 12 min of recovery 
End of recovery 
Mean level during recovery 
Mean level during test 
LDF (AU) 
Baseline 
End of cooling 
Decrease (%) 
Mean level during cooling 
After 12 min of recovery 
End of recovery 
Mean level during recovery 
Mean level during test 
34.2 
22.β 
33.5 
25.0 
32.1 
32.8 
30.7 
30.6 
43.6 
22.2 
50.7 
27.0 
35.5 
36.5 
32.5 
33.2 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
1.3 θ 
3.4 θ 
8.8 
2.2 @ 
3.9 e 
з.з e 
3.9 @ 
3.0 θ 
15.4 @ 
19.8 e 
32.8 
16.3 θ 
16.1 e 
16.0 θ 
16.3 β 
15.8 θ 
* 
* 
* 
* 
(28) 
* 
* 
* . 
(28) 
33.4 
21.7 
35.1 
24.3 
28.4 
29.3 
27.4 
28.3 
38.9 
17.2 
57.3 
22.0 
25.1 
24.6 
2Э.4 
26.4 
± 
± 
± 
± 
± 
± 
± 
± 
+ 
± 
± 
± 
± 
± 
± 
± 
2.5 θ 
3.0 @ 
7.8 @ 
2.2 @ 
5.0 β 
4.8 θ 
4.8 θ 
3.6 @ 
16.6 @ 
15.1 θ 
28.5 
14.7 θ 
19.6 @ 
18.3 e 
17.4 e 
15.7 β 
(58) 
(58) 
31.3 
20.6 
33.7 
22.9 
27.6 
29.2 
26.6 
27.1 
25.7 
10.8 
52.4 
17.0 
19.4 
21.5 
17.5 
19.4 
± 
± 
± 
+ 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
3.8 
2.5 
7.4 
2.2 
5.2 
5.0 
4.8 
3.9 
15.4 
10.8 
45.5 
13.6 
19.0 
18.5 
15.4 
15.8 
(22) 
(22) 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
28.6 
19.3 
31.9 
21.6 
23.8 
25.1 
23.1 
24.0 
16.6 
5.6 
59.3 
8.5 
8.9 
9.5 
8.2 
11.2 ± 
4.1 
2.1 
6.6 
2.2 
4.2 
4.3 
3.8 
3.4 
13.4 
6.3 
35.7 
7.7 (61) 
10.1 
11.0 
9.0 
9.0 (61) 
* Refers to a significant difference (ρ < 0.05) between males and females in each group. 
® Refers to a sigmficant difference (p<0.05) between the male healthy subjects and the male Raynaud patients, respectively between the female 
healthy subjects and the female Raynaud patients. 
Table 7.4. Means ± SD of finger skin temperature parameters (FST, upper panel) and laserDopplerflux parameters (LDF', in arbitrary units (AU), 
lower panel) before, during and after cooling in the patients with primary (PRP) and with secondary (SRP) Raynaud's phenomenon. Both groups 
are divided according to sex (M=males and F=females). The numbers between parentheses refer to the number of subjects, when different from the 
whole group. 
FST <0C) 
Baseline 
End of cooling 
Decrease (%) 
Mean level during cooling 
After 12 rain of recovery 
End of recovery 
Mean level during recovery 
Mean level during test 
LDF (AU) 
Baseline 
End of cooling 
Decrease (%) 
Mean level during cooling 
After 12 min of recovery 
End of recovery 
Mean level during recovery 
Mean level during test 
PRP 
M (n=21) 
32.4 
20.7 
36.0 
23.4 
28.1 
30.2 
27.2 
27.7 
28.3 
9.9 
63.8 
10.0 
20.4 
21.8 
18.4 
14.7 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
1 
± 
1 
± 
± 
± 
2.9 
2.4 
7.1 
1.8 
5.0 
4.5 
4.5 
3.5 
14.5 
8.6 
23.5 
7.4 
16.6 
15.1 
13.4 
11.8 
(10) 
(10) 
F 
* 
* 
* 
* 
* 
# 
* 
* 
* 
* 
* 
* 
* 
(n=78) 
28.1 
19.1 
31.3 
21.5 
23.5 
24.7 
26.2 
23.7 
17.8 
5.7 
60.8 
9.8 
8.5 
9.2 
8.0 
12.8 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
4.3 
1.9 
6.6 
2.3 
4.1 
4.2 
5.0 
3.3 
14.3 
6.5 
37.6 
8.3 
9.4 
10.7 
8.2 
9.3 
(37) 
(37) 
SRP 
M (n= 
30.5 
20.6 
32.1 
22.6 
27.2 
28.5 
26.2 
26.6 
23.8 
11.5 
45.1 
22.8 
18.7 
21.3 
16.9 
23.4 
=31) 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
4.1 
2.6 
7.3 
2.4 
5.4 
5.2 
5.0 
4.2 
16.0 
12.2 
54.4 
15.0 
20.8 
20.7 
16.θ 
18.0 
(12) 
(12) 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
F (n= 
29.1 
19.4 
32.6 
21.8 
24.1 
25.5 
23.5 
24.3 
15.2 
5.6 
57.6 
6.7 
9.3 
9.8 
8.5 
8.8 
=66) 
3.9 
2.2 
6.4 
2.2 
4.4 
4.5 
4.1 
3.4 
12.2 
6.1 
33.4 
6.4 (24) 
11.0 
11.4 
9.8 
8.0 (24) 
* Refers to a significant difference (p<0.05) between males and females in each group. 
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Influencing factors 
No significant influence of hemodynamic (MAP, heart rate and FBF) and of biological 
factors (age, body mass index, amount of subcutaneous fat and hand volume) on the 
different test parameters was found when tested by multiple regression. 
Discriminating diagnostic parameters 
In Figure 7.2 all individual values of the healthy subjects and the Raynaud patients 
are given for one parameter: the mean level during recovery of both FST and LDF. 
In Table 7.5 values for sensitivity are shown for each parameter for males as well 
as females, when specificity was 70% for every parameter by choosing the 
appropriate cutoff point below which RP was diagnosed. For males and females 
different cutoff points were found, with lower values in females for all test 
parameters. The sensitivity varied between 55% and 81% for the various parameters. 
No single parameter was superior in the discrimination between healthy subjects and 
Raynaud patients. This was true both for the male and the female groups. The 
likelihood ratio of a positive test result varied between 1.8 (mean level during cooling 
LDF in males: 55/30) and 2.7 (baseline LDF in females: 81/30). The likelihood 
ratios of the test parameters most often used in the past, i.e. the value after 12 min 
of recovery10 and of the mean level during recovery" are almost equal. 
DISCUSSION 
In this study significant differences in FST and LDF were found between healthy 
subjects and patients with RP before, during, and after a standardized cooling 
procedure. No significant differences were present between the PRP and the SRP 
patients. Sex differences were shown in all groups, in the healthy subjects as well as 
in the patients with PRP or SRP, in general with higher values in males. Therefore, 
all results of the finger cooling test were considered separately for males and females. 
Because of the rather poor sensitivity and specificity of the different test 
parameters, a reliable classification of an individual as a healthy subject or as a 
Raynaud patient on the base of this finger cooling test alone is imposssible. In the 
analysis a high sensitivity (high true positive rate) rather than a high specificity of the 
finger cooling test was preferred. Increasing the sensitivity, however, reduces the 
specificity of the test. A specificity of 70% was arbitrary chosen to calculate the 
sensitivity. Unfortunately, with this low specificity, sensitivity was still rather poor, 
varying between 55 and 81%. Moreover, as the prevalence of RP is lower in less 
selected populations than ours, the predictive value of a positive test will then be 
reduced further. 
Table 7.5. Cutoff values with calculated sensitivities and a specificity of 70% for finger skin temperature and laser Doppler flux fin arbitrary units, 
AU). 
Parameter 
Baseline 
End of cooling 
Mean level during cooling 
After 12 min recovery 
End of recovery 
Mean level during recovery 
Mean level during test 
Finger 
Males 
Cutoff 
value 
34.0 
20.1 
23.6 
32.4 
33.1 
28.9 
29.1 
skin temperature (0C) 
Sensitivity 
(%) 
71 
62 
69 
77 
73 
69 
71 
Females 
Cutoff 
value 
33.1 
19.7 
23.2 
24.2 
25.0 
23.4 
25.7 
Sensitivity 
(%) 
79 
72 
74 
72 
65 
71 
75 
Laser Doppler flux (AU) 
Males 
Cutoff 
value 
33.3 
10.0 
15.5 
26.0 
24.0 
19.6 
21.8 
Sensitivity 
(%) 
69 
59 
55 
69 
62 
67 
70 
Females 
Cutoff 
value 
27.0 
7.0 
10.2 
7.0 
9.0 
8.1 
13.2 
Sensitivity 
(%) 
81 
79 
69 
67 
68 
68 
67 
FST mean level during recovery CC) 
36-
3Í 
32 
30 
28 
26 
2¿ 
22 
20-
18 
Τ £<· 
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i . 
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Healthy subj PRP-patients SRP-patients 
N= 101 98 97 
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Figure 7.2. Individual values of finger skin temperature (FST) and laser Doppler flux (LDF, in arbitrary units, AU) of the mean level during the 
recovery period in the healthy subjects and the patients with primary Raynaud's phenomenon (PRP) and secondary Raynaud's phenomenon (SRP). 
Means ± SD are given for the healthy subjects and all patients with Raynaud's phenomenon, separate for males and 
females. 
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Leppert also found a considerable overlap in individual responses and a low sensitivity 
of finger systolic pressure measurements during local and whole body cooling in 
female patients with PRP and in female healthy controls.30 Carter et al, also using 
finger systolic pressure measurements, showed a high accuracy of local and whole 
body cooling in patients with SRP but not in patients with PRP.21 They encountered 
the same difficulty as we did: a considerable overlap between healthy subjects and 
Raynaud patients. 
A critical approach towards peripheral circulatory measurements in Raynaud patients 
is certainly necessary. 
First, cooling tests are meant to evaluate an objective response to cold provocation 
in Raynaud patients. However, as also experienced by other investigators,22 we were 
mostly unable to elicit the typical colour changes in Raynaud patients. Besides, the 
reported lack of relationship between the subjective severeness of the vasospasm and 
the abnormal blood flow response20 questions the reliability of provocative tests in 
Raynaud patients. 
Second, all measurements of the peripheral circulation are hampered by the 
enormous changes in flow over a short period of time due to several physiologic 
stimuli. These factors include changes in position, perfusion pressure, heart rate or 
ambient temperature, vasomotion, hormonal status, previous smoking and stress. 
Although the strict standardization of the test reduces these stimuli, they can never be 
ruled out completely. 
Third, some hypothesize that PRP is an extreme of the normal physiologic 
vasoconstriction to cold. They consider the individual's reactivity towards cold a 
continuum, composed of subjects without any complaints of cold digits at one end, 
subjects with cold digits without or with monophasic discolorations in the middle and 
subjects with bi- or even triphasic discolorations of the fingers at the other end. The 
resulting overlap in circulatory reactivity between patients with PRP and healthy 
subjects is then a logical consequence of this hypothesis. 
Some limitations are applicable to the present study. At the time of the study we were 
unable to perform nailfold capillaroscopy to detect specific capillary alterations 
suggestive for an underlying disease. However, all patients were carefully evaluated 
according to a protocol with special emphasis on clinical1" and immunological' signs 
of an underlying disease. Part of the evaluation protocol consisted of careful 
inspection of the nailfold capillaries by a magnifying glass that enables to detect at 
least some alterations in the nailfold capillaries. Follow-up was extended to at least 
two years before a definite classification was made. 
In the period we started to perform the finger cooling tests, the 25% -calibration 
solution for LDF was not available yet, and therefore results are not given in 
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perfusion units. Recent calibration results showed an apparatus drift of only S % over 
three months. 
We also did not subtract the biological zero LDF. This value is relatively low ( < 2 
AU) in healthy subjects and in PRP patients and therefore would not change LDF 
significantly in these groups.25 However, in SRP patients (especially in progressive 
systemic sclerosis) the biological zero can be higher (up to 6 AU). This suggests that 
in these patients LDF after subtraction of the biological zero would become lower. 
This consequently would result in a better discrimination between primary and 
secondary Raynaud patients as described here. 
Since the differences in FST and LDF between the groups might be caused by 
biological (age, hand volume, body mass index, amount of subcutaneous fat) or 
hemodynamic differences (blood pressure, heart rate, FBF, TcP02), multiple 
regression was used to analyse their possible influence on the test results. 
The patients with RP (especially those with SRP) were significantly older than the 
healthy subjects. However, age was shown not to influence the results of the finger 
cooling test. There were no significant differences between the healthy subjects and 
the patients with regard to other factors like the hand volume, the body mass index 
or the amount of body fat. Furthermore, none of these had any significant influence 
on the test results. Previously it was hypothesized that subjects with a small hand 
volume,24 with a low body mass index" and a small amount of subcutaneous fat show 
an increased tendency towards cold induced vasoconstriction. These assumptions are 
not supported by the findings in the present study. 
Blood pressure and heart rate were different between the groups. The higher blood 
pressure in the patient group might partly be due to the higher age. Blood pressure 
could theoretically influence the peripheral circulation by determining skin perfusion 
pressure, but neither SBP, nor DBP or MAP were found to influence FST and LDF. 
In males FBF, which represents mainly muscle blood flow, was higher in the healthy 
subjects compared with the Raynaud patients. Muscle blood flow could influence skin 
perfusion by a competitive mechanism. In this study, however, no such influence was 
found. The relatively high FBF found is explained by the use of a wrist cuff inflated 
at supravenous pressure which does not exclude hand blood flow.26 
TcP02 was different between the healthy subjects and the patients. Skin oxygen 
tension is the resultant of nutritional skin blood flow, and as shown the observed 
difference is due to the low values in patients with underlying disease, which is in 
accordance with their impaired capillary blood flow.*7 The lower TcP02 found in the 
subgroup of SRP patients with scleroderma or CREST is in line with the increased 
formation of avascular fibrotic tissue with an impaired oxygen diffusion capacity of 
the finger skin in these diseases. Moreover, the laser light used in laser Doppler 
fluxmetiy is increasingly dispersed by this connective tissue and therefore also 
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produces a lower signal.2* 
Sex differences were found not only in healthy subjects, but in patients with PRP or 
SRP as well. The curves in Figure 7.1 representing the finger cooling test in healthy 
females and in females with RP show a close resemblance, just like the curves for 
male healthy subjects and male patients with RP. The sex difference is most 
pronounced during the recovery period. Both female healthy subjects and female 
patients recover more slowly after cooling than male healthy subjects and male 
patients. Although found in healthy subjects, this sex difference was not observed in 
Raynaud patients in another study.29 It could reflect either an inability to vasodilate 
after cold induced vasoconstriction or a prolonged vasoconstriction in females. An 
explanation for the observed sex difference could be the modulation of peripheral 
vascular reactivity by female sex hormones.30 31 Estrogens are assumed to increase 
vasoconstriction, probably by up-regulation of α-adrenergic receptors.32 33 However, 
in humans no direct relationship between levels of circulating female sex hormones 
and skin vascular reactivity has been shown yet. 
In conclusion, although FST and LDF during a standardized cooling procedure were 
significantly lower in patients with RP in comparison with healthy subjects, the 
pronounced overlap limits the diagnostic value in individual cases. However, when 
comparing groups in pathophysiologic or in therapeutic studies this finger cooling test 
can be useful. Not only in healthy subjects, but also in Raynaud patients, sex should 
be considered when interpreting results of cold provocation tests. Consequently 
different cutoff points in diagnostic test parameters should be used for male and 
female patients. 
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ABSTRACT 
It is known that females have a lower skin perfusion than males. In women there are 
also differences in blood flow at different reproductive stages of their lives. As an 
initial investigation of the possible contribution of sex hormones to these differences, 
we studied skin and forearm blood flow during the natural changes in hormone leveL· 
which occur during the menstrual cycle. Thirty-one healthy female volunteers were 
studied. The effect of a standardized finger cooling test (immersion of a gloved hand 
in a 160C water bath) on finger skin temperature and on laser Doppler flux in the 
finger, and forearm blood flow (strain gauge venous occlusion plethysmography) was 
assessed at four different times during one cycle: during menstruation, 1 day before 
ovulation, 2 days after ovulation and at the mid-luteal phase. Test days were 
determined by daily measurements of basal body temperature and were confirmed 
afterwards by determinations of serum luteinizing hormone, follicle-stimulating 
hormone, 17ß-oestradiol and progesterone. Peripheral skin circulation varied 
significantly within one menstrual cycle. The extremes were a mean finger skin 
temperature of 25.9 ± 3.0°С in the luteal phase compared with 28.4 ± 3.70C in the 
pre-ovulatory phase (p=0.002). The respective values for the mean laser Doppler flux 
were 18.4 ± 10.9 compared with 29.2 ± 16.4 arbitrary units (p=0.003). Baseline 
forearm muscle blood flow also varied significantly (p=0.04) within one menstrual 
cycle, with low values in the menstrual phase compared with the other phases. We 
have shown that peripheral skin circulation and forearm muscle blood flow exhibit 
significant variability during the hormonal changes in a menstrual cycle. 
INTRODUCTION 
There are several observations indicating that sex hormones affect peripheral blood 
flow. Healthy women, in their fertile phase of life, show up to 50% lower peripheral 
skin blood now than men, whereas there is no difference between the sexes before 
the menarche and after the menopause.12 The severity and frequency of cold-induced 
vasospastic attacks and the measured skin blood flow vary within the different phases 
of the menstrual cycle.' * ' 6 Disturbances in the peripheral circulation are not equally 
distributed between the sexes either. Vasospastic diseases, such as Raynaud's 
phenomenon, migraine and variant angina, are more common in women, whereas men 
more often suffer from atherosclerotic vascular diseases. In primary Raynaud's 
phenomenon the female/male ratio ranges between 2 and 9.' 7 ' ' The prevalence 
varies from 5% up to 20% in otherwise healthy females.7 10 " l2 The onset of 
vasospastic complaints shortly after the menarche,3 ' the improvement of symptoms 
after the menopause710 and the decrease in frequency and severity of the attacks 
during pregnancy, all suggest the influence of female sex hormones. Moreover, it is 
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suggested that oral contraceptives worsen the complaints." " 
Unfortunately there are no studies showing a correlation between naturally 
occurring levels of sex hormones and changes in blood flow. We investigated the 
possible correlation between the level of sex hormones and peripheral blood flow by 
measuring vascular reactivity during the normal changes in hormone levels which 
occur during the menstrual cycle of healthy women. 
SUBJECTS AND METHODS 
Subjects 
We selected 31 healthy female volunteers, 15-45 yr of age, with a regular menstrual 
cycle of between 26 and 32 days during the previous 4 months. None used 
medications or oral contraceptives, and no symptoms of Raynaud's phenomenon were 
present. They all gave informed consent to the protocol, which was approved by the 
hospital ethical committee. 
Methods 
On four occasions within one menstrual cycle, a provocative finger cooling test (FCT) 
was performed in order to quantify cold-induced vasoconstriction. Previously, we 
have demonstrated that finger skin temperature (FST) recovery in this test has a good 
reproducibility if room temperature and other factors influencing the finger perfusion 
are standardized.13 For this reason, all volunteers were asked to abstain from smoking 
for 24 hr, from caffeine- and alcohol-containing beverages for 12 hr and to fast for 
at least 2 hr before the test. All FCTs were performed at the same time of the day, 
in a climate room (ambient temperature: 24.7 ± 0.3oC; humidity: 59 ± 2%) with 
the subjects in a comfortable supine position, their arms at heart level. After an 
acclimatization period of at least 20 min, the following measurements were 
performed. Systolic (SBP) and diastolic (DBF) blood pressure (in mmHg) were 
measured in the left arm by Arteriosonde (Roche Medical Electronics Ine, 
Oranjeburg, NJ, USA)" and heart rate (HR, in beats/minute) was calculated from an 
electrocardiogram strip. Forearm muscle blood flow (FBF, in ml/100 ml/min) was 
measured at the left forearm by strain gauge venous occlusion plethysmography 
(Loosco BVP 96, Hoekloos, Amsterdam, The Netherlands), using a wrist-cuff 
(inflated to 40-50 mmHg) to exclude the venous return from the hand. FST (in eC) 
was measured on the second volar fingertip of the right hand (Thermocouple, Ellab 
Instruments, Copenhagen, Denmark). Laser Doppler flux (LDF, in arbitrary units) 
was measured on the third volar fingertip of the right hand (Periflux Pf-ld, Perimed, 
Stockholm, Sweden) after zero calibration. For all measurements the average of three 
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pre-test values obtained after the acclimatization period was used as the baseline 
value. After this, the gloved right hand was immersed in a water bath at 160C for S 
min, during which FST and LDF were recorded every min. During a recovery period 
of 20 min FST and LDF were measured every 2 min, whereas FBF, HR, SBP and 
DBP were measured separately every 10 min. 
The first FCT took place on the second or third day of the cycle, during 
menstruation (menstrual phase). The second FCT was performed 1 day before the 
expected day of ovulation (pre-ovulatory phase). The third test was carried out 2 days 
after ovulation (post-ovulatory phase) and the last FCT took place 8 days after 
ovulation, in the mid-luteal phase. The menstrual phase exhibits low values of all the 
sex hormones measured. In the pre-ovulatory phase 17ß-oestradiol levels are at their 
peak, progesterone levels are slightly rising and levels of both luteinizing hormone 
(LH) and follicle-stimulating hormone (FSH) are increasing. After ovulation, in the 
post-ovulatory phase, 17ß-oestradiol levels are falling, progesterone levels are still 
rising and levels of both LH and FSH are low. In the mid-luteal phase ITß-oestradiol 
levels are again at their peak, progesterone levels are at their peak and levels of both 
LH and FSH are still low (see Table 8.1). The duration of previous menstrual cycles 
was used to determine the days on which an FCT should be performed. It was 
assumed that the luteal phase had a duration of 14 days and that ovulation took place 
14 days before the first day of the next menstruation. 
Table 8.1. Hormone levels during the four phases of the menstrual cycle. Results are shown 
as mean (range). 
Phase 
17ß-Oestradiol 
(pmol/1) 
Progesterone 
(nmol/1) 
LH (Ш/1) 
FSH (Ш/1) 
Menstrual 
n=31 
207 
(75-330) 
2.4 
(1.3-5.4) 
9.4 
(5.2-16.0) 
5.1 
(1.1-9.2) 
Pre-ovulatory 
n=30 
1081 
(190-2000) 
4.6 
(1.3-13.0) 
26.8 
(8.2-72.0) 
3.1 
(2.7-16.0) 
Post-ovulatory 
n=23 
550 
(260-900) 
24.6 
(4.7-64.0) 
15.5 
(4.0-38.0) 
4.9 
(1.5-9.2) 
Mid-luteal 
n=26 
733 
(380-1000) 
68.0 
(23.0-120.0) 
10.1 
4.5-20.0) 
2.9 
(1.1-6.1) 
AH women recorded their basal body temperature during the investigation cycle 
starting on the first day of the menstrual period. Rectal temperature (during at least 
3 min) was measured each morning at the same time, before leaving the bed. The last 
low point in the temperature curve before the rise towards a hyperthermic plateau 
started, was considered the day of ovulation. In case of a difference between the 
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expected day of ovulation and the recorded basal body temperature extra FCTs were 
carried out. 
On the days on which an FCT was performed, blood was sampled by 
venepuncture of the antecubital vein for determination of the serum levels of FSH, 
LH, 17ß-oestradiol and progesterone. The samples were frozen (-20oC) and the 
hormone levels were determined later by radioimmunoassay.'7 " After the 
investigation cycle, the available hormonal data and basal body temperature charts 
were submitted to an independent, experienced observer, who verified the phase of 
the cycle. 
To control for a number of other influences on skin blood flow that might explain 
the differences in peripheral blood flow between the sexes, we also determined the 
body weight (in kg), the height (in m) and calculated the amount of subcutaneous fat 
(in %) by measuring the skinfold thickness at four standardized places of the body." 
The hand volume was determined (in ml) by immersing the right hand up to the wrist 
in a fixed amount of water. 
The mean arterial pressure (MAP, in mmHg) was calculated from the formula 
MAP=(SBP+2DBP)/3, and the forearm vascular resistance (FVR, in arbitrary units) 
was obtained by dividing MAP by FBF. The Quetelet index was calculated by 
dividing weight by (height)2 and was expressed in kg/m2. 
Data Analysis and Statistics 
The data from those tests which were retrospectively confirmed to be correctly timed 
were used. In 19 of the original 31 subjects, we obtained results in all four desired 
phases of the cycle. In the remaining 12 subjects, tests, mostly in the post-ovulatory 
phase, appeared not to have been performed at the appropriate time. Results are given 
for, and statistical analysis was performed on, all the data from correctly timed tests 
(menstrual phase, n=31; pre-ovulatory phase, n=30; post-ovulatory phase, n=23; 
mid-luteal phase, η=26). 
To obtain a measure of the overall level of FST and LDF during the FCT, the 
area under the curve during the test was calculated and divided by the total length 
(min) of the test period. The resulting quotient is a weighted average of the periods 
for which each value is representative. It is called 'mean (immersion and recovery)'. 
We used the same procedure for the cooling period (5 min), the 'mean (immersion 
only)' and for the level of FST and LDF during the recovery period (20 min), the 
'mean (recovery only)'.2" The absolute changes in FST and LDF from baseline values 
were calculated as well. 
We also made an approximation of the course of FST over time (during recovery) 
by using an exponential model.21 For each test the change in FST after recovery with 
respect to the baseline value was approximated by a simple exponentional model: 
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baseline-FST(t 'after recovery')=a exp'4*, where t is the time in min from the start 
of recovery, a is the temperature drop during immersion, and b is the rate of 
recovery. The estimated values for a and b were used as parameters for the relation 
between FST and the four phases. Statistical comparisons between the test results in 
the different phases were performed by an analysis of variance, mixed model, with 
subject as the random factor and phase as the fixed factor, and allowing some empty 
cells. Pairwise comparison between the phases was performed by using the method 
of Scheffé. 
For each subject we calculated the Kendall correlation coefficient between the 
hormone levels and mean (recovery only) FST, and to investigate the consistency of 
these relations in all women together, we used a signed rank test. Correlations 
between hormone levels and FST values for all women were calculated by Pearson 
correlation coefficients. A ρ value of less than 0.05 (two-tailed) was considered to be 
significant. All results are given as means + SD, unless indicated otherwise. 
RESULTS 
We investigated 31 females with an age of 25.0 ± 4 . 1 yr, a cycle length of 29.3 ± 
3.5 days, a body weight of 62.0 ± 9.6 kg, a height of 1.67 ± 0.07 m, a Quetelet 
index of 21.5 ± 2.5 kg/m2, an amount of subcutaneous fat of 26 ± 4% of total body 
mass, and a hand volume of 312 ± 51 ml. 
Table 8.1 gives the means and the range of the levels of the sex hormones in the 
different phases of the menstrual cycle. In Figures 8.1 and 8.2, the mean of all 
measurements of FST and LDF during the whole FCT is shown in all four phases of 
the cycle. Table 8.2 shows the FST in the different phases. There was no significant 
difference in the baseline FST between the four phases. However, on further analysis 
significant variations were found during the menstrual cycle (all ρ < 0.005) for the 
mean (immersion and recovery) FST, the mean (immersion only) FST and the mean 
(recovery only) FST. Significant Scheffé contrasts were observed between the mid-
luteal phase and the pre-ovulatory phase. Also, in the exponentional model, significant 
differences for the temperature drop a (p=0.03) and the recovery rate b (p=0.005) 
were calculated. Again, the significant contrast was between the mid-luteal phase and 
the pre-ovulatory phase for b, and between the menstrual phase and the post-ovulatory 
phase for a. Table 8.2 also shows that the LDF values varied significantly during one 
menstrual cycle. The baseline LDF showed a significant difference (p=0.04), as did 
the mean (immersion and recovery) LDF, the mean (immersion only) LDF and the 
mean (recovery only) LDF (all ρ < 0.005). Again the significant contrasts for all the 
parameters were found between the mid-luteal phase and the preovulatory phase. 
Since the baseline values were already different, the changes were also expressed as 
absolute changes from baseline and then all the mean LDF values during the different 
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phases were no longer significant. Table 8.2 gives only the most representative, the 
mean (recovery only) LDF value. 
Finger skin temperature 
FST (C) 
3 0 
2 5 
2 0 
16 
preovulatory 
menstrual 
_ ^ η postovulatory 
luteal 
Coolin (-ooline 
17 25 
TIME (MIN) 
Figure 8.1. FST before, during and after cooling, in the four different phases of the menstrual 
cycle. Results are means ± SEM. 
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Figure 8.2. LDF, in arbitrary units (AU) before, during and after cooling, in the four different 
phases of the menstrual cycle. Results are means ± SEM. 
Table 8.2. FST and LDF during the four phases of the menstrual cycle. Results are means ± SD for η tests. Abbreviation: NS, not significant. Ρ 
values refer to the analysis of variance for differences between phases. Comparisons refer to significant (p<0.05) Scheffé comparisons. 
FST ("C) 
Baseline value 
Mean (Immersion 
and recovery) 
Mean (immersion only) 
Mean (recovery only) 
Baseline minus 
mean (recovery only) 
Temperature drop a (0C) 
Recovery rate b (min ) 
LDF (arbitrary units) 
Baseline value 
Mean (immersion 
and recovery) 
Mean (immersion only) 
Mean (recovery only) 
Baseline minus 
mean (recovery only) 
Menstrual 
(M, n=31) 
32.9 
27.7 
24.5 
26.7 
6.3 
11.7 
0.12 
39.0 
26.1 
19.5 
23.4 
15.6 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
2.8 
3.6 
2.1 
4.6 
3.5 
3.0 
0.13 
17.9 
16.7 
12.5 
19.1 
14.2 
Pre-
ovulatory 
(Pro, 
33.8 
28.4 
24.8 
27.4 
6.5 
12.3 
0.18 
43.9 
29.2 
25.7 
25.0 
18.9 
, n=30) 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
2.4 
3.7 
1.8 
4.9 
4.0 
2.6 
0.21 
15.8 
16.4 
14.4 
17.7 
12.2 
Post-
ovulatory 
(PO, 
33.6 
27.2 
24.0 
25.9 
7.8 
13.5 
0.10 
38.3 
22.5 
17.8 
18.6 
19.1 
n= 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
=23) 
2.0 
3.2 
1.4 
4.3 
3.5 
1.9 
0.14 
13.4 
12.3 
9.9 
14.5 
13.6 
Mid-luteal 
(Μ, η·26) 
33.1 
25.9 
23.6 
24.1 
9.0 
12.9 
0.07 
33.9 
18.4 
16.1 
13.7 
20.3 
± 2.6 
± 3.0 
± 1.5 
± 3.9 
± 3.6 
± 2.3 
±0.12 
±12.8 
±10.9 
± 9.0 
±12.5 
±13.4 
Ρ value 
NS 
0.002 
0.004 
<0.001 
<0.001 
0.03 
0.005 
0.04 
0.003 
0.001 
0.002 
NS 
Comparisons 
Pro vs L 
PrO ve L 
PrO and M vs L 
M ve L 
M vs PO 
PrO vs L 
PrO в L 
PrO VB L 
PrO and PO ve L 
PrO and M vs L 
Table 8.3. Baseline values of blood pressure, heart rate, FBF and FVR in the four phases of the menstrual cycle. Results are means ± SD for η 
tests. Abbreviation: NS, not significant. Ρ values refer to the analysis of variance for differences between phases. 
Phase Menstrual Pre-ovulatory Post-ovulatory Mid-luteal Ρ value 
n=31 n=30 n=23 n=26 
Blood pressure (mmHg) 
Systolic 103.7 
Diastolic 69.8 
Mean 81.1 
Heart rate (beats/min) 63.5 
FBF (ml/100ml/min) 2.90 
FVR (arbitrary units) 37.6 
± 
± 
± 
t 
t 
± 
6 . 5 
6 . 5 
6 . 0 
8 . 6 
1.5 
2 7 . 3 
1 0 3 . 8 ± 
6 9 . 4 ± 
8 0 . 9 ± 
6 4 . 8 ± 
3 . 7 9 ± 
2 6 . 3 ± 
6.7 102.7 ± 
6.0 68.1 ± 
5.7 79.6 ± 
9.5 63.8 1 
2.0 3.93 ± 
10.9 24.1 ± 
5.4 103.: 
5.7 68.3 
5.1 79.9 
10.0 64.7 
1.7 3.88 
9.4 24.8 
±6.1 NS 
± 5 . 6 NS 
± 5 . 3 NS 
± 9 . 0 NS 
± 1.8 0.041 
± 10.2 0.002 
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Table 8.3 gives further baseline haemodynamic data. The baseline measurements at 
the four phases of the menstrual cycle were similar for blood pressure and HR, but 
different for FBF (p<0.05) and calculated FVR (p=0.002). The most striking finding 
here was the lower FBF in the menstrual phase compared with more or less similar 
values in the other three phases. As expected, the baseline FVR was increased in the 
menstrual phase in comparison with the three other phases. During the FCT no 
changes in blood pressure, HR and forearm parameters were detected in any of the 
four phases (data not shown). 
We looked for correlations between the results of the FCT (expressed as mean 
(recovery only) FST) and the levels of 17ß-oestradiol, progesterone, LH, FSH and 
the 17ß-oestradiol/progesterone ratio. We did not see any correlation between these 
hormones (for all subjects and all phases) and the test results. We further calculated 
correlations between the sex hormones and the test results in the different phases. We 
found a negative correlation (r=-0.48, n=26, p=0.012) between the level of 17ß-
oestradiol and the mean (recovery only) FST in the mid-luteal phase but not in the 
other three phases. 
Within subjects we found a positive correlation between the 170-
oestradiol/progesterone ratio and the mean (recovery only) FST, by calculating the 
Kendall correlation coefficients between hormone level and FST for each woman. The 
mean of these correlation coefficients was 0.38, with ρ <0.05 in the signed rank test. 
No significant correlations were found between the results of the FCT and the 
Quetelet index, the amount of subcutaneous fat or hand volume. 
DISCUSSION 
This study shows an effect of menstrual cycle phase on the peripheral skin perfusion 
and FBF. In the luteal phase, finger skin perfusion shows the greatest cold-induced 
vasoconstriction and the slowest recovery afterwards as compared with the other 
phases of the cycle. The adaptation to changes in environmental temperatures and 
emotions results in large physiological fluctuations in peripheral skin blood flow, 
which causes difficulties in measuring this parameter. Consequently, both methods, 
FST and LDF, have a high SD. 
Lafferty et al/ and Terregino & Seibold3 also found cyclic differences in finger 
skin blood flow, but in a different pattern from that which we found. In contrast with 
these studies, we studied a much larger group of subjects, our FCT was strictly 
standardised" and we used the combined determination of serum 17ß-oestradiol, 
progesterone, LH and FSH and a basal body temperature chart to determine the 
correct timing of ovulation. 
We have also shown a cyclic change in FBF, consisting mainly of muscle flow. 
This appeared to be low in the menstrual phase, consistent with other reports of a 
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lower blood flow in the calf during menstruation.22 
The particular role played by sex hormones in the regulation of the peripheral 
circulation is not yet known. There might be a direct influence on the blood vessel 
wall or through other peripheral regulation mechanisms, or an indirect systemic 
hormonal action causing a cyclic pattern in females. Besides, non-hormonal factors 
might be responsible for differences in women compared with men. The influence of 
natural and synthetic oestrogens on different tissues and arteries and veins has been 
the object of studies both in vitro or in vivo, mostly in animals. Observations are 
largely dependent on the species and the tissue used and cannot be automatically 
extrapolated to other species or tissues. Natural and synthetic oestrogens may 
sometimes exhibit a completely opposite effect on the same target.23 u и u 
The regulation of cutaneous blood flow and the response to cold challenge is 
mainly under sympathetic nervous system control. The vasomotor tone within skin 
vessels, particularly the arteriovenous anastomoses, is reflexly influenced by both 
local circulating mediators and the sympathetic nervous system. Nutritional capillary 
skin flow is more constant and is influenced by local factors rather than directly by 
sympathetic nerves. The sympathetic nervous system releases catecholamines into the 
synaptic cleft that may stimulate vasoconstrictive ^-adrenoceptors and vasodilating 
fl2-adrenoceptors. Some investigators have found cyclical changes in platelet Oj-
adrenoceptors,27 others found cyclical changes only in ßj-adrenoreceptors,2* and some 
no change at all.2* Studies point to an influence of oestrogens on the sympathetic 
nervous system and there is evidence that oestrogens induce an up-regulation of 
(vasoconstrictive) aj-adrenoceptors.30 " 32 Experiments in arteries and veins of rats 
revealed a dose-dependent reactivity of oestrogens, with vasoconstriction after low and 
vasodilation after high dosage.33 " Although much less investigated, the same seems 
true for progesterone, leading to a vasoconstrictive as well as a vasodilatory effect, 
the latter possibly by influencing the vasodilating ß-adrenoceptors.26 3* The most 
satisfying hypothesis is that the cyclical 170-oestradiol/progesterone ratio and its 
continuous fluctuation is of major importance in the vascular responsiveness in 
women. Indeed, we did find a correlation between this ratio and the blood flow, 
although it was a weak. 
The sex hormonal influenced premenstrual fluid and electrolyte retention or the 
progesterone-induced post-ovulatory elevated core temperature may play an indirect 
role in the regulation of the peripheral circulation. Eventually, non-hormonal factors 
may have an influence on the skin circulation. For example, a low Quetelet index or 
a low amount of subcutaneous fat may lead to less isolation against low temperature. 
Also, a low hand volume may imply that a relatively greater surface is in contact with 
the environmental temperature." Yet we could not establish that any of these factors 
influenced the FCT. 
In conclusion, this study has demonstrated that during the menstrual cycle with its 
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natural changes in sex hormone levels, the peripheral circulation and its response to 
cold changes. These differences are worth considering when the peripheral circulation 
of females is investigated without knowledge of the phase of the menstrual cycle. 
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ABSTRACT 
To investigate the influence of the hormonal status on skin vascular reactivity 18 
males, 18 women using oral contraceptives (oc), 17 premenopausal and 18 
postmenopausal women were studied. Finger sldn temperature (FST in "C) and laser 
Doppler flux (LDF in perfusion units) were measured during heating (45е С water 
bath) and cooling (15 "C) followed by a subsequent recovery period. Maximal heat-
induced vasodilation was significantly higher in women using oc and in premenopausal 
women when compared with males. During cooling, FST and LDF were significantly 
higher in males compared with, respectively, women using oc and premenopausal 
women. FST was also higher in postmenopausal women compared with women using 
oc. During recovery, FST was significantly higher in males than in women using oc. 
LDF was significantly higher in males than in women using oc and in premenopausal 
women. These findings are consistent with a less pronounced and less prolonged cold 
induced vasoconstriction in males. Other hemodynamic (such as blood pressure or 
heart rate) or biological factors (such as age, amount of subcutaneous fat, hand 
volume or body mass index) that possibly influence peripheral blood flow were found 
not to influence the results. In conclusion, the observed differences in vascular 
reactivity towards temperature changes between subjects with a different hormonal 
status suggest that sex hormones influence finger skin perfusion. 
INTRODUCTION 
Vasospastic syndromes such as Raynaud's phenomenon (RP) and migraine are more 
common in females than in males.1 2 In women the severity of complaints of RP is 
most pronounced in the period between menarche and menopause.12 3 * Occasionally 
case reports suggest a negative influence of oral contraceptives (oc) on the 
complaints.3 
In healthy subjects sex differences in peripheral circulation have been found as 
well.'7 * ' 10 The observed lower resting skin blood flow in females in comparison 
with males disappears in postmenopausal women.6 Administration of oc induces 
alterations in both peripheral muscle and skin blood flow in premenopausal women.9 " 
12
 " Several investigators observed a variation in finger skin blood flow in 
premenopausal women in different phases of the menstrual cycle." u l3 " Although 
a clear and direct relationship between circulating endogenous or exogenous estrogens 
or progestagens has not been shown in these studies in humans, the observations 
suggest an influence of these female sex hormones on the peripheral circulation. In 
animal studies, however, synthetic as well as endogenous estrogens, progestagens and 
androgens have been observed to influence vascular reactivity.17 " In general, it is 
assumed that estrogens are able to enhance vascular tone, whereas progesterone either 
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has no effect or tends to do the reverse. The effects of testosterone, luteinizing 
hormone (LH) or follicle stimulating hormone (FSH) are not well documented." 
To investigate the influence of hormonal status on skin blood flow, four groups 
of healthy volunteers with a different hormonal status were studied, respectively a 
group of males and three groups of females: premenopausal and postmenopausal 
women and women using oc. As shown in Table 9.1, testosterone is present in males 
but both female sex hormones ITB-estradiol and progesterone are almost absent. All 
women have low levels of testosterone. The menstrual phase of women is 
characterized by low 17fl-estradiol and progesterone after previously high levels. Use 
of the combined oral contraceptive pill produces high levels of synthetic estrogens and 
progestagens with consequent depression of FSH and LH and the endogenous 
production of sex hormones. After the menopause involution of the ovaries results in 
very low 17ß-estradiol and progesterone levels with high FSH and LH levels. We 
hypothesize that subjects with elevated levels of synthetic sex hormones or endogenous 
estradiol and progesterone show enhanced vascular reactivity compared with 
postmenopausal women and males. The absence of female sex hormones in males and 
postmenopausal women might induce less vascular reactivity compared with the other 
groups of females. 
Table 9.1. Level of sex hormones in the four groups: women using oral contraceptives, 
premenopausal women, postmenopausal women and males. 
Testosterone 
17fl-Estradiol 
Synthetic estrogens 
Progesterone 
Synthetic progestagens 
FSH, LH 
Oral 
contraceptives 
low 
low 
high 
low 
high 
low 
Premeno-
pausal 
low 
low, but 
cyclic 
variation 
-
low, but 
cyclic 
variation 
-
low 
Post-
menopausal 
low 
low 
-
low 
-
high 
Males 
high 
low 
-
low 
-
low 
To quantify finger skin reactivity and to study whether the presence of estrogens and 
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progestagens enhances vascular reactivity in this area, a standardized finger heating 
and cooling test was used. In this test finger skin temperature (FST) and laser Doppler 
flux (LDF) are measured before and during direct local heating and cooling. 
SUBJECTS AND METHODS 
Subjects 
We selected 71 healthy volunteers from the general population not using any 
vasoactive medication. None had complaints of discolorations of fingers or toes. 
Four groups were distinguished: 18 males, 17 premenopausal women with regular 
menstrual cycles (between 26 and 32 days), 18 postmenopausal women (last 
menstruation at least 6 months prior to the study) and 18 premenopausal women using 
oc for at least 6 months (30 μ£ ethinylestradiol and ISO μg desogestrel in 8 females 
and 30 ¿ig ethinylestradiol and ISO μ£ levonorgestrel in 10 females). All subjects were 
> 18 yr of age. The protocol was approved by the hospital ethical committee. 
Methods 
In males and postmenopausal women an arbitrary day was chosen to perform a 
standardized finger heating and cooling test. Premenopausal women were tested in the 
same phase of the menstrual cycle (the 3rd, 4th, or 5th day of menstruation), because 
skin blood flow varies within a menstrual cycle.14 Furthermore, the hormone levels 
are the least variable between individuals in this phase of the menstrual cycle. In 
women using oc the tests were performed during usage of the 10th to 21th pill of the 
strip, because it takes a minimum of 4 days to obtain maximal plasma levels of the 
exogenous hormones after the monthly withdrawal period. The levels of endogenous 
estradiol and progesterone are constantly low during the pill cycle." 
Factors influencing peripheral circulation were eliminated by asking all subjects 
to refrain from smoking for 24 hr,20 alcohol- and caffeine-containing beverages for 12 
hr and not to eat for at least 2 hr prior to the test. All tests were performed in a quiet 
climatized room with a constant ambient temperature of 24.5 ± \0C and a humidity 
of 59 ± 0.9%. All subjects were lightly dressed and rested supine with their arms 
supported on heart level. All tests were performed in the moming. Mean outside 
temperature during the tests was 6.5 ± 3.2eC. 
The amount of subcutaneous fat (% of total body mass) was determined by 
measuring skinfold thickness at four standardized sites of the body (in mm), after 
which the corresponding percentage of subcutaneous fat according to the age and sex 
was read from a table.2' The hand volume (in ml) was determined by the increase in 
volume after immersion of the hand up to the wrist in a definite amount of water. 
Influence of Hormonal Status on Skin Vascular Ractivity 103 
Length (in m) and weight (in kg) were determined. 
After an equilibration period of at least 20 min systolic (SBP) and diastolic (DBP) 
blood pressure were measured in the left arm by an Arteriosonde (in mmHg; Roche 
Medical Electronics Inc., Oranjeburg, NJ, USA). The heart rate (in beats per minute) 
was calculated from 10 RR-intervals of an electrocardiogram-strip. 
Finger skin perfusion was quantified by laser Doppler fluxmetry (LDF) and fìnger 
skin temperature (FST). LDF was measured in the center of the third volar fingertip 
of the right hand (in perfusion units (PU); Periflux Pf-ld, Perimed, Stockholm, 
Sweden). The gain was adjusted to 3, the cutoff frequency to 12 kHz and the time 
constant to 3 sec. LDF was continuously registered on a chart recorder and a personal 
computer. Flux zero calibration was performed by readjusting the pen of the recorder 
to zero, when the probe was fixed to a white, non-moving surface. Once a week a 
calibration with 25%-calibration fluid (Periflux motility standard, Perimed) was 
performed. LDF was calculated afterwards as the mean of a 1-min period. The 
biological zero was determined by arresting the circulation of the third finger during 
5 min by a suprasystolic inflated cuff. The resulting LDF was readjusted to zero. 
FST (in "C) was measured at the volar side of the intermediate phalanx of the 
third finger (Thermocouple, Ellab Instruments, Copenhagen, Denmark). The part of 
the thermocouple in contact with the water was isolated. FST therefore mainly 
represents the temperature of the finger skin and not of the surrounding water. 
In order to obtain comparable baseline values, the gloved right hand was immersed 
in a 30oC water bath during 10 min. Preheating and precooling LDF was obtained 
by the average of the last 5 min. The preheating and precooling FST was the value 
just before respectively heating and cooling. 
Heating was performed by immersion of the gloved right hand in water of 45"С 
during 10 min. Cooling was performed by immersing the gloved hand in water of 
150C during 5 min. During these procedures every min the average LDF and the 
momentary FST were registered. After cooling a subsequent recovery period of 20 
min followed with the hand exposed to room temperature. During recovery LDF 
(average of the previous min) and FST (momentary) were registered every minute in 
the first 6 min and every 2 min afterwards. 
Data analysis and statistics 
Unless stated otherwise, results are shown as means ± SD. The mean arterial 
pressure (MAP; in mmHg) was calculated from the formula MAP=(SBP+2DBP)/3. 
The body mass index was calculated by dividing weight by height2 and expressed as 
kg/m2. The following parameters for both FST and LDF were used in the analysis: 
the preheating value, the maximum value during heating, the precooling value and 
respectively the minimum value and the percentual decrease during cooling. 
Table 9.2. General characteristics of the four groups: women using oral contraceptives, premenopausal women, postmenopausal women and males. 
Results are means ± SD. 
Oral Premeno- Post- Males 
contracept ives pausai menopausal 
(n=18) (n=17) (n=18) (n»18) 
Age (yr) 
range 
Smokers (η) 
Subcutaneous fat (*) 
Hand volume (ml) 
BodymaBB index (kg/m ) 
Blood pressure (mmHg) 
Systolic 
Diastolic 
Mean 
Heart rate (beate/min) 
25.6 ± 4.7 
18-35 
6 
28.9 ± 5.1 
307 ± 25 
23.2 ± 3.Θ 
103.0 ± 10.5 
70.5 ± 7.4 
81.3 ± 8.0 
67.0 ± 9.9 
30.0 ± 8.0 
41-75 
4 
27.7 ± 3.4 
318 ± 60 
21.0 ± 1.8 
100.0 1 11.5 
72.5 ± 8.0 
81.7 ± 8.6 
67.7 ± 10.5 
58.1 ± 4.2 
51-68 
2 
38.2 ± 3.0 
350 ± 49 
24.4 ± 4.2 
115.1 ± 14.3 
79.7 ± 9.8 
91.5 ± 10.7 
67.5 ± 7.6 
38.8 1 15.8 
18-68 
8 
20.7 ± 5.6 
465 ± 66 
22.6 ± 2.4 
111.8 ± 14.4 
75.6 ± 6.7 
87.7 ± 8.8 
64.7 ± 9.9 
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Furthermore we calculated the mean level during heating, during cooling and during 
recovery by determining the area under the curve of each test period divided by the 
duration of that test period.22 
Statistical analysis was performed by analysis of variance and multiple comparisons 
according to the method of Tukey. Parameters which showed a skewed distribution 
(not Gaussian) were first logarithmically transformed. Comparison of the percentual 
changes was performed by the Kruskal-Wallis test. Results were considered to be 
significant if ρ <0.05 (two-sided). 
Stepwise regression, with the factor group included, was used to detect an 
influence of smoking, heart rate, MAP, amount of subcutaneous fat, body mass index 
and hand volume on the test parameters. 
RESULTS 
In Table 9.2 the general characteristics of the subjects are shown. Mean age was the 
highest in the group of postmenopausal women and the lowest in the group of women 
using oc (ρ < 0.001). The amount of subcutaneous fat was significantly higher in 
postmenopausal women than in all other groups. In males it was significantly lower 
in comparison with all female groups (both ρ<0.001). Hand volume in males was 
considerably higher than in females (p<0.001). The mean arterial blood pressure in 
postmenopausal women was significantly higher than in both other groups of women 
(p<0.01). 
Table 9.3 and Figure 9.1 show the results of the finger heating test. Women using 
oc had the lowest preheating FST (30.5 ± 1.ГС versus males, 32.2 ± 1.0oC; 
p<0.01) and reached the highest maximum FST during heating (women using oc, 
39.4 ± 0.3oC versus males, 39.0 ± O^'C; ρ<0.05). The percentual increase of 
FST was significantly different between the groups (p< 0.001, median in women 
using oc 28.9%, in premenopausal women 26.3%, in postmenopusal women 25.3% 
and in males 21.4%). Preheating LDF was not different between the groups. Both 
women using oc and premenopausal women reached a higher maximal LDF than 
males (premenopausal women, 62.3 ± 10.9 PU versus males, 50.7 ± 11.0 PU; 
ρ <0.01). The percentual increase of LDF was significantly different between the 
groups as well (p<0.01, median in premenopausal women 198%, in premenopausal 
women 171%, in postmenopausal women 147% and in males 66%). Both the mean 
level of FST and LDF during heating showed no significant differences between the 
groups. 
Results of the finger cooling test are shown in Table 9.4 and Figure 9.2. Women 
using oc had a significantly lower precooling FST than postmenopausal women and 
males (women using oc, 32.0 ± 0.9oC versus males, 32.9 ± 0.8oC; p<0.01). The 
minimum FST during cooling in women using oc was significantly lower than in 
Table 9.3. Finger skin temperature (FST) and laser Doppler flux (LDF in perfusion units, PU) for the four groups (women using oral contraceptives, 
premenopausal women, postmenopausal women and males) before (preheating value) and during heating (the maximum value, the percentual increase 
and the mean level during heating). Results are means ± SD. 
FST (»C) 
Preheating 
Maximum 
Іпсгеаве (%, 
Mean 
LDF (PU) 
Preheating 
Max iroum 
Increase (%, 
Mean 
median) 
median) 
Oral contra-
ceptivee (oc) 
(η=1θ) 
30.5 
39.4 
28.9 
37.4 
24.1 
62.1 
171 
45.0 ± 
1.1 
0.3 
0.6 
15.2 
13.8 
12.4 
Premeno­
pausal 
(n-17) 
31.1 
39.1 
26.3 
37.6 
24.2 
62.3 
198 
46.6 
± 
± 
± 
± 
± 
± 
(pre) 
1.2 
0.4 
0.6 
12.8 
10.9 
8.0 
Poetmeno-
paueal 
(n=18) 
31.3 
39.1 
25.3 
37.4 
25.1 
60.7 
147 
44.3 ± 
(pom) 
1.5 
0.5 
0.7 
15.7 
11.6 
11.6 
Males | 
(n=18) 
32.2 ± 
39.0 ± 
21.4 
37.8 ± 
32.9 ± 
50.7 ± 
66 
42.2 ± 
;m) 
1.0 
0.4 
0.5 
11.3 
11.0 
10.2 
Comparieone 
oc ve m 
oc vs m 
S 
NS 
NS 
oc,pre ve m 
S 
NS 
Comparisons refer to significant multiple comparisons according the Tukey method. Comparison of the percentual changes was рефгтеа ty the 
Kruskal-Wallis test. NS means no significant difference, whereas S means a significant difference. 
Table 9.4. Finger skin temperature (FST) and laser Doppler flux (LDF in perfusion units, PU) before (precooling value), during (the minimum value, 
the percentual decrease and the mean level during cooling) and after cooling (the mean level during the recovery period) for the four groups: women 
using oral contraceptives, premenopausal women, postmenopausal women and males. Results are means ± SD. 
FST (0C) 
Precooling 
Mininum 
Decrease (%, 
Mean during 
Mean during 
LDF (PU) 
Precooling 
Minimum 
Decreaae (%, 
Mean during 
Mean during 
median) 
cooling 
recovery 
median) 
cooling 
recovery 
Oral 
cept: 
contra-
Lves (oc) 
(n=18) 
32.0 
20.9 
34.2 
25.5 
22.0 
33.8 
8.1 
83 
14.4 
11.1 
± 
± 
± 
± 
± 
± 
± 
± 
0.9 
0.7 
1.7 
2.5 
15.5 
7.6 
9.2 
13.4 
Premeno-
pausal 
(n-17) 
32.2 
21.4 
34.0 
25.9 
23.5 
29.6 
8.3 
79 
12.5 
12.0 
± 
± 
± 
± 
± 
± 
± 
± 
(pre) 
0.9 
1.0 
1.0 
3.0 
11.0 
7.1 
5.9 
11.0 
Postmeno-
pausal 
(n=18) 
32.8 
22.3 
32.3 
26.8 
24.5 
35.9 
9.8 
77 
16.7 
16.0 
± 
± 
± 
± 
± 
± 
± 
± 
(pom) 
0.8 
1.5 
1.1 
3.5 
14.5 
6.9 
9.0 
14.9 
Males | 
(n=18) 
32.9 
23.2 
30.7 
27.1 
26.5 
37.6 
19.5 
61 
24.4 
25.4 
± 
± 
± 
± 
± 
± 
1 
± 
[m) 
0.8 
2.3 
1.4 
4.4 
11.1 
18.4 
14.8 
17.2 
Comparisons 
oc 
oc 
6 
S 
oc 
oc 
NS 
oc 
NS 
oc 
oc 
ve pom fi m 
vs pom fi m 
pre vs m 
vs pom fi m 
pre vs m 
vs m 
fipre vs m 
fi pre ve m 
fi pre vs m 
Comparisons refer to significant multiple comparisons according the Tukey method. Comparison of the percentual changes was performed by the 
Kruskal-Wallis test. NS means no significant difference, whereas S means a significant difference. 
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postmenopausal women and males, as was the minimum FST in premenopausal 
women compared to males (women using oc, 20.9 + 0.7oC versus males, 23.2 ± 
2.30C; ρ<0.001). The same differences between the groups were observed for the 
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Figure 9.1. Finger skin temperature (upper panel) and laser Doppler flux (in perfusion units, 
PU, lower panel) during 10 min of immersion of the hand in a 45 "C water bath in the four 
groups: women using oral contraceptives (oc), premenopausal women (pre), postmenopausal 
women (pom) and males. Means and SEM are given; when the SEM can not be distinguished 
it is within the symbol. 
mean level of FST during cooling (women using oc, 25.2 ± 1.6eC versus males, 
27.1 ± 1.4oC;p<0.001). The percentual decrease was significantly different between 
the groups (p<0.01, median in males 30.7%, in postmenopausal women 32.3%, in 
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premenopausal women 34.0% and in women using oc 34.2%). During recovery, the 
mean level of FST was the highest in males (males, 26.5 ± 4.40C versus women 
using oc, 22.0 ± 2.50C; <0.01). 
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Figure 9.2. Finger skin temperature (upper panel) and laser Doppler flux (in perfusion units, 
PU, lower panel) during immersion of the hand in a 150C water bath for the first 5 min and 
a recovery period of 20 min in the four groups: women using oral contraceptives (oc), 
premenopausal women (pre), postmenopausal women (pom) and males. Means and SEM (at 
three points) are given. 
No significant differences in precooling LDF were seen between the groups 
(premenopausal women, 29.6 ± 11.0 PU versus males, 37.6 ± 1 1 . 1 PU). The 
minimum LDF during cooling was significantly lower in women using oc and in 
premenopausal women than in males (women using oc, 8.1 ± 7.6 PU versus males, 
по 
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19.5 ± 18.4 PU; р<0.05). The mean level of LDF during cooling showed the same 
results (premenopausal women, 12.5 ± 5.9 PU versus males, 24.4 ± 14.8 PU; 
ρ<0.01). The percentual decrease in LDF was not significantly different between the 
groups. The mean level of LDF during recovery was the highest in males (25.4 ± 
17.2 PU versus women using oc, 11.1 ± 13.4 PU; p<0.01). 
Stepwise regression with the groups included as factor showed a significant 
influence of the group and not of biological factors (age, amount of subcutaneous fat, 
hand volume and body mass index) or hemodynamic parameters (MAP and heart 
rate). 
DISCUSSION 
This study shows that skin vascular reactivity to heat and cold challenge is different 
between males and females and that skin vascular reactivity to a cold challenge is 
different between females with a different hormonal status as well. Women who use 
oc and premenopausal women showed the most pronounced changes in skin blood 
flow during both heating and cooling and recovered slower after cooling. The vascular 
reactivity in postmenopausal women was intermediate between the males and the two 
other groups of women. 
The groups were not matched and differed in age, amount of subcutaneous fat, 
hand volume, body mass index or hemodynamic parameters (MAP and heart rate). 
However, these factors are not likely to account for the observed differences between 
the groups, as they were all found not to have influenced the results. 
In a previous study we have shown that vascular reactivity towards cold is less in 
case of a low baseline skin blood flow.23 Therefore we have used a 30oC water bath 
before provocation to obtain comparable pre-test values in the four groups. Despite 
this, women who used oc exhibited both a lower preheating and a lower precooling 
FST compared with males. In order to correct for this, we also calculated percentual 
changes. 
Bollinger et al4 determined FST and finger blood flow by venous occlusion 
plethysmography in healthy postmenopausal and premenopausal women and males. 
They found nearly no difference in finger blood flow at rest between postmenopausal 
women and males. In both groups fìnger blood flow was significantly higher than in 
premenopausal women, although no significant differences in FST were observed. The 
prolonged recovery time after direct cooling in the premenopausal group is in 
correspondence with our findings. Tooke et al13 investigated the influence of oc on 
finger skin temperature, nailfold capillary pressure and fìnger blood flow, the latter 
measured by venous occlusion plethysmography. In contrast with our results they 
found significantly higher baseline finger blood flow values and capillary pressure in 
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women using oc when compared with premenopausal women without oc, whereas 
FST was not significantly different. A lower baseline LDF7 and a lower baseline FST* 
were observed in healthy females compared with healthy males. In both of these 
studies no further subdivision in the group of females was made. 
In the present study, women using synthetic, exogenous hormones showed the most 
pronounced vasodilation as well as vasoconstriction during respectively heating and 
cooling, and in the recovery period after cooling vasoconstriction continued. Thus, 
vascular reactivity towards both heat and cold challenge seems to be enhanced by 
exogenous synthetic estrogens and progestagens. Premenopausal women, investigated 
in a phase with low endogenous sex hormone levels, showed a vascular reactivity 
comparable with women using oc. How to explain these apparently contrasting 
findings? Endogenous and exogenous hormones may exert opposite effects on the 
penpheral skin circulation, as it is not well documented whether natural and synthetic 
oestrogens exhibit the same effect on the same target." However, a more likely 
explanation of the findings is that although estradiol and progesterone were only 
present in low concentrations in premenopausal women at the time of menstruation, 
the presence of these hormones in fluctuating levels during the menstrual cycle 
accounted for a state of high vascular reactivity. In accordance with this hypothesis 
postmenopausal women, who also have low concentrations of endogenous female sex 
hormones, showed a pattern different from that of the other two female groups, being 
more in line with the males. This latter group showed less vasodilation during heating 
and less vasoconstriction during cooling and recovered more rapidly after cooling. 
The findings in the postmenopausal and male group could be ascribed to the absence 
(at least in concentrations high enough to exert any influence) of the female sex 
hormones which would have enhanced vascular reactivity or, alternatively, to the 
presence of androgens in (relatively) high concentrations, which might depress 
vascular reactivity. However, rather than the presence or absence of a specific sex 
hormone, the ratio of 17ß-estradiol, progesterone and testosterone may be the most 
important, as previously suggested.14 LH and FSH are not likely to influence (e.g. 
depress) vascular reactivity, as the postmenopausal females (high levels) do not differ 
from the males (low levels). 
The precise mechanism by which sex hormones are able to modulate skin blood 
flow is still unknown. They could exert a direct influence on the blood vessel wall. 
In the endothelial and vascular smooth muscle cells of animals estrogen receptors have 
been demonstrated.14 Sex hormones could also influence the production of vasoactive 
substances produced by the endothelial or by the blood cells." Besides, sex hormones 
could indirectly influence regulatory mechanisms of the peripheral circulation. An 
influence on the sympathetic nervous system has been described17" и The sympathetic 
nervous system releases catecholamines that stimulate vasoconstrictive α-adrenoceptors 
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and vasodilating ß2-adrenoceptors. 17ß-Estradiol modulates the response to 
sympathetic stimuli by enhancing vasoconstriction by mechanisms not yet fully 
understood. Upregulation of α-adrenoceptors may play a part in this complicated 
process.2* " M Finally, sex hormones could exert another, more systemic influence. 
For example, oc stimulate the renin-angiotensin-aldosterone system,29 ^0 thereby 
increasing peripheral resistance. Also fibrinogen and hemorheological indices such as 
viscosity show a variation within the menstrual cycle and are elevated in women using 
oc. 
Although the precise mechanisms still remain obscure, from the present study we 
conclude that the hormonal status exerts significant effects on fìnger skin perfusion. 
Synthethic as well as endogenous estrogens and/or progesterone cause enhanced skin 
vascular reactivity, whereas testosterone may depress skin vascular reactivity. Most 
likely FSH and LH have no important modulating effect. 
As a consequence of these observed differences in finger skin vascular reactivity 
between males and females and between females with a different hormonal status, in 
future studies in which finger skin perfusion is measured the hormonal status of the 
subjects should be taken into account. 
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ABSTRACT 
The influence of sex, menstrual cycle, oral contraceptives, pregnancy and menopause 
on skin perfusion in healthy subjects and in Raynaud patients suggests a role of female 
sex hormones. However, no clear relationship between skin blood flow and levels of 
circulating estrogens or progestagens has been found yet. Aim of the present study 
was to investigate the effect of orally administered 17ß-estradiol and progesterone on 
finger skin blood flow before and during heat and cold challenge in 17 healthy 
normotensive female volunteers and in 12 female Raynaud patients. In each subject 
a standardized finger heating (45''C water bath, 10 min) and cooling test (IS'Cwater 
bath, 5 min and 20 min recovery) was performed twice on the second (or third) day 
of two consecutive menstrual cycles. 17ß-Estradiol (9 mg) and progesterone (300 mg) 
were administered in a randomized order in a double blind placebo-controlled design. 
Both doses resulted in (high) physiological levels. During the experiment, fingertip 
skin temperature (FST) and laser Doppler flux (LDF) were measured. There were no 
significant differences in test results after placebo and after progesterone 
administration. Although values of FST and LDF after 17ß-estradiol administration 
tended to be higher, only precooling values in the healthy subjects reached 
significance (FST with placebo and with estradiol (mean ± SD), respectively, 32.7 
± 1.0 and 33.1 ± O.S'C; LDF with placebo and with estradiol, 33.6 ± 11.7 and 
42.2 ± 9.5 perfusion units; both ρ<0.05). In this study, short term administration 
of female sex hormones had only minor influence on finger skin circulation, both in 
control subjects and in Raynaud patients. 
INTRODUCTION 
Animal studies show that estrogens and progestagens exert effects on the peripheral 
circulation.1 Several observations strongly suggest that estrogens and progestagens are 
also able to influence peripheral skin circulation in humans. In general, the differences 
in skin blood flow between men and women after menarche and before menopause2 ' 
are explained this way. Finger skin perfusion and its response to a local cold 
challenge were demonstrated to variate during the menstrual cycle with the lowest 
perfusion in the mid-luteal phase (high levels of both 17ß-estradiol and progesterone) 
and the highest perfusion pre-ovulatory (high levels of 17ß-estradiol).4 Oral 
contraceptives5 and pregnancy' have also been shown to influence peripheral skin 
circulation. 
Raynaud's phenomenon (RP), a vasospastic syndrome with acroteric 
discolourations provoked by cold or emotions, is more common in women.7 
Furthermore, the complaints of RP are influenced by the phase of the menstrual cycle, 
the use of oral contraceptives, and by pregnancy and menopause.' 
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However, no relationship with the levels of circulating estrogens or progestagens has 
been found up to now. The aim of the present study was to investigate the effect of 
orally administered natural 17ß-estradiol and progesterone on fìnger skin blood flow 
before and during standardized heat and cold challenge. Because a possible influence 
of sex hormones might be more pronounced in subjects with an already impaired 
finger blood flow, both female healthy subjects and female Raynaud patients were 
studied. 
SUBJECTS AND METHODS 
Subjects 
We selected 18 healthy normotensive female volunteers without any sign or symptom 
of a vascular disease who did not use any vasoactive medication. None had complaints 
of discolorations of fingers or toes. The second group consisted of 13 female patients 
with primary RP (according to the criteria of Allen and Brown', supplemented with 
negative clinical" and immunological10 signs of an underlying disease), who did not 
use medication for their complaints. They all had regular menstrual cycles (between 
26 and 32 days) and had not used oral contraceptives for at least 6 months. The study 
protocol was approved by the local ethical committee and all subjects gave written 
informed consent. 
Methods 
The present study was carried out in the early follicular phase of the menstrual cycle 
when levels of endogenous sex hormones are low. In each subject a standardized 
finger heating and cooling test was performed twice on the second (or third) day of 
two consecutive menstrual cycles. On each test day, the first test was always 
performed after oral placebo administration (single blind) and the second test after 
randomized oral 17ß-estradiol or progesterone administration (double blind). The 
subjects were instructed to take the placebo tablets 90 min prior to arrival in the 
hospital. After the first test was performed, they took either 9 mg 17ß-estradiol 
(tablets of 1.5 mg micronized 17ß-estradiol, Organon, Oss, The Netherlands) or 300 
mg progesterone (tablets of 100 mg micronized progesterone: Progestan, Organon, 
Oss, The Netherlands). After another 90 min, the second test was started. The dose 
of each hormone was chosen after pilot experiments during which frequent venous 
blood samples were taken (with an interval of 20 min during 3 hr). Aim was to obtain 
high, but still physiological levels of both hormones during the experiments. In the 
normal menstrual cycle high blood levels of 17ß-estradiol are seen in the luteal phase 
(between 220 and 1000 pmol/1); the pre-ovulatory peak may reach values up to 1800 
118 Chapter 10 
pmol/1. The luteal progesterone level varies between 19 and 120 nmol/1. 
Factors influencing peripheral circulation were eliminated by asking all subjects 
to refrain from respectively smoking for 24 hr," alcohol- and caffeine-containing 
beverages for 12 hr, and not to eat for at least 1 hr prior to the tests. After each 
first test they were allowed to have a light meal. The tests were performed in a quiet 
climatized room with a constant ambient temperature (mean ± SD) of 24.5 ± 1 "С 
and a humidity of 59 ± 0.9%. All subjects were lightly dressed and rested supine 
with their arms supported on heart level. 
Before the first test, before the second test (90 min after intake) and after the 
second test (180 min after intake), blood was sampled by venepuncture of the 
antecubital vein for determination of serum levels of 17ß-estradiol, progesterone, 
luteinizing hormone (LH) and follicle stimulating hormone (FSH). The samples were 
frozen (-20oC) and the sex hormone levels were determined afterwards by specific 
radioimmunoassays,12 whereas the pituitary hormones were measured by applying 
specific immunoradiometric assays (Medgenix, Fleurus, Belgium), as described 
previously." After the experiments, the available hormonal data were submitted to an 
independent, experienced observer, who verified the menstrual phase of the cycle. 
Prior to the study minimal values that should be exceeded were defined as follows: 
500 pmol/1 after 17B-estradiol administration and 10 nmol/1 after progesterone 
administration. 
During the test the rectal temperature was recorded continuously (in "С, 
Yellowspring probe, type YSI401 combined with a Hewlett Packard datalogger). The 
amount of subcutaneous fat (% of total body mass) was determined by measuring 
skinfold thickness at four standardized sites of the body (in mm), after which the 
corresponding percentage of subcutaneous fat according to the age and sex was read 
from a table.14 The hand volume (in ml) was determined by the increase in volume 
after immersion of the hand up to the wrist in a definite amount of water. Finger 
circumference (third finger) was measured (in cm), and length and weight were 
determined to assess the body mass index. 
After an acclimatization period of at least 20 minutes systolic and diastolic blood 
pressure were measured at the left arm by an Arteriosonde (in mmHg; Roche Medical 
Electronics Inc., Oranjeburg, NJ, USA). The heart rate (in beats per minute) was 
calculated from 10 RR-intervals of an electrocardiogram-strip. 
Forearm muscle blood flow (FBF) was measured at the left forearm by strain 
gauge venous occlusion plethysmography (in ml/100 ml/min; Loosco В VP 96, 
Hoekloos, Amsterdam, The Netherlands). A wrist cuff was inflated to a suprasystolic 
value to exclude the hand circulation.15 On every time point the average of three 
subsequent measurements was taken. 
Finger skin perfusion was quantified by laser Doppler fluxmetry (LDF) and 
determination of finger skin temperature (FST). LDF was measured with an unheated 
Influence of Estradiol and Progesterone on Finger Skin Circulation 119 
probe on the third volar fingertip of the right hand (in perfusion units (PU); Periflux 
Pf-ld, Perimed, Stockholm, Sweden). The gain was adjusted to 3, the cutoff frequency 
to 12 kHz and the time constant to 3 sec. LDF was continuously registered on a chart 
recorder. Flux zero calibration was performed by readjusting the pen of the recorder 
to zero, when the probe was fixed to a white, non-moving surface. Once a week a 
calibration with 25%-calibration fluid (Periflux motility standard, Perimed) was 
performed. LDF values were calculated afterwards as the mean of a one minute 
period. The biological zero was determined by arresting the circulation of the third 
finger during 5 min by a cuff inflated to a suprasystolic value. The resulting LDF 
signal was readjusted to zero. To prevent a variation in LDF between the first and the 
second test due to a change in the position of the probe, the probe holder remained 
fixed on the finger in between both tests. 
FST (in 0C) was measured at the volar side of the intermediate phalanx of the 
third finger (Thermocouple, Ellab Instruments, Copenhagen, Denmark). The sensor 
part was isolated on the outside. 
Before heating and cooling the gloved right hand was immersed in a 30oC water 
bath during 10 min. Preheating and precooling LDF values were obtained by the 
average of three 1-min values during the last 5 min. The preheating and precooling 
FST were the values just before respectively heating and cooling. 
Heating was performed by immersing the gloved right hand in water of 45°C 
during 10 min and cooling in water of 15°C during S min. During these procedures 
the momentary FST was registered and the averaged mean LDF of that minute was 
added afterwards. A subsequent recovery period of 20 min followed after cooling with 
the hand exposed to room temperature. During recovery LDF and FST were obtained 
every min in the first 6 min and every 2 min afterwards. 
Data analysis and statistics 
Unless stated otherwise, results are shown as means ± SD. The mean arterial 
pressure (MAP; in mmHg) was calculated from the formula MAP=(SBP+2DBP)/3. 
Forearm vascular resistance (FVR; in arbitrary units) was obtained by dividing MAP 
by FBF. Laser Doppler resistance in the skin (in mmHg/PU) was calculated by 
dividing MAP by baseline LDF." The body mass index was expressed as kg/m2. The 
following parameters for both FST and LDF were used in the analysis: the preheating 
value, the maximum value during heating, the precooling value, the minimum value 
and the percentual decrease during cooling. Furthermore, we calculated the mean level 
during heating, during cooling, and during recovery by determining the area under 
the curve of each test period divided by the length in min of the test period. 
The differences between the placebo test and the hormone tests were used in the 
statistical analysis, which was performed by the paired Student t test or, if these 
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differences were not normally distributed, by the signed rank test. Pearson correlation 
coefficients were calculated between the difference in hormone levels before and 
during the test and the changes that took place in FST or in LDF. Results were 
considered to be significant if the ρ value was less than 0.0S (two-sided). 
RESULTS 
Hormone levels 
Table 10.1 shows serum levels of 17ß-estradiol, progesterone, FSH and LH, before 
and after administration. All but one subject in the Raynaud group (with high levels 
of 17fl-estradiol before administration of this hormone) were in the menstrual phase. 
Another subject in this group did not reach a sufficiently high level of progesterone 
after administration of this hormone (4.7 nmol/1 and 11.0 nmol/1 after 90 and 180 
min, respectively). Therefore, in the comparison of either the 17ß-estradiol or the 
progesterone test 12 subjects were included. In the healthy subjects, 17 subjects were 
analyzed: in one female we were not able to reach sufficient levels of both sex 
hormones (17ß-estradiol: 190 and 220 pmol/1 and progesterone: 3.4 and 4.2 nmol/1 
after 90 and 180 min, respectively). There were no significant differences between the 
groups regarding the baseline hormone levels or the levels reached after administration 
of both sex hormones. 
Table 10.1. Hormone levels at different time points in both groups. 
Healthy Raynaud 
BubjectB patients 
(n-17) (n=12) 
17ß-EBtradiol (pmol/1) 
baseline 213 1 
90 rain after intake 923 ± 
180 min after intake 9Θ4 ± 
Progesterone (nmol/1) 1.6 1 
Luteinizing Hormone (IU/1) 3.2 ± 
Follicle Stimulating Hormone (IU/1) 6.1 i 
Progesterone (nmol/1) 
baseline 2.1 ± 
90 min after intake 170 1 
180 min after intake 63 ± 
170-Eetradiol (pmol/1) 226 ± 
Luteinizing Hormone (IU/1) 3.8 ± 
Follicle Stimulating Hormone (IU/1) 5.9 ± 
70 
271 
237 
0.5 
1.5 
2.7 
0.9 
351 
87 
85 
1.6 
2.6 
256 
931 
962 
3.0 
5.8 
7.9 
2.0 
87 
36 
239 
5.0 
8.7 
± 
± 
± 
± 
1 
± 
± 
± 
± 
± 
± 
± 
37 
248 
318 
3.3 
1.8 
4.1 
0.5 
132 
37 
91 
1.2 
5.R 
Means ± SD are given. IU means international units. 
heating 
4 6 8 
time (minutes) 
12 0 
time (minutes) 
Figure 10.1. Mean finger skin temperature (in "C) and laser Doppler flux fin perfusion units, PU) during finger heating with placebo (open symbols) 
and with 17fi-estradiol (closed syinbols, left panel), and with placebo (open symbols) and with progesterone (closed symbols, right panel) in healthy 
subjeas (triangles) and in Raynaud patients (dots). SEM is given at 5 and 10 min. 
cooling 
10 15 20 
time (minutes) 
30 0 10 15 20 
time (minutes) 
25 30 
Figure 10.2. Mean finger skin temperature fin °C) and laser Doppler flux (in perfitsion units, PU) during finger cooling withplacebo (open symbols) 
and with 17fi-estradiol (closed symbols, left panel), and with placebo (open symbols) and with progesterone (closed symbols, right panel) in healthy 
subjects (triangles) and in Raynaud patients (dots). SEM is given at 5, 17 and 25 min. 
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General characteristics 
There were no major differences between the healthy subjects and the Raynaud 
patients with regard to respectively age (29.8 ± 7.2 and 35.3 ± 5.7 yr), body mass 
index (22.2 ± 1.7 and 21.7 ± 2.6 kg/m2), amount of subcutaneous body fat (28.6 
± 4.4 and 29.1 ± 5.2%), hand volume (307 ± 37 and 313 ± 23 ml), and finger 
circumference (6.2 ± 0.3 and 6.2 ± 0.4 cm). 
Table 10.2. Hemodynamic baseline parameters before 17ß-estradiol administration (placebo), 
the differences (represented by the symbol d) between the test after placebo and the test after 
17ß-estradiol administration, and the differences between the test after placebo and the test 
after progesterone administration. 
Healthy aubj. 
(n=17) 
Placebo 
Blood pressure (mmHg) 
Systolic 
Diastolic 
Mean 
Heart rate 
(beate/min) 
101.4 
62.8 
75.6 
66.5 
Forearm Blood Flow 
(ml/100ml/min) 
Forearm Vascular 
Resistance (AU) 
Raynaud pat. 
(n=12) 
2.3 
37.7 
± 
± 
± 
± 
± 
± 
Placebo 
Blood pressure (mmHg) 
Systolic 
Diastolic 
Mean 
Heart rate 
(beats/min) 
104.3 
70.1 
81.5 
65.3 
Forearm Blood Flow 
(ml/100ml/min) 
Forearm Vascular 
Resistance (AU) 
2.0 
44.3 
± 
± 
± 
± 
± 
± 
7.7 
5.7 
5.8 
9.8 
1.0 
14.2 
8.0 
7.7 
7.4 
7.1 
0.5 
13.2 
û (Placebo-
17ß-Eetradiol) 
0.8 ± 
0.3 ± 
0.5 ± 
-1.3 ± 
-0.2 ± 
3.5 ± 
5.8 
3.9 
3.7 
7.6 
0.9 
14.1 
û (Placebo-
17ß-Eetradiol) 
3.2 ± 
6.8 ± 
5.6 ± 
-6.7 ± 
-1.0 ± 
11.2 ± 
6.5 
5.1 
4.3 
7.9 
1.5 
17.4 
û (Placebo-
Progesterone) 
0.8 ± 
-0.8 ± 
-0.3 ± 
0.3 ± 
-0.4 ± 
6.0 ± 
6.3 
4.2 
4.2 
8.5 
1.0 
24.4 
û (Placebo-
Progesterone) 
1.3 ± 
3.5 ± 
2.8 ± 
-0.8 ± 
-0.1 ± 
5.5 ± 
6.1 
6.8 
5.7 
6.3 
1.4 
13.6 
Means ± SD are given. AU means arbitrary units. 
Baseline hemodynamic parameters 
Table 10.2 shows that there were no changes in the hemodynamic parameters in the 
healthy subjects after the administration of both 17ß-estradiol and progesterone. In the 
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Raynaud patients progesterone induced no significant hemodynamic changes. After 
ITB-estradiol systolic blood pressure did not decrease significantly, but the decrease 
in diastolic blood pressure was significant (from 70.1 ± 7.7 to 63.3 ± 8.1 mmHg, 
p<0.01). Also the MAP decreased significantly from 81.5 ± 7.4 to 75.9 ± 7.3 
mmHg (ρ <0.01). Heart rate increased significantly after 17ß-estradiol administration 
from 65.3 ± 7.1 to 72.0 ± 8.3 beats/min (p<0.05). Although a rise in FBF was 
seen of about 50%, it did not reach significance (p=0.05). As a result, FVR 
decreased from 44 ± 13 to 33 ± 17 AU (p=0.05). 
Table 10.3. Skin circulation parameters before 17ß-estradiol administration (placebo), the 
differences (represented by the symbol &) between the test after placebo and the test after 
17ß-estradiol administration, and the differences between the test after placebo and the test 
after progesterone administration in the healthy subjects. 
Healthy subjecte Placebo û (Placebo- û (Placebo-
(n=17) 17ß-Eatradiol) Progeetercne) 
Rectal temperature (0C) 36.8 ± 0.2 -0.1 ± 0.2 0.0 ± 0.2 
Finger Heating Test 
FST (0C) 
0.3 ± 
0.2 ± 
0.3 ± 
6.8 ± 
•1.6 ± 
3.9 ± 
1.1 
O.S 
0.6 
13.3 
13.4 
11.4 
0.1 ± 1.2 
-0.2 ± 0.5 
-0.1 ± 0.6 
2.5 ± 15.4 
-1.6 ± 17.3 
-2.6 ± 15.0 
preheating 
max imum 
mean during 
,DF (PU) 
preheating 
maximum 
mean during 
heating 
heating 
31. 
39. 
37, 
25, 
61. 
47. 
.7 
.2 
,8 
,5 
,5 
.3 
± 
± 
± 
± 
± 
± 
1.0 
0.4 
0.4 
10.8 
16.6 
12.3 
Finger Cooling Test 
FST (eC) 
precooling 
end of cooling 
mean during cool 
12 min recovery 
mean recovery 
-DF (PU) 
precooling 
end of cooling 
ing 
mean during cooling 
12 min recovery 
mean recovery 
32. 
21, 
26. 
24. 
23. 
33. 
8. 
16. 
16, 
12, 
.7 
.9 
.2 
.1 
.5 
.6 
.9 
.6 
,2 
,8 
± 
+ 
± 
± 
± 
± 
± 
± 
± 
± 
1. 
1. 
1. 
3. 
2, 
11, 
5, 
7. 
12, 
8, 
.0 
.3 
,0 
.4 
.7 
.7 
.1 
.1 
,6 
.3 
0.4 ± 
0.1 ± 
0.1 ± 
0.7 ± 
0.7 ± 
8.6 ± 
2.1 ± 
7.7 ± 
1.8 ± 
4.8 ± 
0.8 
1.5 
1.2 
4.0 
3.1 
9.5 
7.4 
10.8 
18.0 · 
14.7 
0.3 
0.5 
0.6 
0.2 
0.3 
-1.3 
0.9 
0.8 
4.3 
-0.1 
0.9 
1.4 
1.4 
3.1 
2.4 
13.0 
6.7 
8.2 
14.7 
6.4 
Means ± SD are given. PU means perfusion units. 
Rectal temperature 
Rectal body temperature (Table 10.3) did not change significantly after progesterone. 
In the healthy subjects, but not in the Raynaud patients, rectal temperature was 0.1 
Influence of Estradiol and Progesterone on Finger Skin Grculation 125 
± 0.2oC higher after 17ß-estradiol (ρ <0.05). Although this difference reached 
significance, it does not seem relevant. 
Finger skin circulation (Tables 10.3 and 10.4, Figures 10.1 and 10.2) 
Preheating LDF in the Raynaud group was significantly lower after progesterone 
administration (the difference was 9.6 ± 11.6 PU, p<0.05). None of the parameters 
during finger heating were significantly influenced by administration of either 
hormone. 
Table 10.4. Sldn circulation parameters before 17fi-estradiol administration (placebo), the 
differences (represented by the symbol d) between the test after placebo and the test after 
17ß-estradiol administration, and the differences between the test after placebo and the test 
after progesterone administration in the Raynaud patients. 
Raynaud patients 
<n=12) 
Placebo û (Placebo-
17ß-Eetradiol) 
û (Placebo-
Progesterone ) 
Rectal temperature (°C) 
Finger Heating Test 
FST ("C) 
preheating 
maximum 
mean during heating 
LDF (PU) 
preheating 
maximum 
mean during heating 
Finger Cooling Test 
FST (0C) 
precooling 
end of cooling 
mean during cooling 
12 min recovery 
mean recovery 
LDF (PU) 
precooling 
end of cooling 
mean during cooling 
12 min recovery 
mean recovery 
36.8 ± 0.3 
31.1 ± 2.0 
39.3 ± 0.5 
37.5 ± 0.2 
20.1 ± 16.1 
55.8 ± 13.3 
40.5 ± 12.0 
32.5 ± 0.7 
21.3 ± 0.7 
25.7 ± 0.8 
22.2 ± 1.1 
21.9 ± 1.0 
28.4 ± 18.6 
6.3 ± 6.2 
13.3 ± 9.3 
5.3 ± 4.8 
6.4 1 4.9 
-0.1 ± 0.2 
-0.4 ± 2.1 
-0.1 ± 0.5 
-0.5 ± 0.7 
-5.0 ± 20.0 
-3.8 ± 13.7 
-7.3 ± 14.8 
-0.6 ± 1.0 
-0.5 ± 1.2 
-0.4 ± 1.2 
-0.9 ± 2.9 
-0.8 ± 2.3 
-10.0 ± 17.3 
-2.8 ± 9.2 
-7.3 ± 11.8 
-9.8 ± 18.1 
-6.1 ± 13.8 
-0.1 ± 0.3 
0.5 ± 1.5 
-0.2 ± 0.4 
0.1 ± 0.5 
9.6 ± 11.6 
-1.2 ± 10.8 
1.8 ± 12.0 
0.0 ± 0.9 
-0.1 ± 0.9 
0.1 ± 1.1 
0.7 ± 4.2 
0.5 ± 3.4 
3.4 ± 11.4 
0.7 ± 2.1 
-0.9 ± 5.5 
1.0 ± 23.0 
-0.8 ± 10.6 
Means ± SD are given. PU means perfusion units. 
Only in the healthy subjects, precooling FST, precooling LDF and the mean LDF 
during cooling were significantly higher after 17ß-estradiol (the differences were 0.4 
± 0.8oC, 8.6 ± 9.5 PU and 7.7 ± 10.8 PU respectively, all ρ<0.05). Laser 
126 Chapter 10 
Doppler resistance did also not show significant differences after placebo and after 
17ß-estradiol, nor in the Raynaud patients (8.5 ± 9.6 and 5.8 ± 7.0 mmHg/PU 
respectively), nor in the healthy subjects (2.2 ± 1 . 1 and 3.1 ± 3.3 mmHg/PU, 
respectively). 
Correlations 
There were no significant correlations between the differences in hormone levels 
before and after administration (i.e. the mean of the values at 90 and 180 min) and 
the differences in FST and LDF between the tests with placebo and with either sex 
hormone. 
DISCUSSION 
In the present study, short term administration of either 17ß-estradiol or progesterone 
has only minor influence on finger skin circulation both in healthy subjects and in 
Raynaud patients. 
Some problems regarding the study design have to be considered. Intravenous 
administration of drugs should preferably be used to assess acute effects. 
Consequences of oral administration of sex steroids are the interindividual differences 
in absorption, the formation of metabolites in the gastrointestinal tract and the first 
pass effect in the liver. However, neither of the sex hormones is available in an 
intravenous form. For natural progesterone intramuscular administration is a 
parenteral alternative and for 17ß-estradiol chronic transdermal administration would 
be possible. Finally, to standardize the administration and to enable a double-blind 
design, we have chosen for the oral administration of both hormones. 
Both sex hormones are rapidly metabolized. Metabolites of progesterone are 17a-
hydroxyprogesterone and 20a-hydroxy-4 pregnene-3-one. The biological half-life of 
progesterone varies between 25 and 45 minutes and peak plasma levels can be 
expected after one to four hours after ingestion.17 " 17ß-Estradiol is metabolized (in 
the gut wall and in the liver) into estriol, estrone and estrone sulphate. The biological 
half-life of 17ß-estradiol is about one hour and peak plasma levels (after 
administration of 1.5 mg) are reached after one hour." " However, most of these 
metabolites are biologically less active or even inactive as compared with the 
precursor hormones and are not expected to influence our results in a major way. 
Because of the variability in absorption and the short biological half-life, the single-
dose oral administration design results in variable high peak levels with subsequent 
rapid decrease of both hormones used. Nevertheless, we have reached sufficiently 
high levels of either hormone during the course of the whole test in almost all 
subjects, though the levels of 17ß-estradiol were more constant compared with the 
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levels of progesterone. 
The acute administration used in this study is the next point of discussion. It is 
questionable whether an influence -if any- of 17fl-estradiol or progesterone can be 
detected immediately after a single oral dose of either hormone. It is possible that a 
more prolonged exposure to the sex hormones or a longer time period may be 
required to exert detectable effects. 
Finally, more than the absolute concentration of one specific hormone, a certain 
relationship in concentrations of both sex hormones over time might be necessary to 
exert effects on the peripheral circulation. Besides the concentration of hormones per 
se, the ratio of 17ß-estradiol and progesterone or other sex hormones may play a 
major role. It could also be necessary that one hormone acts as the primer for the the 
other or that the rapid changes in hormone levels as seen during the menstrual cycle 
are of importance. 
Up to now, no direct relationship between alterations in the peripheral circulation and 
plasma levels of estrogens or progestagens has been demonstrated in humans. 
Nevertheless, not only human arteries of the genital tract and the breasts, but also 
vascular smooth muscle of the heart, aorta and other large arteries have been shown 
to contain estrogen21 and progesterone2 receptors. The presence of these receptors 
may influence vessel wall reactivity directly or modulate the action of various 
vasoactive factors (e.g. catecholamines, angiotensin, acetylcholine, histamine, 
prostaglandins). Besides an influence of sex hormones on vascular tone, 
hemorheological variables, like viscosity and erythrocyte deformability that have an 
important influence on the microcirculation, showed a correlation with estradiol levels 
during the menstrual cycle.23 
Animal studies did show an influence of both natural and synthetic estrogens and 
progestagens on different vascular beds.1 Acute or chronic administration of natural 
or synthetic estrogens increases vascular responsiveness to adrenergic agonists in some 
vascular beds. Whether this also occurs in humans, remains unclear. On the contrary, 
our study suggests a skin vasodilatory effect of 17ß-estradiol intake, though the 
changes did not reach significance. 
Effects of exogenous sex hormones and of the cyclical variations in endogenous 
hormones have been investigated on human platelet adrenoceptors, with conflicting 
results." M The influence of estrogens and progestagens on peripheral vascular human 
adrenoceptors has not been investigated yet. Finger blood flow responses to brachial 
artery infusions of adrenergic agonists differed between men and women, indicating 
that the sensitivity and/or density of peripheral vascular adrenoceptors is lower in 
women.26 
In the literature, the effect of either 17ß-estradiol or progesterone on blood pressure 
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is not straightforward. During the menstrual cycle morning blood pressure has been 
shown to vary significantly, with the highest values during menstruation and the 
lowest in the luteal phase.27 Natural progesterone (in contrast with synthetic 
progesterone) exerts a blood pressure lowering effect through an anti-
mineralocorticoid action at doses which result in plasma levels that are just above 
luteal phase concentrations.2* It is unlikely that the short term elevation of 
progesterone levels would already induce a drop in blood pressure in our 
normotensive subjects. Indeed, no significant differences between the placebo and the 
progesterone test in either systolic, diastolic or mean arterial blood pressure were 
found. Effects on blood pressure of estrogens are attributed to retention of salt and 
water by an effect on the renin-angiotensin system. However, no changes in blood 
pressure were described after either chronic oral conjugated estradiol or percutaneous 
ITß-estradiol administration, although plasma renin substrate increased in the group 
using oral estradiol.29 Again, these influences are present during chronic 
administration and hence can not be expected just after short term administration. 
Surprisingly, a decrease in diastolic and mean arterial blood pressure and an increase 
in heart rate were found after ITB-estradiol administration in our study, although only 
in the Raynaud patients. In contrast, FBF and FVR as well as laser Doppler resistance 
in the skin did not change significantly in this group. 
In conclusion, no major influence of either 17ß-estradiol or progesterone on finger 
skin circulation could be demonstrated after single-dose oral administration either in 
healthy female volunteers nor in female patients with primary RP. Further studies are 
needed to investigate the effect of long-term administration and the effect of exposure 
to a combination of 17fl-estradiol and progesterone. In this study no explanation could 
be found for the higher prevalence of RP in females and for the hormonal influence 
on the complaints of Raynaud patients. 
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CHAPTER 11 
SUMMARY AND CONCLUSIONS 
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In this thesis we presented several epidemiological, methodological and clinical studies 
on vasospastic syndromes. As outlined in the general introduction, we tried to find 
answers to the following questions: 
1. What is the prevalence in males and females of both migraine and Raynaud's 
phenomenon (RP)? Do these disorders often occur simultaneously? 
2. Do female sex hormones have an effect on these vasospastic complaints? Do sex 
hormones influence the regulation of peripheral blood flow? And if so, which of 
the sex hormones could be responsible? 
The first part of this thesis deals with epidemiological aspects of RP and migraine. 
For migraine (Chapter 2) the average annual prevalence was 4 per 1000 men and 
16 per 1000 women. Of 140 patients diagnosed as having migraine by their general 
practitioners 85% fulfilled the criteria of the International Classification of Health 
Problems in Primary Care. In this group the female to male ratio was 5:1. Despite 
substantial overlap migraine differed from non-vasospastic tension headache regarding 
photo- and phonophobia, duration and provoking factors. RP was present in 15% of 
the migraine patients (n = 102) but also in 16% of the patients with tension headaches 
(n=56)> almost exclusively women. Especially the complaints of migraine were 
perceived to increase during and before menstruation and to decrease during 
pregnancy and menopause. 
To assess the prevalence of RP (Chapter 3) 508 subjects (202 men and 306 
women) visiting their general practitioners completed a questionnaire. When strict 
criteria (cold digits, numbness and at least a biphasic discoloration) were applied, 
prevalence was 0.5% in males and 2.9% in females. When monophasic discolorations 
were included, prevalence increased largely (by 5.4% and 7.5%, respectively). 
Complaints of cold digits were present in 22.7% of the males and in 35% of the 
females. Therefore we conclude that the variation in prevalence of RP, as reported 
in the literature, can be explained to a large extent by differences in definition. 
At the out-patient clinic a detailed questionnaire was completed by 130 primary 
Raynaud patients (31 males, 99 females), whereas (for the duration of three months) 
27 females kept a diary with daily registration of frequency, severity and duration of 
the vasospastic attacks (Chapter 4). From the results of the questionnaire it turned out 
that complaints decreased during pregnancy in 6 out of 23 females. No influence of 
the menopause or the use of oral contraceptives was found. In some phase of the 
menstrual cycle an exacerbation was reported by 15 out of 80 females. The diaries, 
however, did not support the existence of influence of the menstrual cycle phase. 
Migraine was present in 21% of the Raynaud patients. We conclude that in contrast 
to most reports in literature and contrary to the results of laboratory research, most 
females do not experience an important influence of their sex hormonal status on the 
frequency, duration and severity of their vasospastic attacks. 
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The second part of this thesis comprises studies on the finger skin blood flow. We 
first discuss the finger cooling test we have used in these studies. During standardized 
cold challenge the finger skin temperature and the laser Doppler flux were measured. 
As described in Chapter S, we did not find any relation between subjective complaints 
of RP, recorded in a diary, and the objective measurement of the finger blood flow 
during cooling. In contrast to findings obtained in a previous study in a small selected 
group, the reproducibility of the finger cooling test appeared to be only moderate. 
Laser Doppler readings showed a high variability and a poor reproducibility when 
compared with temperature measurements, particularly in the group of healthy 
subjects (Chapter 6). There were important differences in response to cold provocation 
between males and females both in healthy subjects and in Raynaud patients (Chapter 
7): the skin blood flow in females was much lower. Although the finger skin 
temperature and the laser Doppler flux are significantly higher in the group of healthy 
subjects compared with the group of Raynaud patients, the diagnostic value of the 
finger cooling test in individual cases is limited: when a specificity of 70% was 
assumed a sensitivity of between 55% and 81% for the different parameters was 
obtained. 
In Chapter 8 we show that, although we did not find an influence of the menstrual 
cycle on complaints of RP (see Chapter 4), the finger blood flow varies significantly 
within one menstrual cycle. There was a poor recovery after cooling in the mid-luteal 
phase (with high endogenous levels of both 17ß-estradiol and progesterone) compared 
with the best recovery in the pre-ovulatory phase (with high levels of 17ß-estradiol 
and low levels of progesterone). Within subjects we found a positive correlation 
between the 17ß-estradiol/progesterone ratio and the mean finger skin temperature 
during recovery, suggesting that besides the absolute concentrations of the different 
sex hormones their ratio may be important. 
In Chapter 9 we compare males and females with different hormonal status using 
the finger heating and cooling test. Women using oral contraceptives and 
premenopausal women showed the most pronounced vasodilation during heating as 
well as the most pronounced vasoconstriction during cooling, while in the recovery 
period after cooling vasoconstriction endured. Males and postmenopausal women 
showed less vasodilation during heating, less vasoconstriction during cooling and 
recovered more rapidly after cooling. We concluded that vascular reactivity towards 
both heat and cold challenge seems to be enhanced by both synthetic and natural 
estrogens and progestagens. The findings in the postmenopausal and male group could 
be ascribed to the absence of female sex hormones or, alternatively, to the presence 
of androgens in (relatively) high concentrations. However, rather than the 
concentration of a specific sex hormone the ratio between 170-estradiol, progesterone 
or testosterone may be critical. 
In the placebo controlled and double blind study in Chapter 10 no evidence is 
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found for the influence of either 17ß-estradiol or progesterone on the fìnger skin 
circulation after single-dose oral administration, both in healthy subjects and in 
Raynaud patients. There were no significant relations between hormone levels and 
differences in finger skin temperature and laser Doppler flux. Further studies are 
needed to investigate the effects of chronic exposure to a single hormone and of 
combined exposure to ITB-estradiol and progesterone. 
In conclusion, prevalence of both migraine and RP differs between males and females. 
For women with migraine the relationship between their migraine and their hormonal 
status is much more apparent than for women with non-vasospastic tension headache. 
In RP this relationship is less clear. Measurement of the finger skin blood flow clearly 
shows sex differences and an influence of the hormonal status in females. However, 
single-dose administration of the female sex hormones exerts no relevant influence 
on the finger skin perfusion. Although it still seems likely that sex hormones may play 
an important role, we cannot attribute the observed sex differences and the variation 
in skin blood flow during life to any specific sex hormone. 
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INLEIDING 
Vasospasme (vaatwandspasme) 
Vasospasme veroorzaakt de aanvallen van witte, blauwe en rode verkleuringen van 
de vingers of de tenen, onder invloed van koude of stress, bij het fenomeen van 
Raynaud ('dode vingers'). Ook bij migraine speelt vasospasme een belangrijke rol, 
of als primaire oorzaak of secundair aan veranderingen in de hersenen. Verder is 
bekend dat vasospasme ook voorkomt in bloedvaten van andere organen, zoals het 
hart en de longen. 
Een patiënt kan last hebben van zowel het fenomeen van Raynaud als van 
migraine. Er zijn dan ook aanwijzingen dat een gemeenschappelijke factor 
verantwoordelijk zou kunnen zijn voor het optreden van vasospasme in meerdere 
vaatgebieden. 
Epidemiologie 
De diagnose 'fenomeen van Raynaud' wordt zelden opgenomen in registraties in de 
huisartspraktijk. Dit geeft aan dat de huisarts de klachten van het fenomeen van 
Raynaud niet onderkent of dat de verschijnselen ervan niet vaak worden 
gepresenteerd. Inderdaad blijkt uit studies dat voor de meeste mensen de klachten niet 
ernstig of alarmerend genoeg zijn om een arts te consulteren. De in 
bevolkingsonderzoeken gerapporteerde prevalentie (het vóórkomen) varieert echter van 
5% tot 20%, afhankelijk van de gebruikte definitie, het lokale klimaat en de 
samenstelling (bijvoorbeeld wat betreft geslacht of leeftijd) van de onderzochte groep. 
Voor veel mensen zijn de klachten van het fenomeen van Raynaud zeer onaangenaam 
in het dagelijkse leven of bij het werken in een koude omgeving, zeker in het koude 
en natte Westeuropese klimaat. 
De prevalentie van migraine ligt tussen de 2% en 25%. De verschillen zijn te 
wijten aan de geslachtsverdeling en de leeftijdsopbouw van de onderzochte groep, en 
de gebruikte criteria om de diagnose te stellen. Vaak is het moeilijk om migraine te 
onderscheiden van andere soorten hoofdpijn, te meer daar er waarschijnlijk 
overgangen bestaan: van spanningshoofdpijn via migraine zonder naar migraine met 
neurologische verschijnselen. Hoewel migraine niet zo vaak voorkomt als andere 
vormen van hoofdpijn, is het vanwege de ernst van de klachten voor patiënten een 
belangrijk probleem. 
Invloed van vrouwelijke geslachtshormonen 
In de literatuur wordt vermeld dat het fenomeen van Raynaud tussen de 2 en 9 maal 
Samenvatting 137 
vaker voorkomt bij vrouwen. Ook uit experimentele studies blijken sekse-verschillen: 
de gemeten vingerhuiddoorbloeding bij premenopauzale vrouwen is tot de helft lager 
dan bij mannen en bij vrouwen na de menopauze. Ook is beschreven dat er variaties 
in vingerhuiddoorbloeding optreden tijdens de menstruele cyclus. In deze laatste 
studies werden echter geen eenduidige veranderingen gevonden in een bepaalde fase 
van de cyclus en tevens ontbraken correlaties met de circulerende vrouwelijke 
geslachtshormonen 17ß-oestradiol en progesteron. In een enkel geval is beschreven 
dat tijdens zwangerschap de klachten verminderen. Het gebruik van de pil zou de 
subjectieve klachten doen verergeren, hoewel in een experimentele studie de gemeten 
vingerhuiddoorbloeding juist toenam. 
Interessant is het dat ook migraine vaker voorkomt bij vrouwen. Men neemt aan 
dat er een relatie met de menstruele cyclus is, hoewel ook hier geen duidelijke fase 
aangewezen kan worden waarin de klachten bij iedereen verergeren. Een verergering, 
maar ook een vermindering van de hoofdpijnaan vallen tijdens pilgebruik, tijdens 
zwangerschap en na de menopauze is beschreven. 
Al deze bevindingen wijzen in de richting van een invloed van geslachtshormonen 
op het ontstaan van vasospasme. Helaas zijn er geen studies waarin een relatie wordt 
gevonden tussen de normaal aanwezige geslachtshormonen en veranderingen in de 
vingerhuiddoorbloeding of het optreden van migraine-aanvallen. Bovendien maken de 
uiteenlopende resultaten van de eerder genoemde studies het onmogelijk een bepaald 
hormoon aan te wijzen dat verantwoordelijk zou zijn voor het optreden van 
vasospasme. Kortom, er bestaat nog veel onduidelijkheid. In dierstudies is wel een 
invloed aangetoond van zowel natuurlijke als synthetische oestrogenen, progestagenen 
en androgenen op verschillende vaatgebieden. 
De verandering in de doorbloeding van de vingerhuid als reactie op koude wordt 
geregeld door het sympathisch zenuwstelsel. De huidbloedvaten zijn zodoende 
belangrijk bij de temperatuurregulatie. Bij stimulatie van het sympathisch zenuwstelsel 
door koude, maar ook bij stress, komen catecholamines (adrenaline en noradrenaline) 
vrij die verschillende receptoren in de vaatwand stimuleren, zodat vasoconstrictie 
(vaatvemauwing) of vasodilatatie (vaatverwijding) optreedt in de huidvaten. Een 
geringe stoornis ergens in dit complexe systeem zou al tot een aanzienlijk vasospasme 
kunnen leiden, zoals door Maurice Raynaud al in 1862 werd verondersteld. Er zijn 
onderzoeken die wijzen op een invloed van oestrogenen op het sympathisch 
zenuwstelsel in die zin dat oestrogenen de hoeveelheid vasoconstrictieve a2-receptoren 
in de bloedvatwand zouden doen toenemen. Ook bij het ontstaan van migraine wordt 
een rol toegekend aan het sympathisch zenuwstelsel, dat op zijn beurt weer beïnvloed 
zou kunnen worden door geslachtshormonen. Wellicht kunnen geslachtshormonen 
vasospasme induceren via beïnvloeding van het sympathisch zenuwstelsel. 
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Meettechnieken en provocatietesten 
Om vasospasme te objectiveren dient de vingerhuiddoorbloeding gemeten te worden. 
Het kwantificeren van de perifere circulatie is echter moeilijk, omdat onder normale 
omstandigheden de huiddoorbloeding aan sterk varieert, met grote veranderingen in 
een zeer korte periode onder invloed van diverse stimuli. Er worden verschillende 
koude-provocatietesten gebruikt om vasospasme te bestuderen. Sommige onderzoekers 
maken gebruik van lokale koeling, anderen koelen de ene en meten aan de andere 
hand en weer anderen koelen het gehele lichaam. Evenzo wordt een heel scala aan 
meettechnieken gebruikt. Er is daarom weinig uniformiteit in deze testen. Ze worden 
meestal niet voldoende gestandariseerd uitgevoerd, en de reproduceerbaarheid noch 
de diagnostische waarde ervan zijn vastgesteld. 
Samenvattend werd geprobeerd een antwoord te vinden op de volgende vragen: 
1. Wat is de prevalentie van migraine en het fenomeen van Raynaud bij mannen en 
bij vrouwen. Komen deze aandoeningen vaak gecombineerd voor? 
2. Hebben vrouwelijke geslachtshormonen een invloed op de klachten van patiënten 
met deze vasospastische aandoeningen? Beïnvloeden vrouwelijke geslachts-
hormonen de perifere circulatie? Welke van de geslachtshormonen is in dat geval 
verantwoordelijk? 
INHOUD VAN DIT PROEFSCHRIFT 
In het eerste deel worden epidemiologische aspecten van migraine en het fenomeen 
van Raynaud bestudeerd. 
Om de invloed van vrouwelijke geslachtshormonen te onderzoeken, zijn de 
prevalentie bij mannen en vrouwen en de invloed van respectievelijk menarche, 
menopauze, zwangerschap, pilgebruik en de fase van de menstruele cyclus bestudeerd 
bij patiënten met migraine of het fenomeen van Raynaud. 
Hoofdstuk 2 beschrijft de prevalentie van migraine in de huisartspraktijk, zoals die 
volgens specifieke criteria geregistreerd wordt in de Continue Morbiditeitsregistratie 
(de CMR). Verder is gekeken naar het tegelijkertijd voorkomen van het fenomeen van 
Raynaud en andere vasospastische aandoeningen en naar de samenhang met stress en 
vrouwelijke geslachtshormonen. Een controlegroep met (niet-vasospastische) 
spanningshoofdpijn werd geselecteerd en vergeleken met de migrainegroep. 
In Hoofdstuk 3 wordt de prevalentie van het fenomeen van Raynaud beschreven 
en de invloed van verschillende criteria die gebruikt worden om deze diagnose te 
stellen. Omdat deze diagnose niet was opgenomen in de CMR, is een grote groep 
patiënten uit verschillende huisartspraktijken ondervraagd. 
In Hoofdstuk 4 wordt de invloed van vrouwelijke geslachtshormonen op de 
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subjectieve klachten van het fenomeen van Raynaud onderzocht. 
Het tweede gedeelte van dit proefschrift bevat studies over de gemeten 
vingerhuiddoorbloeding. We gebruikten een gestandariseerde vingerkoelingstest (5 
minuten lokale afkoeling in een waterbad van 160C, waarna een herstelperiode van 
20 minuten) met registratie van de vingerhuidtemperatuur en de laser Doppler flux. 
Deze laatste meetmethode maakt gebruik van laserlicht dat op de vingerhuid valt. Dit 
licht ondergaat door de stromende rode bloedcellen een frequentie-verschuiving 
(Doppler-effect). Een deel van dit teruggekaatste licht wordt weer opgevangen, en via 
het Doppler-principe omgerekend in 'rode-bloedcelsnelheden': een maat voor de 
bloeddoorstroming. 
In Hoofdstuk S wordt de relatie tussen de resultaten van deze test en de subjectieve 
ernst van de klachten van patiënten met het fenomeen van Raynaud bestudeerd. De 
reproduceerbaarheid van de test bij een groep van 90 personen wordt beschreven in 
Hoofdstuk 6. In Hoofdstuk 7 worden de diagnostische waarde van deze test en de 
verschillen in testresultaten tussen mannen en vrouwen beschreven. 
Om de cyclische invloed van vrouwelijke geslachtshormonen te bestuderen, werd 
de vingerhuiddoorbloeding bestudeerd in verschillende fasen van de menstruele cyclus 
bij gezonde vrijwilligsters (Hoofdstuk 8). 
Om de test beter te standariseren (er werd gestart met een waterbad van 30oC, 
waardoor de uitgangswaarde van de vingertemperatuur zoveel mogelijk gelijk gemaakt 
werd) en om ook een warmteprovocatie toe te voegen (10 minuten in water van 
450C), werd een gecombineerde vingerverwarmings- en vingerkoelingstest uitgevoerd. 
Met deze test werden verschillen in vingerhuiddoorbloeding tussen groepen 
proefpersonen met een verschil in hormonale status bestudeerd: mannen en drie 
groepen vrouwen: pilgebmiksters, premenopauzale en postmenopauzale vrouwen 
(Hoofdstuk 9). 
Tot slot onderzochten we in een dubbel-blinde, placebo-gecontroleerde studie de 
invloed van eenmalige toediening van de natuurlijke vrouwelijke geslachtshormonen 
17ß-oestradiol en progesteron op de perifere circulatie bij gezonde vrijwilligsters en 
bij patiënten met een primair fenomeen van Raynaud (Hoofdstuk 10). 
RESULTATEN EN CONCLUSIES 
De jaarlijkse prevalentie van migraine in de CMR was 4 per 1000 mannen en 16 per 
1000 vrouwen (Hoofdstuk 2). Migraine verschilde wat betreft de duur van de 
hoofdpijn, de begeleidende verschijnselen, provocerende factoren en medicijngebruik 
duidelijk van (niet-vasospastische) spanningshoofdpijn. Het fenomeen van Raynaud 
was aanwezig bij 15% van de migraine-patiënten en bij 16% van de groep met 
spanningshoofdpijn, bijna uitsluitend bij vrouwen. Vooral migraine verergerde tijdens 
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en kort voor de menstruatie en verbeterde tijdens zwangerschap en de menopauze. 
Om de prevalentie van het fenomeen van Raynaud te bepalen vulden 508 patiënten 
die hun huisarts bezochten een vragenlijst in. Indien 'strenge' criteria werden 
toegepast (koude vingers, doof gevoel en een bi- of trifasische verkleuring) was de 
prevalentie 0,5% bij mannen en 2,9% bij vrouwen. Als ook monofasische 
verkleuringen werden meegerekend, steeg de prevalentie tot 22,7% bij mannen en 
35,0% bij vrouwen. Daarom wordt in Hoofdstuk 3 geconcludeerd dat een groot 
gedeelte van de variatie in prevalentiecijfers in de literatuur berust op de verschillen 
in de gebruikte definities. 
Onder de patiënten met het fenomeen van Raynaud die gecontroleerd worden op 
de polikliniek Inwendige Geneeskunde van het Academisch Ziekenhuis Nijmegen werd 
een enquête gehouden, om de invloed van de hormonale status op de klachten te 
onderzoeken. Een aantal van deze vrouwen noteerde gedurende drie maanden 
dagelijks in een dagboek de emst, de frequentie en de duur van de verkleuringen. Uit 
de enquête bleek dat de klachten in een aantal gevallen tijdens de zwangerschap 
verminderden. Er werd geen invloed gevonden van de menopauze of van pilgebruik. 
Een verergering van de klachten in een bepaalde fase van de menstruele cyclus werd 
gevonden bij enkele van de vrouwen in de enquête, maar deze bevinding werd niet 
gesteund door de resultaten van het dagboekonderzoek. Migraine kwam voor bij 21 % 
van deze Raynaud-patiënten. We concluderen derhalve, dat vrouwen in het dagelijkse 
leven geen belangrijke invloed ervaren van vrouwelijke geslachtshormonen op de 
klachten van het fenomeen van Raynaud (Hoofdstuk 4). Dit is in tegenstelling met wat 
in de literatuur beweerd wordt en in tegenstelling met de resultaten van experimenteel 
circulatie-onderzoek. 
In het tweede gedeelte van het proefschrift wordt eerst de gebruikte provocatietest 
besproken. In Hoofdstuk 5 wordt beschreven dat er geen relatie is tussen de 
subjectieve klachten van patiënten en de meetresultaten. In tegenstelling tot een 
eerdere studie, uitgevoerd in een kleine geselecteerde groep, bleek de 
reproduceerbaarheid van de vingerkoelingstest matig. Vooral de laser Doppler 
metingen vertoonden grote variatie en de reproduceerbaarheid ervan was slechter dan 
die van de temperatuurmetingen, vooral in de groep van de gezonde proefpersonen 
(Hoofdstuk 6). Vrouwen hadden een lagere vingerhuiddoorbloeding dan mannen. 
Hoewel de vingerhuiddoorbloeding bij patiënten met een fenomeen van Raynaud lager 
was dan bij gezonde vrijwilligers, bleek de diagnostische waarde van deze test in 
individuele patiënten matig, zowel vanwege de matige specificiteit (percentage terecht 
als gezond geclassificeerden) als vanwege de matige sensitiviteit (percentage terecht 
als Raynaud-patiënt geclassificeerden). 
In Hoofdstuk 8 wordt aangetoond dat, ondanks het ontbreken van een invloed van 
de menstruele cyclus op de klachten, de gemeten vingerhuiddoorbloeding een duidelijk 
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cyclische variatie vertoont. In de luteale fase (hoge concentraties van oestradiol en 
progesteron) vertoonden de vrouwen een slechter herstel na koelen in vergelijking met 
het beste herstel na koelen in de pre-ovulatoire fase (hoge concentratie oestradiol, lage 
concentratie progesteron). Een positieve correlatie werd gevonden tussen de 
oestradiol/progesteron-ratio en de resultaten in de herstelperiode. Dit suggereert dat 
de verhouding tussen de verschillende geslachtshormonen belangrijker is dan de 
absolute concentraties van beide hormonen. 
In Hoofdstuk 9 worden de resultaten van de verwarmings- en afkoelingstest van 
mannen en verschillende groepen vrouwen vergeleken. Pilgebruiksters en 
premenopauzale vrouwen lieten een sterkere vasodilatatie na verwarmen en een 
sterkere vasoconstrictie na afkoelen zien dan mannen en postmenopauzale vrouwen. 
We concludeerden dat de vasculaire reactiviteit na verwarmen en afkoelen verhoogd 
lijkt in de aanwezigheid van zowel synthetische als natuurlijke vrouwelijke 
geslachtshormonen. Een verklaring voor de resultaten bij mannen en postmenopauzale 
vrouwen zou de lage concentratie vrouwelijke geslachtshormonen, dan wel de relatief 
hoge concentratie mannelijke geslachtshormonen kunnen zijn. Ook hier lijkt voor de 
hand te liggen dat niet de absolute hoeveelheid van een bepaald geslachtshormoon, 
maar de onderlinge verhouding het belangrijkst is. 
In de dubbel-blinde, placebo-gecontroleerde laatste studie (Hoofdstuk 10) werd 
geen duidelijke invloed van eenmalig toegediend oestradiol en progesteron op de 
vingerhuiddoorbloeding gevonden. Er waren geen significante correlaties tussen de 
hormoonspiegels en de testresultaten. Er zijn meer studies nodig om de effecten van 
chronische of van gecombineerde toediening van geslachtshormonen te bestuderen. 
We vinden duidelijke verschillen tussen mannen en vrouwen in de prevalentie van 
zowel migraine als van het fenomeen van Raynaud. Beide aandoeningen komen 
inderdaad vaak samen voor. 
Vrouwen met migraine kunnen beter dan vrouwen met spanningshoofdpijn een 
verband tussen de hormonale status en hun klachten aangeven; bij vrouwen met het 
fenomeen van Raynaud is dit verband niet zo duidelijk. Meting van de 
vingerhuiddoorbloeding laat een duidelijke invloed van sekse en hormonale status zien. 
Desondanks heeft eenmalige toediening van 17ß-oestradiol en van progesteron geen 
invloed op de vingerhuiddoorbloeding. Hoewel het duidelijk lijkt dat 
geslachtshormonen de vaatwandreactiviteit beïnvloeden, kunnen de gevonden sekse-
verschillen nog niet goed verklaard worden en kan de variatie in verschijnselen en de 
gemeten vingerhuiddoorbloeding bij verschillende hormoonspiegels nog niet aan een 
specifiek hormoon toegeschreven worden. 
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